_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,baseline-decision,orig_e1,orig_e2,relation,sent_id,orig_sentence,term1,term2
725480614,5/25/2015 11:40:10,1642984667,5/25/2015 11:39:52,false,clixsense,1,24329110,USA,FL,Tampa,66.192.17.130,92,56,,,98,67,THRUSH,FLUCONAZOLE,THRUSH,92,56,FLUCONAZOLE,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.",92,56,92,56,-1,98,67,TWrex-cause,800455,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors",thrush,fluconazole
725480614,5/25/2015 11:56:53,1642987957,5/25/2015 11:56:38,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,92,56,,,98,67,THRUSH,FLUCONAZOLE,THRUSH,92,56,FLUCONAZOLE,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.",92,56,92,56,-1,98,67,TWrex-cause,800455,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors",thrush,fluconazole
725480614,5/25/2015 12:02:21,1642988975,5/25/2015 12:01:51,false,prodege,1,22429517,USA,VA,Charlottesville,76.5.71.105,92,56,,,98,67,THRUSH,FLUCONAZOLE,THRUSH in patients responding to combination antiviral therapy including protease inhibitors.,92-99-102-111-122-125-137-147-155-165-174,56-68-80,FLUCONAZOLE suppressive therapy,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.",92,56,92,56,-1,98,67,TWrex-cause,800455,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors",thrush,fluconazole
725480614,5/25/2015 12:42:32,1642997774,5/25/2015 12:42:13,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,92,56,,,98,67,THRUSH,FLUCONAZOLE,THRUSH,92,56-68-80,FLUCONAZOLE suppressive therapy,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.",92,56,92,56,-1,98,67,TWrex-cause,800455,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors",thrush,fluconazole
725480614,5/25/2015 12:43:07,1642997972,5/25/2015 12:42:34,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,92,56,,,98,67,THRUSH,FLUCONAZOLE,suppressive therapy for THRUSH,68-80-88-92,42-53-56-68-80,Withdrawal of FLUCONAZOLE suppressive therapy,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.",92,56,92,56,-1,98,67,TWrex-cause,800455,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors",thrush,fluconazole
725480614,5/25/2015 12:49:40,1642999066,5/25/2015 12:49:07,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,92,56,,,98,67,THRUSH,FLUCONAZOLE,THRUSH,92,56,FLUCONAZOLE,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.",92,56,92,56,-1,98,67,TWrex-cause,800455,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors",thrush,fluconazole
725480614,5/25/2015 12:51:57,1642999551,5/25/2015 12:51:20,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,92,56,,,98,67,THRUSH,FLUCONAZOLE,THRUSH,92,56-68-80,FLUCONAZOLE suppressive therapy,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.",92,56,92,56,-1,98,67,TWrex-cause,800455,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors",thrush,fluconazole
725480614,5/25/2015 12:56:03,1643000260,5/25/2015 12:55:48,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,92,56,,,98,67,THRUSH,FLUCONAZOLE,suppressive therapy for THRUSH,68-80-88-92,56-68-80,FLUCONAZOLE suppressive therapy,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.",92,56,92,56,-1,98,67,TWrex-cause,800455,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors",thrush,fluconazole
725480614,5/25/2015 12:56:54,1643000452,5/25/2015 12:56:43,false,clixsense,1,6352682,GBR,H9,London,2.122.19.138,92,56,,,98,67,THRUSH,FLUCONAZOLE,suppressive therapy for THRUSH in patients responding,68-80-88-92-99-102-111,38-42-53-56-68-80-88,al. Withdrawal of FLUCONAZOLE suppressive therapy for,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.",92,56,92,56,-1,98,67,TWrex-cause,800455,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors",thrush,fluconazole
725480614,5/25/2015 13:06:50,1643002191,5/25/2015 13:06:24,false,prodege,1,6309240,USA,CA,San Diego,50.113.93.215,92,56,,,98,67,THRUSH,FLUCONAZOLE,THRUSH,92,56,FLUCONAZOLE,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.",92,56,92,56,-1,98,67,TWrex-cause,800455,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors",thrush,fluconazole
725480615,5/25/2015 08:16:22,1642938865,5/25/2015 08:16:05,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,277,299,,,285,310,DISORDER,LAMOTRIGINE,bipolar DISORDER,269-277,299,LAMOTRIGINE.,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine.",277,299,277,299,-1,285,310,TWrex-cause,800992,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine",disorder,lamotrigine
725480615,5/25/2015 08:21:00,1642939830,5/25/2015 08:20:40,false,gifthunterclub,1,30901412,GBR,G5,Margate,85.210.116.56,277,299,,,285,310,DISORDER,LAMOTRIGINE,seizure disorders adults with bipolar DISORDER who received lamotrigine.,184-257-264-269-277-286-290-299-192,264-277-286-290-299-269,with bipolar disorder who received LAMOTRIGINE.,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine.",277,299,277,299,-1,285,310,TWrex-cause,800992,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine",disorder,lamotrigine
725480615,5/25/2015 08:40:23,1642943234,5/25/2015 08:40:03,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,277,299,,,285,310,DISORDER,LAMOTRIGINE,bipolar DISORDER,269-277,299,LAMOTRIGINE.,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine.",277,299,277,299,-1,285,310,TWrex-cause,800992,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine",disorder,lamotrigine
725480615,5/25/2015 08:45:59,1642944113,5/25/2015 08:45:39,false,elite,1,26544151,GBR,"","",213.205.252.245,277,299,,,285,310,DISORDER,LAMOTRIGINE,DISORDER,277,299,LAMOTRIGINE.,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine.",277,299,277,299,-1,285,310,TWrex-cause,800992,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine",disorder,lamotrigine
725480615,5/25/2015 08:53:42,1642945485,5/25/2015 08:53:28,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,277,299,,,285,310,DISORDER,LAMOTRIGINE,bipolar DISORDER,269-277,299,LAMOTRIGINE.,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine.",277,299,277,299,-1,285,310,TWrex-cause,800992,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine",disorder,lamotrigine
725480615,5/25/2015 08:58:35,1642946209,5/25/2015 08:58:23,false,neodev,1,11001780,AUS,07,Elwood,14.201.215.31,277,299,,,285,310,DISORDER,LAMOTRIGINE,bipolar DISORDER,269-277,299,LAMOTRIGINE.,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine.",277,299,277,299,-1,285,310,TWrex-cause,800992,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine",disorder,lamotrigine
725480615,5/25/2015 09:05:38,1642947214,5/25/2015 09:04:44,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,277,299,,,285,310,DISORDER,LAMOTRIGINE,"Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively, 1 and in no adults with bipolar DISORDER who received lamotrigine.",36-47-58-63-74-82-86-94-102-105-113-121-126-131-140-143-148-151-157-160-167-170-179-184-192-202-206-215-228-243-247-251-257-264-269-277-286-290-299-254,36-47-58-63-74-82-86-94-102-105-113-121-126-131-140-143-148-151-157-160-167-170-179-184-192-202-206-215-228-243-247-251-254-257-264-277-286-290-299-269,"Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively, 1 and in no adults with bipolar disorder who received LAMOTRIGINE.","1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine.",277,299,277,299,-1,285,310,TWrex-cause,800992,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine",disorder,lamotrigine
725480615,5/25/2015 09:08:16,1642947656,5/25/2015 09:07:20,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,277,299,,,285,310,DISORDER,LAMOTRIGINE,bipolar DISORDER,269-277,299,LAMOTRIGINE.,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine.",277,299,277,299,-1,285,310,TWrex-cause,800992,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine",disorder,lamotrigine
725480615,5/25/2015 09:25:09,1642949982,5/25/2015 09:24:59,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,277,299,,,285,310,DISORDER,LAMOTRIGINE,bipolar DISORDER,269-277,299,LAMOTRIGINE.,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine.",277,299,277,299,-1,285,310,TWrex-cause,800992,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine",disorder,lamotrigine
725480615,5/25/2015 09:28:37,1642950726,5/25/2015 09:28:26,false,clixsense,1,6340330,USA,NY,Canajoharie,67.248.115.74,277,299,,,285,310,DISORDER,LAMOTRIGINE,DISORDER,277,299,LAMOTRIGINE.,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine.",277,299,277,299,-1,285,310,TWrex-cause,800992,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with bipolar disorder who received lamotrigine",disorder,lamotrigine
725480616,5/25/2015 10:11:42,1642957629,5/25/2015 10:11:27,false,clixsense,1,31482589,NLD,"","",31.201.11.16,25,8,,,31,10,CHOREA,HD,CHOREA,25,8,HD,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate.",25,8,25,8,1,31,10,TWrex-cause,812691,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate",chorea,HD
725480616,5/25/2015 10:12:46,1642957880,5/25/2015 10:12:20,false,clixsense,1,6330007,AUS,02,Sydney,49.195.38.217,25,8,,,31,10,CHOREA,HD,CHOREA,25,8,HD,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate.",25,8,25,8,1,31,10,TWrex-cause,812691,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate",chorea,HD
725480616,5/25/2015 10:14:35,1642958173,5/25/2015 10:14:16,false,vivatic,1,13889585,GBR,A1,Dagenham,2.28.66.9,25,8,,,31,10,CHOREA,HD,CHOREA,25,8-11,"HD patients,","In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate.",25,8,25,8,1,31,10,TWrex-cause,812691,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate",chorea,HD
725480616,5/25/2015 10:25:20,1642961025,5/25/2015 10:25:03,false,clixsense,1,6338946,CAN,ON,Brampton,216.58.108.145,25,8,,,31,10,CHOREA,HD,CHOREA,25,8,HD,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate.",25,8,25,8,1,31,10,TWrex-cause,812691,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate",chorea,HD
725480616,5/25/2015 10:40:07,1642971114,5/25/2015 10:39:41,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,25,8,,,31,10,CHOREA,HD,CHOREA,25,8,HD,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate.",25,8,25,8,1,31,10,TWrex-cause,812691,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate",chorea,HD
725480616,5/25/2015 10:41:14,1642972078,5/25/2015 10:40:52,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,25,8,,,31,10,CHOREA,HD,CHOREA,25,8-11,"HD patients,","In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate.",25,8,25,8,1,31,10,TWrex-cause,812691,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate",chorea,HD
725480616,5/25/2015 10:45:09,1642974561,5/25/2015 10:44:54,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,25,8,,,31,10,CHOREA,HD,CHOREA,25,0-8-21,In HD the,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate.",25,8,25,8,1,31,10,TWrex-cause,812691,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate",chorea,HD
725480616,5/25/2015 10:45:52,1642974740,5/25/2015 10:45:41,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,25,8,,,31,10,CHOREA,HD,"HD patients, the CHOREA becomes severe and",8-11-21-25-32-40-47,0-3-8-11-21-25,"In some HD patients, the chorea","In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate.",25,8,25,8,1,31,10,TWrex-cause,812691,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate",chorea,HD
725480616,5/25/2015 10:48:02,1642975123,5/25/2015 10:47:30,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,25,8,,,31,10,CHOREA,HD,CHOREA,25,8-11,"HD patients,","In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate.",25,8,25,8,1,31,10,TWrex-cause,812691,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate",chorea,HD
725480616,5/25/2015 10:50:23,1642975499,5/25/2015 10:50:04,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,25,8,,,31,10,CHOREA,HD,"HD patients, the CHOREA becomes severe",8-11-21-25-32-40,0-3-8-11-21-25-32-40-51-59,"In some HD patients, the chorea becomes severe impairs function;","In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate.",25,8,25,8,1,31,10,TWrex-cause,812691,"In some HD patients, the chorea becomes severe and impairs function; in those instances, treatment is appropriate",chorea,HD
725480617,5/25/2015 10:55:05,1642976213,5/25/2015 10:54:52,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,120,46,,,128,61,LEUKEMIA,DEOXYCOFORMYCIN,hairy cell LEUKEMIA.,109-115-120,46,DEOXYCOFORMYCIN:,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.",120,46,120,46,-1,128,61,TWrex-cause,804277,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia",leukemia,deoxycoformycin
725480617,5/25/2015 11:01:18,1642977281,5/25/2015 11:00:45,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,120,46,,,128,61,LEUKEMIA,DEOXYCOFORMYCIN,Deoxycoformycin: active new drug for hairy cell LEUKEMIA.,46-66-73-77-82-109-115-120,46-63-66-73-77-95-109-115-120-105,DEOXYCOFORMYCIN: an active new drug lymphomas and hairy cell leukemia.,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.",120,46,120,46,-1,128,61,TWrex-cause,804277,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia",leukemia,deoxycoformycin
725480617,5/25/2015 11:36:45,1642984162,5/25/2015 11:36:36,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,120,46,,,128,61,LEUKEMIA,DEOXYCOFORMYCIN,hairy cell LEUKEMIA.,109-115-120,46,DEOXYCOFORMYCIN:,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.",120,46,120,46,-1,128,61,TWrex-cause,804277,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia",leukemia,deoxycoformycin
725480617,5/25/2015 11:53:44,1642987453,5/25/2015 11:53:34,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,120,46,,,128,61,LEUKEMIA,DEOXYCOFORMYCIN,LEUKEMIA.,120,46,DEOXYCOFORMYCIN:,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.",120,46,120,46,-1,128,61,TWrex-cause,804277,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia",leukemia,deoxycoformycin
725480617,5/25/2015 11:55:13,1642987632,5/25/2015 11:54:44,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,120,46,,,128,61,LEUKEMIA,DEOXYCOFORMYCIN,hairy cell LEUKEMIA.,109-115-120,46-63-66-73-77-82-86-95-105-109-115-120,DEOXYCOFORMYCIN: an active new drug for indolent lymphomas and hairy cell leukemia.,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.",120,46,120,46,-1,128,61,TWrex-cause,804277,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia",leukemia,deoxycoformycin
725480617,5/25/2015 11:57:47,1642988077,5/25/2015 11:57:26,false,prodege,1,22031444,GBR,M4,Southampton,2.98.199.6,120,46,,,128,61,LEUKEMIA,DEOXYCOFORMYCIN,hairy cell LEUKEMIA.,109-115-120,46,DEOXYCOFORMYCIN:,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.",120,46,120,46,-1,128,61,TWrex-cause,804277,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia",leukemia,deoxycoformycin
725480617,5/25/2015 12:15:02,1642991975,5/25/2015 12:14:46,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,120,46,,,128,61,LEUKEMIA,DEOXYCOFORMYCIN,LEUKEMIA.,120,46,DEOXYCOFORMYCIN:,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.",120,46,120,46,-1,128,61,TWrex-cause,804277,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia",leukemia,deoxycoformycin
725480617,5/25/2015 12:32:59,1642995803,5/25/2015 12:32:34,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,120,46,,,128,61,LEUKEMIA,DEOXYCOFORMYCIN,and hairy cell LEUKEMIA.,105-109-115-120,37-39-42-46,B et al. DEOXYCOFORMYCIN:,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.",120,46,120,46,-1,128,61,TWrex-cause,804277,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia",leukemia,deoxycoformycin
725480617,5/25/2015 12:34:54,1642996319,5/25/2015 12:34:43,false,neodev,1,32438173,USA,VA,Manassas,207.244.77.2,120,46,,,128,61,LEUKEMIA,DEOXYCOFORMYCIN,and hairy cell LEUKEMIA.,105-109-115-120,37-39-42-46-63,B et al. DEOXYCOFORMYCIN: an,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.",120,46,120,46,-1,128,61,TWrex-cause,804277,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia",leukemia,deoxycoformycin
725480617,5/25/2015 12:36:53,1642996760,5/25/2015 12:36:28,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,120,46,,,128,61,LEUKEMIA,DEOXYCOFORMYCIN,hairy cell LEUKEMIA.,109-115-120,46,DEOXYCOFORMYCIN:,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.",120,46,120,46,-1,128,61,TWrex-cause,804277,"O'Dwyer PJ, Cheson BD, Leyland-Jones B et al. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia",leukemia,deoxycoformycin
725480618,5/25/2015 08:24:18,1642940564,5/25/2015 08:23:55,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,127,18,,,145,26,SECONDARY SYPHILIS,PALLIDUM,primary and SECONDARY SYPHILIS,115-123-127-137,18,PALLIDUM,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",127 137,18,127,18,1,145,26,TWrex-cause,812466,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy",secondary syphilis,pallidum
725480618,5/25/2015 08:52:58,1642945367,5/25/2015 08:52:38,false,elite,1.0,26544151,GBR,"","",213.205.252.245,127,18,,,145,26,SECONDARY SYPHILIS,PALLIDUM,SECONDARY SYPHILIS,127-137,18,PALLIDUM,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",127 137,18,127,18,1,145,26,TWrex-cause,812466,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy",secondary syphilis,pallidum
725480618,5/25/2015 08:52:59,1642945399,5/25/2015 08:52:42,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,127,18,,,145,26,SECONDARY SYPHILIS,PALLIDUM,SECONDARY SYPHILIS,127-137,18,PALLIDUM,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",127 137,18,127,18,1,145,26,TWrex-cause,812466,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy",secondary syphilis,pallidum
725480618,5/25/2015 09:01:03,1642946556,5/25/2015 09:00:40,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,127,18,,,145,26,SECONDARY SYPHILIS,PALLIDUM,SECONDARY SYPHILIS,127-137,15-18,T. PALLIDUM,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",127 137,18,127,18,1,145,26,TWrex-cause,812466,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy",secondary syphilis,pallidum
725480618,5/25/2015 09:06:51,1642947441,5/25/2015 09:06:33,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,127,18,,,145,26,SECONDARY SYPHILIS,PALLIDUM,SECONDARY SYPHILIS,127-137,18,PALLIDUM,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",127 137,18,127,18,1,145,26,TWrex-cause,812466,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy",secondary syphilis,pallidum
725480618,5/25/2015 09:23:17,1642949781,5/25/2015 09:22:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,127,18,,,145,26,SECONDARY SYPHILIS,PALLIDUM,"T. pallidum in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",15-18-28-31-40-45-51-58-67-70-79-82-92-95-101-115-123-127-137-146-150-161-166-172-178-185-188-198-207-209-220-226-233-236,15-18-28-31-40-45-51-58-67-70-79-82-92-95-101-115-123-127-137-146-150-161-166-172-178-185-188-198-207-209-220-226-233-236,"T. PALLIDUM in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.","Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",127 137,18,127,18,1,145,26,TWrex-cause,812466,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy",secondary syphilis,pallidum
725480618,5/25/2015 09:31:26,1642951138,5/25/2015 09:30:33,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,127,18,,,145,26,SECONDARY SYPHILIS,PALLIDUM,SECONDARY SYPHILIS,127-137,11-15-18,• T. PALLIDUM,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",127 137,18,127,18,1,145,26,TWrex-cause,812466,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy",secondary syphilis,pallidum
725480618,5/25/2015 09:36:16,1642952137,5/25/2015 09:36:02,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,127,18,,,145,26,SECONDARY SYPHILIS,PALLIDUM,SECONDARY SYPHILIS,127-137,18,PALLIDUM,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",127 137,18,127,18,1,145,26,TWrex-cause,812466,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy",secondary syphilis,pallidum
725480618,5/25/2015 09:50:45,1642954269,5/25/2015 09:50:33,false,clixsense,1,26492726,GBR,C2,Halifax,2.103.117.226,127,18,,,145,26,SECONDARY SYPHILIS,PALLIDUM,SECONDARY SYPHILIS,127-137,18,PALLIDUM,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",127 137,18,127,18,1,145,26,TWrex-cause,812466,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy",secondary syphilis,pallidum
725480618,5/25/2015 09:59:54,1642955854,5/25/2015 09:58:27,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,127,18,,,145,26,SECONDARY SYPHILIS,PALLIDUM,SECONDARY SYPHILIS,127-137,15-18,T. PALLIDUM,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",127 137,18,127,18,1,145,26,TWrex-cause,812466,"Rationale: •   T. pallidum  in patients with early latent syphilis is presumed to replicate at rates approximating primary and secondary syphilis and therefore, like those early stages of syphilis, requires a relatively short course of therapy",secondary syphilis,pallidum
725480619,5/25/2015 10:07:18,1642956957,5/25/2015 10:06:45,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,139,95,,,147,113,FIBROID,LEUPROLIDE ACETATE,uterine FIBROIDS.,131-139,95-106,LEUPROLIDE ACETATE,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids.,139,95 106,139,95,-1,147,113,TWrex-cause,800845,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids,fibroid,leuprolide acetate
725480619,5/25/2015 10:09:37,1642957237,5/25/2015 10:09:24,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,139,95,,,147,113,FIBROID,LEUPROLIDE ACETATE,uterine FIBROIDS.,131-139,95-106,LEUPROLIDE ACETATE,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids.,139,95 106,139,95,-1,147,113,TWrex-cause,800845,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids,fibroid,leuprolide acetate
725480619,5/25/2015 10:12:22,1642957749,5/25/2015 10:11:55,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,139,95,,,147,113,FIBROID,LEUPROLIDE ACETATE,uterine FIBROIDS.,131-139,95-106,LEUPROLIDE ACETATE,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids.,139,95 106,139,95,-1,147,113,TWrex-cause,800845,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids,fibroid,leuprolide acetate
725480619,5/25/2015 10:14:23,1642958157,5/25/2015 10:14:13,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,139,95,,,147,113,FIBROID,LEUPROLIDE ACETATE,uterine FIBROIDS.,131-139,95-106,LEUPROLIDE ACETATE,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids.,139,95 106,139,95,-1,147,113,TWrex-cause,800845,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids,fibroid,leuprolide acetate
725480619,5/25/2015 10:23:30,1642960309,5/25/2015 10:23:15,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,139,95,,,147,113,FIBROID,LEUPROLIDE ACETATE,uterine FIBROIDS.,131-139,95-106,LEUPROLIDE ACETATE,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids.,139,95 106,139,95,-1,147,113,TWrex-cause,800845,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids,fibroid,leuprolide acetate
725480619,5/25/2015 10:28:09,1642962069,5/25/2015 10:27:53,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,139,95,,,147,113,FIBROID,LEUPROLIDE ACETATE,uterine FIBROIDS.,131-139,95-106,LEUPROLIDE ACETATE,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids.,139,95 106,139,95,-1,147,113,TWrex-cause,800845,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids,fibroid,leuprolide acetate
725480619,5/25/2015 10:36:44,1642967885,5/25/2015 10:36:24,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,139,95,,,147,113,FIBROID,LEUPROLIDE ACETATE,uterine FIBROIDS.,139-131,95-106,LEUPROLIDE ACETATE,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids.,139,95 106,139,95,-1,147,113,TWrex-cause,800845,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids,fibroid,leuprolide acetate
725480619,5/25/2015 10:39:20,1642970471,5/25/2015 10:39:05,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,139,95,,,147,113,FIBROID,LEUPROLIDE ACETATE,uterine FIBROIDS.,131-139,95-106,LEUPROLIDE ACETATE,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids.,139,95 106,139,95,-1,147,113,TWrex-cause,800845,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids,fibroid,leuprolide acetate
725480619,5/25/2015 10:43:33,1642973752,5/25/2015 10:43:19,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,139,95,,,147,113,FIBROID,LEUPROLIDE ACETATE,uterine FIBROIDS.,131-139,95-106,LEUPROLIDE ACETATE,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids.,139,95 106,139,95,-1,147,113,TWrex-cause,800845,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids,fibroid,leuprolide acetate
725480619,5/25/2015 10:43:52,1642973907,5/25/2015 10:43:38,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,139,95,,,147,113,FIBROID,LEUPROLIDE ACETATE,leuprolide acetate tibolone for uterine FIBROIDS.,95-118-127-131-139-106,81-84-90-95-106-114-118-127-139-131,25 women with LEUPROLIDE ACETATE and tibolone for uterine fibroids.,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids.,139,95 106,139,95,-1,147,113,TWrex-cause,800845,• A prospective open clinical trial evaluated the effects of 2-year treatment on 25 women with leuprolide acetate and tibolone for uterine fibroids,fibroid,leuprolide acetate
725480620,5/25/2015 09:52:42,1642954571,5/25/2015 09:52:33,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,188,157,,,191,171,EYE,CONJUNCTIVITIS,dry EYE.,184-188,157,"CONJUNCTIVITIS,","c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye.",188,157,188,157,-1,191,171,TWrex-cause,802449,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye",eye,conjunctivitis
725480620,5/25/2015 10:04:46,1642956627,5/25/2015 10:03:58,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,188,157,,,191,171,EYE,CONJUNCTIVITIS,"conjunctivitis, dry EYE.",157-188-184,157,"CONJUNCTIVITIS,","c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye.",188,157,188,157,-1,191,171,TWrex-cause,802449,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye",eye,conjunctivitis
725480620,5/25/2015 10:08:49,1642957182,5/25/2015 10:08:36,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,188,157,,,191,171,EYE,CONJUNCTIVITIS,dry EYE.,184-188,157,"CONJUNCTIVITIS,","c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye.",188,157,188,157,-1,191,171,TWrex-cause,802449,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye",eye,conjunctivitis
725480620,5/25/2015 10:10:52,1642957487,5/25/2015 10:10:26,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,188,157,,,191,171,EYE,CONJUNCTIVITIS,dry EYE.,184-188,157,"CONJUNCTIVITIS,","c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye.",188,157,188,157,-1,191,171,TWrex-cause,802449,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye",eye,conjunctivitis
725480620,5/25/2015 10:13:39,1642958004,5/25/2015 10:13:29,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,188,157,,,191,171,EYE,CONJUNCTIVITIS,dry EYE.,184-188,157,"CONJUNCTIVITIS,","c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye.",188,157,188,157,-1,191,171,TWrex-cause,802449,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye",eye,conjunctivitis
725480620,5/25/2015 10:22:38,1642960041,5/25/2015 10:22:22,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,188,157,,,191,171,EYE,CONJUNCTIVITIS,dry EYE.,184-188,157,"CONJUNCTIVITIS,","c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye.",188,157,188,157,-1,191,171,TWrex-cause,802449,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye",eye,conjunctivitis
725480620,5/25/2015 10:27:17,1642961655,5/25/2015 10:26:58,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,188,157,,,191,171,EYE,CONJUNCTIVITIS,dry EYE.,184-188,130-141-149-157,"blanching, blurred vision, CONJUNCTIVITIS,","c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye.",188,157,188,157,-1,191,171,TWrex-cause,802449,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye",eye,conjunctivitis
725480620,5/25/2015 10:34:19,1642965777,5/25/2015 10:33:26,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,188,157,,,191,171,EYE,CONJUNCTIVITIS,dry EYE.,184-188,157,"CONJUNCTIVITIS,","c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye.",188,157,188,157,-1,191,171,TWrex-cause,802449,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye",eye,conjunctivitis
725480620,5/25/2015 10:38:17,1642969430,5/25/2015 10:37:50,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,188,157,,,191,171,EYE,CONJUNCTIVITIS,dry EYE.,188-184,157-173,"CONJUNCTIVITIS, discharge,","c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye.",188,157,188,157,-1,191,171,TWrex-cause,802449,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye",eye,conjunctivitis
725480620,5/25/2015 10:43:02,1642973437,5/25/2015 10:42:43,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,188,157,,,191,171,EYE,CONJUNCTIVITIS,"Discomfort, hyperemia, pruritus, tearing, lid edema, conjunctivitis, discharge, dry EYE.",42-54-65-84-88-157-173-184-188-75,42-54-65-75-84-130-141-149-157-173-184-188-88,"Discomfort, hyperemia, pruritus, tearing, lid edema, blanching, blurred vision, CONJUNCTIVITIS, discharge, dry eye.","c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye.",188,157,188,157,-1,191,171,TWrex-cause,802449,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, conjunctivitis, discharge, dry eye",eye,conjunctivitis
725480621,5/25/2015 09:52:18,1642954524,5/25/2015 09:52:04,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,105,133,,,115,145,INFECTION,AMPHOTERICIN,fungal INFECTIONS,98-105,123-133,liposomal AMPHOTERICIN,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215.",105,133,105,133,-1,115,145,TWrex-cause,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215",infection,amphotericin
725480621,5/25/2015 10:01:58,1642956181,5/25/2015 10:01:03,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,105,133,,,115,145,INFECTION,AMPHOTERICIN,fungal INFECTIONS,98-105,123-133-146-148,liposomal AMPHOTERICIN B group,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215.",105,133,105,133,-1,115,145,TWrex-cause,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215",infection,amphotericin
725480621,5/25/2015 10:03:17,1642956357,5/25/2015 10:02:36,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,105,133,,,115,145,INFECTION,AMPHOTERICIN,fungal INFECTIONS,98-105,123-133-146-148-156,liposomal AMPHOTERICIN B group 215.,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215.",105,133,105,133,-1,115,145,TWrex-cause,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215",infection,amphotericin
725480621,5/25/2015 10:08:17,1642957114,5/25/2015 10:08:03,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,105,133,,,115,145,INFECTION,AMPHOTERICIN,fungal INFECTIONS,98-105,123-133-146-148,liposomal AMPHOTERICIN B group,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215.",105,133,105,133,-1,115,145,TWrex-cause,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215",infection,amphotericin
725480621,5/25/2015 10:09:51,1642957348,5/25/2015 10:08:42,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,105,133,,,115,145,INFECTION,AMPHOTERICIN,fungal INFECTIONS,98-105,123-133-146,liposomal AMPHOTERICIN B,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215.",105,133,105,133,-1,115,145,TWrex-cause,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215",infection,amphotericin
725480621,5/25/2015 10:22:00,1642959813,5/25/2015 10:21:27,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,105,133,,,115,145,INFECTION,AMPHOTERICIN,fungal INFECTIONS,98-105,133-146-148-123,liposomal AMPHOTERICIN B group,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215.",105,133,105,133,-1,115,145,TWrex-cause,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215",infection,amphotericin
725480621,5/25/2015 10:26:29,1642961414,5/25/2015 10:25:15,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,105,133,,,115,145,INFECTION,AMPHOTERICIN,breakthrough fungal INFECTIONS,98-105-85,123-133-146,liposomal AMPHOTERICIN B,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215.",105,133,105,133,-1,115,145,TWrex-cause,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215",infection,amphotericin
725480621,5/25/2015 10:32:19,1642964387,5/25/2015 10:31:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,105,133,,,115,145,INFECTION,AMPHOTERICIN,fungal INFECTIONS,98-105,123-133,liposomal AMPHOTERICIN,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215.",105,133,105,133,-1,115,145,TWrex-cause,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215",infection,amphotericin
725480621,5/25/2015 10:37:27,1642968605,5/25/2015 10:37:00,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,105,133,,,115,145,INFECTION,AMPHOTERICIN,fungal INFECTIONS,98-105,123-133,liposomal AMPHOTERICIN,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215.",105,133,105,133,-1,115,145,TWrex-cause,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215",infection,amphotericin
725480621,5/25/2015 10:42:33,1642973084,5/25/2015 10:42:14,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,105,133,,,115,145,INFECTION,AMPHOTERICIN,fungal INFECTIONS,98-105,133-146-148-123,liposomal AMPHOTERICIN B group,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215.",105,133,105,133,-1,115,145,TWrex-cause,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough fungal infections in the liposomal amphotericin B group ( 215",infection,amphotericin
725480622,5/25/2015 10:55:23,1642976271,5/25/2015 10:55:07,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,70,108,,,92,120,VISCERAL LEISHMANIASIS,AMPHOTERICIN,VISCERAL LEISHMANIASIS,70-79,98-108-121,liposomal AMPHOTERICIN B,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome.",70 79,108,70,108,-1,92,120,TWrex-cause,800170,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome",visceral leishmaniasis,amphotericin
725480622,5/25/2015 11:01:42,1642977350,5/25/2015 11:01:20,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,70,108,,,92,120,VISCERAL LEISHMANIASIS,AMPHOTERICIN,Short course treatment of VISCERAL LEISHMANIASIS with liposomal amphotericin B,44-50-57-67-70-79-93-98-108-121,57-67-79-93-98-108-121-70,treatment of visceral leishmaniasis with liposomal AMPHOTERICIN B,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome.",70 79,108,70,108,-1,92,120,TWrex-cause,800170,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome",visceral leishmaniasis,amphotericin
725480622,5/25/2015 11:37:00,1642984200,5/25/2015 11:36:46,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,70,108,,,92,120,VISCERAL LEISHMANIASIS,AMPHOTERICIN,VISCERAL LEISHMANIASIS,70-79,98-108-121,liposomal AMPHOTERICIN B,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome.",70 79,108,70,108,-1,92,120,TWrex-cause,800170,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome",visceral leishmaniasis,amphotericin
725480622,5/25/2015 11:53:58,1642987513,5/25/2015 11:53:46,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,70,108,,,92,120,VISCERAL LEISHMANIASIS,AMPHOTERICIN,VISCERAL LEISHMANIASIS,70-79,108,AMPHOTERICIN,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome.",70 79,108,70,108,-1,92,120,TWrex-cause,800170,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome",visceral leishmaniasis,amphotericin
725480622,5/25/2015 11:55:44,1642987773,5/25/2015 11:55:16,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,70,108,,,92,120,VISCERAL LEISHMANIASIS,AMPHOTERICIN,VISCERAL LEISHMANIASIS,70-79,98-108-121,liposomal AMPHOTERICIN B,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome.",70 79,108,70,108,-1,92,120,TWrex-cause,800170,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome",visceral leishmaniasis,amphotericin
725480622,5/25/2015 11:58:01,1642988117,5/25/2015 11:57:49,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,70,108,,,92,120,VISCERAL LEISHMANIASIS,AMPHOTERICIN,VISCERAL LEISHMANIASIS,70-79,98-108-121,liposomal AMPHOTERICIN B,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome.",70 79,108,70,108,-1,92,120,TWrex-cause,800170,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome",visceral leishmaniasis,amphotericin
725480622,5/25/2015 12:16:35,1642992298,5/25/2015 12:15:03,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,70,108,,,92,120,VISCERAL LEISHMANIASIS,AMPHOTERICIN,VISCERAL LEISHMANIASIS,70-79,108,AMPHOTERICIN,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome.",70 79,108,70,108,-1,92,120,TWrex-cause,800170,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome",visceral leishmaniasis,amphotericin
725480622,5/25/2015 12:33:52,1642996107,5/25/2015 12:33:00,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,70,108,,,92,120,VISCERAL LEISHMANIASIS,AMPHOTERICIN,course treatment of VISCERAL LEISHMANIASIS,50-57-67-70-79,79-93-98-108,leishmaniasis with liposomal AMPHOTERICIN,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome.",70 79,108,70,108,-1,92,120,TWrex-cause,800170,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome",visceral leishmaniasis,amphotericin
725480622,5/25/2015 12:35:14,1642996409,5/25/2015 12:34:56,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,70,108,,,92,120,VISCERAL LEISHMANIASIS,AMPHOTERICIN,course treatment of VISCERAL LEISHMANIASIS with liposomal amphotericin,50-57-67-70-79-93-98-108,108-121,AMPHOTERICIN B,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome.",70 79,108,70,108,-1,92,120,TWrex-cause,800170,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome",visceral leishmaniasis,amphotericin
725480622,5/25/2015 12:37:19,1642996883,5/25/2015 12:36:54,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,70,108,,,92,120,VISCERAL LEISHMANIASIS,AMPHOTERICIN,VISCERAL LEISHMANIASIS,70-79,98-108-121,liposomal AMPHOTERICIN B,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome.",70 79,108,70,108,-1,92,120,TWrex-cause,800170,"Davidson RN, di Martino L, Gradoni L et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome",visceral leishmaniasis,amphotericin
725480623,5/25/2015 10:12:28,1642957793,5/25/2015 10:12:11,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,146,78,,,158,91,SPLENOMEGALY,MONONUCLEOSIS,"SPLENOMEGALY,",146,78,MONONUCLEOSIS,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",146,78,146,78,1,158,91,TWrex-cause,813567,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area",splenomegaly,mononucleosis
725480623,5/25/2015 10:14:31,1642958165,5/25/2015 10:13:47,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,146,78,,,158,91,SPLENOMEGALY,MONONUCLEOSIS,"SPLENOMEGALY,",146,78,MONONUCLEOSIS,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",146,78,146,78,1,158,91,TWrex-cause,813567,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area",splenomegaly,mononucleosis
725480623,5/25/2015 10:15:49,1642958397,5/25/2015 10:15:17,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,146,78,,,158,91,SPLENOMEGALY,MONONUCLEOSIS,"SPLENOMEGALY,",146,78,MONONUCLEOSIS,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",146,78,146,78,1,158,91,TWrex-cause,813567,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area",splenomegaly,mononucleosis
725480623,5/25/2015 10:26:11,1642961271,5/25/2015 10:25:54,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,146,78,,,158,91,SPLENOMEGALY,MONONUCLEOSIS,"SPLENOMEGALY,",146,78,MONONUCLEOSIS,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",146,78,146,78,1,158,91,TWrex-cause,813567,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area",splenomegaly,mononucleosis
725480623,5/25/2015 10:41:15,1642972087,5/25/2015 10:40:58,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,146,78,,,158,91,SPLENOMEGALY,MONONUCLEOSIS,"SPLENOMEGALY,",146,78,MONONUCLEOSIS,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",146,78,146,78,1,158,91,TWrex-cause,813567,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area",splenomegaly,mononucleosis
725480623,5/25/2015 10:42:13,1642972807,5/25/2015 10:41:50,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,146,78,,,158,91,SPLENOMEGALY,MONONUCLEOSIS,"SPLENOMEGALY,",146,78,MONONUCLEOSIS,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",146,78,146,78,1,158,91,TWrex-cause,813567,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area",splenomegaly,mononucleosis
725480623,5/25/2015 10:45:51,1642974739,5/25/2015 10:45:37,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,146,78,,,158,91,SPLENOMEGALY,MONONUCLEOSIS,"SPLENOMEGALY,",146,78,MONONUCLEOSIS,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",146,78,146,78,1,158,91,TWrex-cause,813567,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area",splenomegaly,mononucleosis
725480623,5/25/2015 10:46:33,1642974836,5/25/2015 10:46:07,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,146,78,,,158,91,SPLENOMEGALY,MONONUCLEOSIS,"erythrocyte autoantibodies, mycoplasma mononucleosis hemolytic anemias) Fever, SPLENOMEGALY, and hemolysis suggest endemic",27-39-63-78-119-129-139-146-160-164-174-255,39-60-63-74-78-97-109-164-238-146,"autoantibodies, as mycoplasma and MONONUCLEOSIS information on splenomegaly, hemolysis babesiosis","Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",146,78,146,78,1,158,91,TWrex-cause,813567,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area",splenomegaly,mononucleosis
725480623,5/25/2015 10:49:07,1642975303,5/25/2015 10:48:47,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,146,78,,,158,91,SPLENOMEGALY,MONONUCLEOSIS,"SPLENOMEGALY,",146,78,MONONUCLEOSIS,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",146,78,146,78,1,158,91,TWrex-cause,813567,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area",splenomegaly,mononucleosis
725480623,5/25/2015 10:51:48,1642975697,5/25/2015 10:51:13,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,146,78,,,158,91,SPLENOMEGALY,MONONUCLEOSIS,"immune hemolytic anemias) Fever, SPLENOMEGALY, and hemolysis suggest malaria",112-119-129-139-146-160-164-174-182,27-39-55-63-74-78-60,"erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS","Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",146,78,146,78,1,158,91,TWrex-cause,813567,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and mononucleosis (see information on immune hemolytic anemias)  Fever, splenomegaly, and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area",splenomegaly,mononucleosis
725480624,5/25/2015 10:15:51,1642958401,5/25/2015 10:15:37,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,58,13,,,62,23,PAIN,MEPERIDINE,chronic PAIN,50-58,13,MEPERIDINE,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",58,13,58,13,-1,62,23,TWrex-cause,800890,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction",pain,meperidine
725480624,5/25/2015 10:19:19,1642959033,5/25/2015 10:18:57,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,58,13,,,62,23,PAIN,MEPERIDINE,chronic PAIN,50-58,13-24-29-33-47-50-58,MEPERIDINE used for postoperative or chronic pain,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",58,13,58,13,-1,62,23,TWrex-cause,800890,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction",pain,meperidine
725480624,5/25/2015 10:28:54,1642962437,5/25/2015 10:28:38,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,58,13,,,62,23,PAIN,MEPERIDINE,chronic PAIN,50-58,13,MEPERIDINE,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",58,13,58,13,-1,62,23,TWrex-cause,800890,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction",pain,meperidine
725480624,5/25/2015 10:45:26,1642974642,5/25/2015 10:45:09,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,58,13,,,62,23,PAIN,MEPERIDINE,chronic PAIN,50-58,13,MEPERIDINE,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",58,13,58,13,-1,62,23,TWrex-cause,800890,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction",pain,meperidine
725480624,5/25/2015 10:49:51,1642975405,5/25/2015 10:47:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,58,13,,,62,23,PAIN,MEPERIDINE,chronic PAIN,50-58,13,MEPERIDINE,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",58,13,58,13,-1,62,23,TWrex-cause,800890,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction",pain,meperidine
725480624,5/25/2015 10:52:25,1642975799,5/25/2015 10:52:09,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,58,13,,,62,23,PAIN,MEPERIDINE,chronic PAIN,50-58,13,MEPERIDINE,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",58,13,58,13,-1,62,23,TWrex-cause,800890,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction",pain,meperidine
725480624,5/25/2015 10:57:13,1642976493,5/25/2015 10:56:48,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,58,13,,,62,23,PAIN,MEPERIDINE,meperidine used for postoperative or chronic PAIN,13-24-29-33-47-50-58,2-4-10-13-24-29-33-50-58-63-71-76-89-105,A study of MEPERIDINE used for postoperative chronic pain found high incidence neuroexcitatory effects,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",58,13,58,13,-1,62,23,TWrex-cause,800890,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction",pain,meperidine
725480624,5/25/2015 11:34:36,1642983695,5/25/2015 11:34:16,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,58,13,,,62,23,PAIN,MEPERIDINE,postoperative or chronic PAIN,33-47-50-58,13,MEPERIDINE,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",58,13,58,13,-1,62,23,TWrex-cause,800890,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction",pain,meperidine
725480624,5/25/2015 11:42:27,1642985148,5/25/2015 11:42:08,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,58,13,,,62,23,PAIN,MEPERIDINE,PAIN,58,13,MEPERIDINE,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",58,13,58,13,-1,62,23,TWrex-cause,800890,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction",pain,meperidine
725480624,5/25/2015 11:43:42,1642985441,5/25/2015 11:43:19,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,58,13,,,62,23,PAIN,MEPERIDINE,postoperative or chronic PAIN,33-47-50-58,13-24-29-33-47-50-58,MEPERIDINE used for postoperative or chronic pain,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",58,13,58,13,-1,62,23,TWrex-cause,800890,"• A study of meperidine used for postoperative or chronic pain found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction",pain,meperidine
725480625,5/25/2015 08:19:38,1642939475,5/25/2015 08:19:07,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,58,11,,,68,24,INFECTION,MYCOBACTERIUM,INFECTIONS,58,11,MYCOBACTERIUM,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",58,11,58,11,1,68,24,TWrex-cause,812411,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA",infection,mycobacterium
725480625,5/25/2015 08:48:50,1642944601,5/25/2015 08:48:38,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,58,11,,,68,24,INFECTION,MYCOBACTERIUM,Mycobacterial INFECTIONS,44-58,4-11,", MYCOBACTERIUM","108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",58,11,58,11,1,68,24,TWrex-cause,812411,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA",infection,mycobacterium
725480625,5/25/2015 08:49:04,1642944664,5/25/2015 08:48:45,false,elite,1.0,26544151,GBR,"","",213.205.252.245,58,11,,,68,24,INFECTION,MYCOBACTERIUM,INFECTIONS,58,11,MYCOBACTERIUM,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",58,11,58,11,1,68,24,TWrex-cause,812411,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA",infection,mycobacterium
725480625,5/25/2015 08:56:26,1642945881,5/25/2015 08:55:58,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,58,11,,,68,24,INFECTION,MYCOBACTERIUM,Mycobacterial INFECTIONS,44-58,11-25,MYCOBACTERIUM kansasii,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",58,11,58,11,1,68,24,TWrex-cause,812411,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA",infection,mycobacterium
725480625,5/25/2015 09:01:53,1642946663,5/25/2015 09:01:22,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,58,11,,,68,24,INFECTION,MYCOBACTERIUM,Mycobacterial INFECTIONS,44-58,11-25,MYCOBACTERIUM kansasii,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",58,11,58,11,1,68,24,TWrex-cause,812411,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA",infection,mycobacterium
725480625,5/25/2015 09:11:09,1642948007,5/25/2015 09:09:28,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,58,11,,,68,24,INFECTION,MYCOBACTERIUM,"Mycobacterium kansasii and Other Mycobacterial INFECTIONS + &gt; Treatment of Pulmonary or Disseminated Infections Caused by Rifampin - susceptible M. kansasii + Oral: 15 mg / kg once daily in conjunction with rifampin (10 mg / kg [up to 600 mg] daily), isoniazid (5 mg / kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",11-25-34-38-44-58-71-74-80-90-93-103-106-119-130-137-140-148-149-161-164-174-177-184-187-189-190-193-198-204-207-219-224-233-237-239-240-243-247-250-254-258-266-276-279-281-282-285-289-292-296-300-308-312-323-327-330-337-349-352-356-360,0-4-8-11-25-34-38-44-58-71-74-80-90-93-103-106-119-130-137-140-148-149-161-164-174-177-184-187-189-190-193-198-204-207-219-224-233-237-239-240-243-247-250-254-258-266-276-279-281-282-285-289-292-296-300-308-312-323-327-330-337-349-352-356-360,"108 , c MYCOBACTERIUM kansasii and Other Mycobacterial Infections + &gt; Treatment of Pulmonary or Disseminated Infections Caused by Rifampin - susceptible M. kansasii + Oral: 15 mg / kg once daily in conjunction with rifampin (10 mg / kg [up to 600 mg] daily), isoniazid (5 mg / kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.","108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",58,11,58,11,1,68,24,TWrex-cause,812411,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA",infection,mycobacterium
725480625,5/25/2015 09:17:48,1642949003,5/25/2015 09:16:54,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,58,11,,,68,24,INFECTION,MYCOBACTERIUM,Mycobacterial INFECTIONS,44-58,0-4-8-11-25,"108 , c MYCOBACTERIUM kansasii","108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",58,11,58,11,1,68,24,TWrex-cause,812411,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA",infection,mycobacterium
725480625,5/25/2015 09:31:07,1642951091,5/25/2015 09:30:47,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,58,11,,,68,24,INFECTION,MYCOBACTERIUM,INFECTIONS,58,11,MYCOBACTERIUM,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",58,11,58,11,1,68,24,TWrex-cause,812411,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA",infection,mycobacterium
725480625,5/25/2015 09:46:03,1642953507,5/25/2015 09:45:44,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,58,11,,,68,24,INFECTION,MYCOBACTERIUM,Mycobacterial INFECTIONS,44-58,11-25,MYCOBACTERIUM kansasii,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",58,11,58,11,1,68,24,TWrex-cause,812411,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA",infection,mycobacterium
725480625,5/25/2015 09:54:09,1642954694,5/25/2015 09:53:56,false,clixsense,1.0,24763049,GBR,Y8,Welshpool,81.135.56.139,58,11,,,68,24,INFECTION,MYCOBACTERIUM,INFECTIONS,58,11,MYCOBACTERIUM,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",58,11,58,11,1,68,24,TWrex-cause,812411,"108 ,   c  Mycobacterium kansasii and Other Mycobacterial Infections   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin-susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA",infection,mycobacterium
725480626,5/25/2015 11:04:14,1642977796,5/25/2015 11:03:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,104,154,,,115,165,TACHYCARDIA,PROPAFENONE,trial of propafenone prophylaxis of paroxysmal supraventricular TACHYCARDIA and paroxysmal atrial fibrillation.UK,33-39-42-73-76-87-104-116-120-131-138-61,33-39-120-131-138-154-166-171-177-42,trial of propafenone paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17.",104,154,104,154,-1,115,165,TWrex-cause,804941,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17",tachycardia,propafenone
725480626,5/25/2015 11:37:54,1642984331,5/25/2015 11:37:34,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,104,154,,,115,165,TACHYCARDIA,PROPAFENONE,paroxysmal supraventricular TACHYCARDIA,76-87-104,154,PROPAFENONE,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17.",104,154,104,154,-1,115,165,TWrex-cause,804941,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17",tachycardia,propafenone
725480626,5/25/2015 11:54:45,1642987590,5/25/2015 11:54:31,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,104,154,,,115,165,TACHYCARDIA,PROPAFENONE,TACHYCARDIA,104,154,PROPAFENONE,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17.",104,154,104,154,-1,115,165,TWrex-cause,804941,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17",tachycardia,propafenone
725480626,5/25/2015 11:57:39,1642988065,5/25/2015 11:56:52,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,104,154,,,115,165,TACHYCARDIA,PROPAFENONE,paroxysmal supraventricular TACHYCARDIA,76-87-104,154,PROPAFENONE,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17.",104,154,104,154,-1,115,165,TWrex-cause,804941,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17",tachycardia,propafenone
725480626,5/25/2015 12:19:23,1642993005,5/25/2015 12:18:54,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,104,154,,,115,165,TACHYCARDIA,PROPAFENONE,TACHYCARDIA,104,154,PROPAFENONE,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17.",104,154,104,154,-1,115,165,TWrex-cause,804941,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17",tachycardia,propafenone
725480626,5/25/2015 12:36:04,1642996550,5/25/2015 12:35:48,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,104,154,,,115,165,TACHYCARDIA,PROPAFENONE,paroxysmal supraventricular TACHYCARDIA and paroxysmal atrial,76-87-104-116-120-131,138-154-166-171-177,fibrillation.UK PROPAFENONE PSVT Study Group:,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17.",104,154,104,154,-1,115,165,TWrex-cause,804941,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17",tachycardia,propafenone
725480626,5/25/2015 12:37:10,1642996816,5/25/2015 12:36:13,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,104,154,,,115,165,TACHYCARDIA,PROPAFENONE,paroxysmal supraventricular TACHYCARDIA and paroxysmal atrial fibrillation.UK,76-87-104-116-120-131-138,120-131-138-154-166-171-177,paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17.",104,154,104,154,-1,115,165,TWrex-cause,804941,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17",tachycardia,propafenone
725480626,5/25/2015 12:38:47,1642997080,5/25/2015 12:38:11,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,104,154,,,115,165,TACHYCARDIA,PROPAFENONE,paroxysmal supraventricular TACHYCARDIA,76-87-104,154,PROPAFENONE,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17.",104,154,104,154,-1,115,165,TWrex-cause,804941,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17",tachycardia,propafenone
725480626,5/25/2015 12:43:33,1642998025,5/25/2015 12:42:07,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,104,154,,,115,165,TACHYCARDIA,PROPAFENONE,paroxysmal supraventricular TACHYCARDIA,76-87-104,154-166,PROPAFENONE PSVT,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17.",104,154,104,154,-1,115,165,TWrex-cause,804941,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17",tachycardia,propafenone
725480626,5/25/2015 12:44:56,1642998149,5/25/2015 12:44:31,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,104,154,,,115,165,TACHYCARDIA,PROPAFENONE,supraventricular TACHYCARDIA,104-87,154,PROPAFENONE,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17.",104,154,104,154,-1,115,165,TWrex-cause,804941,"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.UK Propafenone PSVT Study Group:  Circulation 92:2550, 1995  17",tachycardia,propafenone
725480627,5/25/2015 10:14:18,1642958141,5/25/2015 10:13:15,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,197,230,,,201,239,LUNG,EMPHYSEMA,LUNG,197,207-217-230,"pulmonary interstitial EMPHYSEMA,","If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung.",197,230,197,230,-1,201,239,TWrex-cause,802971,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung",lung,emphysema
725480627,5/25/2015 10:17:01,1642958619,5/25/2015 10:16:37,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,197,230,,,201,239,LUNG,EMPHYSEMA,"LUNG with pulmonary interstitial emphysema,",197-202-207-217-230,207-217-230,"pulmonary interstitial EMPHYSEMA,","If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung.",197,230,197,230,-1,201,239,TWrex-cause,802971,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung",lung,emphysema
725480627,5/25/2015 10:17:31,1642958688,5/25/2015 10:16:10,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,197,230,,,201,239,LUNG,EMPHYSEMA,LUNG,197,207-217-230,"pulmonary interstitial EMPHYSEMA,","If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung.",197,230,197,230,-1,201,239,TWrex-cause,802971,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung",lung,emphysema
725480627,5/25/2015 10:27:16,1642961632,5/25/2015 10:26:59,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,197,230,,,201,239,LUNG,EMPHYSEMA,LUNG,197,230,"EMPHYSEMA,","If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung.",197,230,197,230,-1,201,239,TWrex-cause,802971,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung",lung,emphysema
725480627,5/25/2015 10:43:24,1642973707,5/25/2015 10:43:07,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,197,230,,,201,239,LUNG,EMPHYSEMA,LUNG,197,207-217-230,"pulmonary interstitial EMPHYSEMA,","If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung.",197,230,197,230,-1,201,239,TWrex-cause,802971,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung",lung,emphysema
725480627,5/25/2015 10:43:41,1642973832,5/25/2015 10:43:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,197,230,,,201,239,LUNG,EMPHYSEMA,LUNG,197,207-217-230,"pulmonary interstitial EMPHYSEMA,","If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung.",197,230,197,230,-1,201,239,TWrex-cause,802971,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung",lung,emphysema
725480627,5/25/2015 10:46:38,1642974851,5/25/2015 10:46:22,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,197,230,,,201,239,LUNG,EMPHYSEMA,LUNG,197,207-217-230,"pulmonary interstitial EMPHYSEMA,","If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung.",197,230,197,230,-1,201,239,TWrex-cause,802971,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung",lung,emphysema
725480627,5/25/2015 10:50:20,1642975493,5/25/2015 10:49:59,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,197,230,,,201,239,LUNG,EMPHYSEMA,LUNG,197,207-217-230,"pulmonary interstitial EMPHYSEMA,","If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung.",197,230,197,230,-1,201,239,TWrex-cause,802971,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung",lung,emphysema
725480627,5/25/2015 10:53:53,1642975969,5/25/2015 10:52:39,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,197,230,,,201,239,LUNG,EMPHYSEMA,"LUNG with pulmonary interstitial emphysema, improving ventilation",197-202-207-217-230-284-294,77-82-87-176-181-184-197-202-207-217-230-241-249-260-264-284-294-94,"laid down on side help to compress lung with pulmonary interstitial EMPHYSEMA, thereby decreasing air leakage improving ventilation","If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung.",197,230,197,230,-1,201,239,TWrex-cause,802971,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung",lung,emphysema
725480627,5/25/2015 11:30:14,1642982783,5/25/2015 11:30:08,false,clixsense,1,22751911,NLD,04,Groningen,195.241.153.97,197,230,,,201,239,LUNG,EMPHYSEMA,to compress the LUNG with pulmonary interstitial,181-184-193-197-202-207-217,202-207-217-230-241-249-260,"with pulmonary interstitial EMPHYSEMA, thereby decreasing air","If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung.",197,230,197,230,-1,201,239,TWrex-cause,802971,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with pulmonary interstitial emphysema, thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) lung",lung,emphysema
725480628,5/25/2015 10:15:35,1642958370,5/25/2015 10:15:24,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,91,123,,,96,126,COUGH,IPF,nonproductive COUGH,77-91,123,IPF.,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF.,91,123,91,123,1,96,126,TWrex-cause,812914,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF,cough,IPF
725480628,5/25/2015 10:18:56,1642958940,5/25/2015 10:18:38,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,91,123,,,96,126,COUGH,IPF,nonproductive COUGH,77-91,123,IPF.,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF.,91,123,91,123,1,96,126,TWrex-cause,812914,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF,cough,IPF
725480628,5/25/2015 10:28:36,1642962261,5/25/2015 10:28:24,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,91,123,,,96,126,COUGH,IPF,COUGH,91,123,IPF.,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF.,91,123,91,123,1,96,126,TWrex-cause,812914,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF,cough,IPF
725480628,5/25/2015 10:45:08,1642974550,5/25/2015 10:44:45,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,91,123,,,96,126,COUGH,IPF,nonproductive COUGH and dyspnea characterizes,77-91-97-101-109,123,IPF.,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF.,91,123,91,123,1,96,126,TWrex-cause,812914,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF,cough,IPF
725480628,5/25/2015 10:47:04,1642974948,5/25/2015 10:46:06,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,91,123,,,96,126,COUGH,IPF,nonproductive COUGH,77-91,123,IPF.,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF.,91,123,91,123,1,96,126,TWrex-cause,812914,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF,cough,IPF
725480628,5/25/2015 10:52:09,1642975773,5/25/2015 10:51:37,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,91,123,,,96,126,COUGH,IPF,nonproductive COUGH and,77-91-97,123,IPF.,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF.,91,123,91,123,1,96,126,TWrex-cause,812914,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF,cough,IPF
725480628,5/25/2015 10:56:47,1642976445,5/25/2015 10:56:28,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,91,123,,,96,126,COUGH,IPF,onset of nonproductive COUGH and dyspnea characterizes IPF.,68-74-77-91-97-101-109-123,58-68-74-77-97-101-109-123-91,insidious onset of nonproductive cough and dyspnea characterizes IPF.,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF.,91,123,91,123,1,96,126,TWrex-cause,812914,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF,cough,IPF
725480628,5/25/2015 11:34:15,1642983623,5/25/2015 11:34:03,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,91,123,,,96,126,COUGH,IPF,nonproductive COUGH,77-91,101-109-123,dyspnea characterizes IPF.,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF.,91,123,91,123,1,96,126,TWrex-cause,812914,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF,cough,IPF
725480628,5/25/2015 11:42:07,1642985026,5/25/2015 11:41:56,false,dailyrewardsca,1.0,32438879,CAN,NB,Fredericton,156.57.46.234,91,123,,,96,126,COUGH,IPF,COUGH,91,123,IPF.,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF.,91,123,91,123,1,96,126,TWrex-cause,812914,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF,cough,IPF
725480628,5/25/2015 11:43:17,1642985402,5/25/2015 11:42:44,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,91,123,,,96,126,COUGH,IPF,nonproductive COUGH,77-91,58-68-74-77-91-97-101-123,insidious onset of nonproductive cough and dyspnea IPF.,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF.,91,123,91,123,1,96,126,TWrex-cause,812914,Clinical Features  History and physical examination   The insidious onset of nonproductive cough and dyspnea characterizes IPF,cough,IPF
725480629,5/25/2015 08:22:46,1642940196,5/25/2015 08:22:18,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,181,59,,,194,66,ENDOMETRIOSIS,DANAZOL,ENDOMETRIOSIS,181,59,DANAZOL,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,181,59,181,59,-1,194,66,TWrex-cause,803874,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women,endometriosis,danazol
725480629,5/25/2015 08:51:48,1642945150,5/25/2015 08:51:32,false,elite,1.0,26544151,GBR,"","",213.205.252.245,181,59,,,194,66,ENDOMETRIOSIS,DANAZOL,ENDOMETRIOSIS,181,59,DANAZOL,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,181,59,181,59,-1,194,66,TWrex-cause,803874,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women,endometriosis,danazol
725480629,5/25/2015 08:51:49,1642945157,5/25/2015 08:51:32,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,181,59,,,194,66,ENDOMETRIOSIS,DANAZOL,ENDOMETRIOSIS,181,59,DANAZOL,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,181,59,181,59,-1,194,66,TWrex-cause,803874,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women,endometriosis,danazol
725480629,5/25/2015 08:59:27,1642946266,5/25/2015 08:59:07,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,181,59,,,194,66,ENDOMETRIOSIS,DANAZOL,ENDOMETRIOSIS,181,59,DANAZOL,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,181,59,181,59,-1,194,66,TWrex-cause,803874,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women,endometriosis,danazol
725480629,5/25/2015 09:05:27,1642947169,5/25/2015 09:05:02,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,181,59,,,194,66,ENDOMETRIOSIS,DANAZOL,ENDOMETRIOSIS,181,59,DANAZOL,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,181,59,181,59,-1,194,66,TWrex-cause,803874,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women,endometriosis,danazol
725480629,5/25/2015 09:20:06,1642949348,5/25/2015 09:18:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,181,59,,,194,66,ENDOMETRIOSIS,DANAZOL,Cochrane Library Ovulation suppression for endometriosis Danazol for pelvic pain associated with endometriosis Gonadotrophin - releasing hormone analogues for pain associated with ENDOMETRIOSIS Modern combined oral contraceptives for pain associated with endometriosis Laparoscopic surgery for pelvic pain associated with endometriosis Progestagens and anti - progestagens for pain associated with endometriosis Interventions for treating chronic pelvic pain in women.,0-9-18-28-40-44-59-67-71-78-83-94-99-114-127-128-138-146-156-160-165-176-181-196-203-212-217-232-236-241-252-257-272-285-293-297-304-309-320-325-340-353-357-361-362-375-379-384-395-400-415-429-433-442-450-457-462-465,0-9-18-28-40-44-59-67-71-78-83-94-99-114-127-128-138-146-156-160-165-176-181-196-203-212-217-232-236-241-252-257-272-285-293-297-304-309-320-325-340-353-357-361-362-375-379-384-395-400-415-429-433-442-450-457-462-465,Cochrane Library Ovulation suppression for endometriosis DANAZOL for pelvic pain associated with endometriosis Gonadotrophin - releasing hormone analogues for pain associated with endometriosis Modern combined oral contraceptives for pain associated with endometriosis Laparoscopic surgery for pelvic pain associated with endometriosis Progestagens and anti - progestagens for pain associated with endometriosis Interventions for treating chronic pelvic pain in women.,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,181,59,181,59,-1,194,66,TWrex-cause,803874,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women,endometriosis,danazol
725480629,5/25/2015 09:27:51,1642950623,5/25/2015 09:25:32,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,181,59,,,194,66,ENDOMETRIOSIS,DANAZOL,ENDOMETRIOSIS,181,44-59,endometriosis DANAZOL,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,181,59,181,59,-1,194,66,TWrex-cause,803874,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women,endometriosis,danazol
725480629,5/25/2015 09:34:20,1642951716,5/25/2015 09:33:53,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,181,59,,,194,66,ENDOMETRIOSIS,DANAZOL,ENDOMETRIOSIS,181,59,DANAZOL,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,181,59,181,59,-1,194,66,TWrex-cause,803874,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women,endometriosis,danazol
725480629,5/25/2015 09:49:46,1642954100,5/25/2015 09:49:30,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,181,59,,,194,66,ENDOMETRIOSIS,DANAZOL,ENDOMETRIOSIS,181,59,DANAZOL,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,181,59,181,59,-1,194,66,TWrex-cause,803874,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women,endometriosis,danazol
725480629,5/25/2015 09:58:19,1642955537,5/25/2015 09:57:38,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,181,59,,,194,66,ENDOMETRIOSIS,DANAZOL,ENDOMETRIOSIS,181,44-59,endometriosis DANAZOL,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,181,59,181,59,-1,194,66,TWrex-cause,803874,Cochrane Library  Ovulation suppression for endometriosis  Danazol for pelvic pain associated with endometriosis  Gonadotrophin-releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with endometriosis  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti-progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women,endometriosis,danazol
725480630,5/25/2015 13:02:09,1643001318,5/25/2015 13:01:56,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,51,73,,,55,82,SKIN,PSORIASIS,SKIN,51,73,PSORIASIS,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,51,73,51,73,-1,55,82,TWrex-cause,802702,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response,skin,psoriasis
725480630,5/25/2015 13:06:00,1643001930,5/25/2015 13:04:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,51,73,,,55,82,SKIN,PSORIASIS,SKIN,51,73,PSORIASIS,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,51,73,51,73,-1,55,82,TWrex-cause,802702,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response,skin,psoriasis
725480630,5/25/2015 13:18:13,1643004258,5/25/2015 13:17:53,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,51,73,,,55,82,SKIN,PSORIASIS,SKIN,51,73,PSORIASIS,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,51,73,51,73,-1,55,82,TWrex-cause,802702,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response,skin,psoriasis
725480630,5/25/2015 13:24:45,1643005645,5/25/2015 13:24:30,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,51,73,,,55,82,SKIN,PSORIASIS,uninvolved SKIN of patients with psoriasis,40-51-56-59-68-73,56-59-68-73-83-87-93-95,of patients with PSORIASIS can cause a lesion,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,51,73,51,73,-1,55,82,TWrex-cause,802702,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response,skin,psoriasis
725480630,5/25/2015 13:24:55,1643005726,5/25/2015 13:24:35,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,51,73,,,55,82,SKIN,PSORIASIS,SKIN psoriasis lesion Kobner response.,51-73-95-180-173,51-73-95-180-173,skin PSORIASIS lesion Kobner response.,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,51,73,51,73,-1,55,82,TWrex-cause,802702,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response,skin,psoriasis
725480630,5/25/2015 13:25:39,1643005888,5/25/2015 13:25:20,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,51,73,,,55,82,SKIN,PSORIASIS,clinically uninvolved SKIN,29-40-51,73,PSORIASIS,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,51,73,51,73,-1,55,82,TWrex-cause,802702,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response,skin,psoriasis
725480630,5/25/2015 13:26:22,1643006042,5/25/2015 13:25:33,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,51,73,,,55,82,SKIN,PSORIASIS,clinically uninvolved SKIN,29-40-51,73,PSORIASIS,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,51,73,51,73,-1,55,82,TWrex-cause,802702,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response,skin,psoriasis
725480630,5/25/2015 13:26:42,1643006097,5/25/2015 13:26:34,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.1,51,73,,,55,82,SKIN,PSORIASIS,the clinically uninvolved SKIN of patients with,25-29-40-51-56-59-68,56-59-68-73-83-87-93,of patients with PSORIASIS can cause a,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,51,73,51,73,-1,55,82,TWrex-cause,802702,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response,skin,psoriasis
725480630,5/25/2015 13:27:41,1643006281,5/25/2015 13:26:37,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,51,73,,,55,82,SKIN,PSORIASIS,SKIN,51,73,PSORIASIS,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,51,73,51,73,-1,55,82,TWrex-cause,802702,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response,skin,psoriasis
725480630,5/25/2015 13:27:46,1643006292,5/25/2015 13:27:15,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,51,73,,,55,82,SKIN,PSORIASIS,clinically uninvolved SKIN,29-40-51,59-68-73,patients with PSORIASIS,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,51,73,51,73,-1,55,82,TWrex-cause,802702,Other Factors  Trauma to the clinically uninvolved skin of patients with psoriasis can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response,skin,psoriasis
725480631,5/25/2015 10:11:26,1642957576,5/25/2015 10:10:51,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,132,97,,,136,110,PAIN,ENDOMETRIOSIS,"pelvic PAIN,",125-132,97,"ENDOMETRIOSIS,","C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility.",132,97,132,97,1,136,110,TWrex-cause,813030,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility",pain,endometriosis
725480631,5/25/2015 10:12:18,1642957740,5/25/2015 10:11:49,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,132,97,,,136,110,PAIN,ENDOMETRIOSIS,"pelvic PAIN,",125-132,97,"ENDOMETRIOSIS,","C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility.",132,97,132,97,1,136,110,TWrex-cause,813030,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility",pain,endometriosis
725480631,5/25/2015 10:14:15,1642958116,5/25/2015 10:13:44,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,132,97,,,136,110,PAIN,ENDOMETRIOSIS,"pelvic PAIN,",125-132,97,"ENDOMETRIOSIS,","C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility.",132,97,132,97,1,136,110,TWrex-cause,813030,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility",pain,endometriosis
725480631,5/25/2015 10:25:02,1642960894,5/25/2015 10:24:44,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,132,97,,,136,110,PAIN,ENDOMETRIOSIS,"pelvic PAIN,",125-132,97,"ENDOMETRIOSIS,","C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility.",132,97,132,97,1,136,110,TWrex-cause,813030,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility",pain,endometriosis
725480631,5/25/2015 10:39:38,1642970728,5/25/2015 10:39:20,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,132,97,,,136,110,PAIN,ENDOMETRIOSIS,"pelvic PAIN,",125-132,97,"ENDOMETRIOSIS,","C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility.",132,97,132,97,1,136,110,TWrex-cause,813030,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility",pain,endometriosis
725480631,5/25/2015 10:40:51,1642971759,5/25/2015 10:40:33,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,132,97,,,136,110,PAIN,ENDOMETRIOSIS,"pelvic PAIN,",125-132,97,"ENDOMETRIOSIS,","C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility.",132,97,132,97,1,136,110,TWrex-cause,813030,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility",pain,endometriosis
725480631,5/25/2015 10:44:53,1642974453,5/25/2015 10:44:36,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,132,97,,,136,110,PAIN,ENDOMETRIOSIS,"pelvic PAIN,",132-125,97,"ENDOMETRIOSIS,","C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility.",132,97,132,97,1,136,110,TWrex-cause,813030,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility",pain,endometriosis
725480631,5/25/2015 10:45:40,1642974723,5/25/2015 10:45:26,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,132,97,,,136,110,PAIN,ENDOMETRIOSIS,"elicit endometriosis, particularly pelvic PAIN, a complex adnexal",97-112-125-132-138-140-148-57,77-83-94-97-112-125-132-148-156,"signs indicative of ENDOMETRIOSIS, particularly pelvic pain, adnexal mass,","C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility.",132,97,132,97,1,136,110,TWrex-cause,813030,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility",pain,endometriosis
725480631,5/25/2015 10:47:29,1642975048,5/25/2015 10:47:10,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,132,97,,,136,110,PAIN,ENDOMETRIOSIS,"pelvic PAIN,",125-132,97,"ENDOMETRIOSIS,","C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility.",132,97,132,97,1,136,110,TWrex-cause,813030,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility",pain,endometriosis
725480631,5/25/2015 10:50:02,1642975420,5/25/2015 10:49:23,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,132,97,,,136,110,PAIN,ENDOMETRIOSIS,"signs indicative of endometriosis, PAIN, complex adnexal mass, infertility.",77-83-94-97-132-140-148-156-165,64-73-77-83-94-97-112-125-132-140-148-156-165,"symptoms and signs indicative of ENDOMETRIOSIS, particularly pelvic pain, complex adnexal mass, infertility.","C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility.",132,97,132,97,1,136,110,TWrex-cause,813030,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of endometriosis, particularly pelvic pain, a complex adnexal mass, or infertility",pain,endometriosis
725480632,5/25/2015 11:59:07,1642988290,5/25/2015 11:58:55,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,140,61,,,158,73,VENTRICULAR ECTOPY,PROCAINAMIDE,VENTRICULAR ECTOPY,140-152,61,"PROCAINAMIDE,","Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",140 152,61,140,61,-1,158,73,TWrex-cause,804433,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization",ventricular ectopy,procainamide
725480632,5/25/2015 12:46:08,1642998334,5/25/2015 12:45:44,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,140,61,,,158,73,VENTRICULAR ECTOPY,PROCAINAMIDE,hemodynamically compromising VENTRICULAR ECTOPY VPCs),111-127-140-152-166,61,"PROCAINAMIDE,","Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",140 152,61,140,61,-1,158,73,TWrex-cause,804433,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization",ventricular ectopy,procainamide
725480632,5/25/2015 12:55:51,1643000227,5/25/2015 12:54:52,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,140,61,,,158,73,VENTRICULAR ECTOPY,PROCAINAMIDE,VENTRICULAR ECTOPY,140-152,61,"PROCAINAMIDE,","Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",140 152,61,140,61,-1,158,73,TWrex-cause,804433,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization",ventricular ectopy,procainamide
725480632,5/25/2015 13:02:06,1643001316,5/25/2015 13:01:33,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,140,61,,,158,73,VENTRICULAR ECTOPY,PROCAINAMIDE,hemodynamically compromising VENTRICULAR ECTOPY,111-127-140-152,61,"PROCAINAMIDE,","Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",140 152,61,140,61,-1,158,73,TWrex-cause,804433,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization",ventricular ectopy,procainamide
725480632,5/25/2015 13:13:49,1643003309,5/25/2015 13:13:21,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,140,61,,,158,73,VENTRICULAR ECTOPY,PROCAINAMIDE,VENTRICULAR ECTOPY,140-152,61,"PROCAINAMIDE,","Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",140 152,61,140,61,-1,158,73,TWrex-cause,804433,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization",ventricular ectopy,procainamide
725480632,5/25/2015 13:16:42,1643003921,5/25/2015 13:16:29,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,140,61,,,158,73,VENTRICULAR ECTOPY,PROCAINAMIDE,hemodynamically compromising VENTRICULAR ECTOPY,111-127-140-152,49-61-75,"amiodarone, PROCAINAMIDE, sotalol)","Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",140 152,61,140,61,-1,158,73,TWrex-cause,804433,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization",ventricular ectopy,procainamide
725480632,5/25/2015 13:17:57,1643004234,5/25/2015 13:17:42,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,140,61,,,158,73,VENTRICULAR ECTOPY,PROCAINAMIDE,VENTRICULAR ECTOPY,140-152,61,"PROCAINAMIDE,","Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",140 152,61,140,61,-1,158,73,TWrex-cause,804433,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization",ventricular ectopy,procainamide
725480632,5/25/2015 13:21:54,1643004965,5/25/2015 13:21:38,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,140,61,,,158,73,VENTRICULAR ECTOPY,PROCAINAMIDE,hemodynamically compromising VENTRICULAR ECTOPY,111-127-140-152,61,"PROCAINAMIDE,","Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",140 152,61,140,61,-1,158,73,TWrex-cause,804433,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization",ventricular ectopy,procainamide
725480632,5/25/2015 13:22:05,1643004998,5/25/2015 13:21:44,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,140,61,,,158,73,VENTRICULAR ECTOPY,PROCAINAMIDE,VENTRICULAR ECTOPY,140-152,61,"PROCAINAMIDE,","Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",140 152,61,140,61,-1,158,73,TWrex-cause,804433,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization",ventricular ectopy,procainamide
725480632,5/25/2015 13:22:10,1643005017,5/25/2015 13:21:26,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,140,61,,,158,73,VENTRICULAR ECTOPY,PROCAINAMIDE,"antiarrhythmic drugs amiodarone, procainamide, sotalol) hemodynamically compromising VENTRICULAR ECTOPY VPCs) myocardial ischemia infarction cardiac cardiac surgery cardiac catheterization.",21-36-49-61-75-111-127-140-152-166-194-205-217-238-278-286-297-305,21-36-49-61-75-111-127-140-152-166-194-205-217-238-278-286-297-305,"antiarrhythmic drugs amiodarone, PROCAINAMIDE, sotalol) hemodynamically compromising ventricular ectopy VPCs) myocardial ischemia infarction cardiac cardiac surgery cardiac catheterization.","Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",140 152,61,140,61,-1,158,73,TWrex-cause,804433,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, procainamide, sotalol) for the acute treatment of hemodynamically compromising ventricular ectopy (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization",ventricular ectopy,procainamide
725480633,5/25/2015 10:13:14,1642957920,5/25/2015 10:12:48,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,91,39,,,99,49,DISORDER,CITALOPRAM,obsessive compulsive DISORDER:,70-80-91,39,CITALOPRAM,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.",91,39,91,39,-1,99,49,TWrex-cause,800351,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study",disorder,citalopram
725480633,5/25/2015 10:16:07,1642958476,5/25/2015 10:15:12,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,91,39,,,99,49,DISORDER,CITALOPRAM,obsessive compulsive DISORDER:,70-80-91,39,CITALOPRAM,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.",91,39,91,39,-1,99,49,TWrex-cause,800351,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study",disorder,citalopram
725480633,5/25/2015 10:16:36,1642958541,5/25/2015 10:16:12,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,91,39,,,99,49,DISORDER,CITALOPRAM,obsessive compulsive DISORDER:,70-80-91,39,CITALOPRAM,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.",91,39,91,39,-1,99,49,TWrex-cause,800351,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study",disorder,citalopram
725480633,5/25/2015 10:26:58,1642961550,5/25/2015 10:26:38,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,91,39,,,99,49,DISORDER,CITALOPRAM,obsessive compulsive DISORDER:,70-80-91,39,CITALOPRAM,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.",91,39,91,39,-1,99,49,TWrex-cause,800351,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study",disorder,citalopram
725480633,5/25/2015 10:43:07,1642973527,5/25/2015 10:42:50,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,91,39,,,99,49,DISORDER,CITALOPRAM,obsessive compulsive DISORDER:,70-80-91,39,CITALOPRAM,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.",91,39,91,39,-1,99,49,TWrex-cause,800351,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study",disorder,citalopram
725480633,5/25/2015 10:43:18,1642973616,5/25/2015 10:41:46,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,91,39,,,99,49,DISORDER,CITALOPRAM,obsessive compulsive DISORDER:,70-80-91,39,CITALOPRAM,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.",91,39,91,39,-1,99,49,TWrex-cause,800351,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study",disorder,citalopram
725480633,5/25/2015 10:46:21,1642974820,5/25/2015 10:46:07,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,91,39,,,99,49,DISORDER,CITALOPRAM,obsessive compulsive DISORDER:,70-80-91,39,CITALOPRAM,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.",91,39,91,39,-1,99,49,TWrex-cause,800351,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study",disorder,citalopram
725480633,5/25/2015 10:46:57,1642974933,5/25/2015 10:46:47,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,91,39,,,99,49,DISORDER,CITALOPRAM,Citalopram of obsessive compulsive DISORDER: an open pilot,67-70-80-91-101-104-109-39,30-32-35-39-50-53-57,E et al. CITALOPRAM in the treatment,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.",91,39,91,39,-1,99,49,TWrex-cause,800351,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study",disorder,citalopram
725480633,5/25/2015 10:49:58,1642975417,5/25/2015 10:49:39,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,91,39,,,99,49,DISORDER,CITALOPRAM,obsessive compulsive DISORDER:,70-80-91,39,CITALOPRAM,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.",91,39,91,39,-1,99,49,TWrex-cause,800351,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study",disorder,citalopram
725480633,5/25/2015 10:52:38,1642975824,5/25/2015 10:52:13,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,91,39,,,99,49,DISORDER,CITALOPRAM,Citalopram treatment of obsessive compulsive DISORDER:,39-67-70-80-91-57,39-50-53-57-70-80-91,CITALOPRAM in the treatment obsessive compulsive disorder:,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.",91,39,91,39,-1,99,49,TWrex-cause,800351,"Kopenen H, Lepola U, Leinonen E et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study",disorder,citalopram
725480634,5/25/2015 12:47:14,1642998576,5/25/2015 12:46:54,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,11,52,,,16,69,• DKA,DIABETES MELLITUS,• DKA,11-13,52-61,DIABETES MELLITUS.,Rationale: • DKA may be the initial presentation of diabetes mellitus.,11 13,52 61,11,52,1,16,69,TWrex-cause,814887,Rationale: • DKA may be the initial presentation of diabetes mellitus,• DKA,diabetes mellitus
725480634,5/25/2015 12:59:15,1643000823,5/25/2015 12:58:51,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,11,52,,,16,69,• DKA,DIABETES MELLITUS,• DKA,11-13,52-61,DIABETES MELLITUS.,Rationale: • DKA may be the initial presentation of diabetes mellitus.,11 13,52 61,11,52,1,16,69,TWrex-cause,814887,Rationale: • DKA may be the initial presentation of diabetes mellitus,• DKA,diabetes mellitus
725480634,5/25/2015 13:02:57,1643001406,5/25/2015 13:02:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,11,52,,,16,69,• DKA,DIABETES MELLITUS,• DKA,11-13,52-61,DIABETES MELLITUS.,Rationale: • DKA may be the initial presentation of diabetes mellitus.,11 13,52 61,11,52,1,16,69,TWrex-cause,814887,Rationale: • DKA may be the initial presentation of diabetes mellitus,• DKA,diabetes mellitus
725480634,5/25/2015 13:15:03,1643003589,5/25/2015 13:14:39,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,11,52,,,16,69,• DKA,DIABETES MELLITUS,• DKA,11-13,52-61,DIABETES MELLITUS.,Rationale: • DKA may be the initial presentation of diabetes mellitus.,11 13,52 61,11,52,1,16,69,TWrex-cause,814887,Rationale: • DKA may be the initial presentation of diabetes mellitus,• DKA,diabetes mellitus
725480634,5/25/2015 13:17:32,1643004152,5/25/2015 13:17:19,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,11,52,,,16,69,• DKA,DIABETES MELLITUS,• DKA,11-13,52-61,DIABETES MELLITUS.,Rationale: • DKA may be the initial presentation of diabetes mellitus.,11 13,52 61,11,52,1,16,69,TWrex-cause,814887,Rationale: • DKA may be the initial presentation of diabetes mellitus,• DKA,diabetes mellitus
725480634,5/25/2015 13:18:43,1643004385,5/25/2015 13:18:28,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,11,52,,,16,69,• DKA,DIABETES MELLITUS,• DKA,11-13,52-61,DIABETES MELLITUS.,Rationale: • DKA may be the initial presentation of diabetes mellitus.,11 13,52 61,11,52,1,16,69,TWrex-cause,814887,Rationale: • DKA may be the initial presentation of diabetes mellitus,• DKA,diabetes mellitus
725480634,5/25/2015 13:22:42,1643005116,5/25/2015 13:22:31,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,11,52,,,16,69,• DKA,DIABETES MELLITUS,• DKA,11-13,52-61,DIABETES MELLITUS.,Rationale: • DKA may be the initial presentation of diabetes mellitus.,11 13,52 61,11,52,1,16,69,TWrex-cause,814887,Rationale: • DKA may be the initial presentation of diabetes mellitus,• DKA,diabetes mellitus
725480634,5/25/2015 13:22:53,1643005158,5/25/2015 13:22:25,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,11,52,,,16,69,• DKA,DIABETES MELLITUS,• DKA,11-13,52-61,DIABETES MELLITUS.,Rationale: • DKA may be the initial presentation of diabetes mellitus.,11 13,52 61,11,52,1,16,69,TWrex-cause,814887,Rationale: • DKA may be the initial presentation of diabetes mellitus,• DKA,diabetes mellitus
725480634,5/25/2015 13:22:59,1643005198,5/25/2015 13:22:37,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,11,52,,,16,69,• DKA,DIABETES MELLITUS,• DKA,11-13,52-61,DIABETES MELLITUS.,Rationale: • DKA may be the initial presentation of diabetes mellitus.,11 13,52 61,11,52,1,16,69,TWrex-cause,814887,Rationale: • DKA may be the initial presentation of diabetes mellitus,• DKA,diabetes mellitus
725480634,5/25/2015 13:23:17,1643005258,5/25/2015 13:22:48,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,11,52,,,16,69,• DKA,DIABETES MELLITUS,• DKA diabetes mellitus.,11-13-52-61,13-52-61-11,• DKA DIABETES MELLITUS.,Rationale: • DKA may be the initial presentation of diabetes mellitus.,11 13,52 61,11,52,1,16,69,TWrex-cause,814887,Rationale: • DKA may be the initial presentation of diabetes mellitus,• DKA,diabetes mellitus
725480635,5/25/2015 10:46:31,1642974838,5/25/2015 10:46:02,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,36,129,,,55,141,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,36-46,110-129,Calymmatobacterium GRANULOMATIS.,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis.,36 46,129,36,129,1,55,141,TWrex-cause,810025,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
725480635,5/25/2015 10:53:28,1642975907,5/25/2015 10:53:07,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,36,129,,,55,141,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,36-46,110-129,Calymmatobacterium GRANULOMATIS.,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis.,36 46,129,36,129,1,55,141,TWrex-cause,810025,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
725480635,5/25/2015 10:58:39,1642976806,5/25/2015 10:58:16,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,36,129,,,55,141,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE (Donovanosis) GRANULOMA INGUINALE,0-10-21-36-46,0-10-61-99-106-110-129-73,GRANULOMA INGUINALE progressive infection caused by Calymmatobacterium GRANULOMATIS.,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis.,36 46,129,36,129,1,55,141,TWrex-cause,810025,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
725480635,5/25/2015 11:35:27,1642983868,5/25/2015 11:35:08,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,36,129,,,55,141,GRANULOMA INGUINALE,GRANULOMATIS,(Donovanosis) GRANULOMA INGUINALE,21-36-46,110-129,Calymmatobacterium GRANULOMATIS.,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis.,36 46,129,36,129,1,55,141,TWrex-cause,810025,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
725480635,5/25/2015 11:44:33,1642985636,5/25/2015 11:42:58,false,dailyrewardsca,1.0,32438879,CAN,NB,Fredericton,156.57.46.234,36,129,,,55,141,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,36-46,129,GRANULOMATIS.,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis.,36 46,129,36,129,1,55,141,TWrex-cause,810025,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
725480635,5/25/2015 11:49:48,1642986698,5/25/2015 11:48:53,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,36,129,,,55,141,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,36-46,110-129,Calymmatobacterium GRANULOMATIS.,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis.,36 46,129,36,129,1,55,141,TWrex-cause,810025,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
725480635,5/25/2015 11:52:19,1642987242,5/25/2015 11:52:04,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,36,129,,,55,141,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE (Donovanosis) GRANULOMA INGUINALE is a progressive infection of genital skin caused by Calymmatobacterium granulomatis.,0-10-21-36-46-56-59-61-73-83-86-94-99-106-110-129,110-129,Calymmatobacterium GRANULOMATIS.,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis.,36 46,129,36,129,1,55,141,TWrex-cause,810025,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
725480635,5/25/2015 11:52:31,1642987298,5/25/2015 11:52:18,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,36,129,,,55,141,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,36-46,129,GRANULOMATIS.,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis.,36 46,129,36,129,1,55,141,TWrex-cause,810025,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
725480635,5/25/2015 12:10:33,1642990613,5/25/2015 12:10:02,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,36,129,,,55,141,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,36-46,129,GRANULOMATIS.,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis.,36 46,129,36,129,1,55,141,TWrex-cause,810025,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
725480635,5/25/2015 12:27:48,1642994674,5/25/2015 12:27:14,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,36,129,,,55,141,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE (Donovanosis) GRANULOMA INGUINALE,0-10-21-36-46,99-106-110-129,caused by Calymmatobacterium GRANULOMATIS.,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis.,36 46,129,36,129,1,55,141,TWrex-cause,810025,GRANULOMA INGUINALE  (Donovanosis)  Granuloma inguinale is a progressive infection of genital skin caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
725480636,5/25/2015 10:10:14,1642957357,5/25/2015 10:09:51,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,12,45,,,28,61,HYPOPHOSPHATEMIA,FANCONI SYNDROME,Familial HYPOPHOSPHATEMIA,3-12,45-53,FANCONI SYNDROME,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +.",12,45 53,12,45,1,28,61,TWrex-cause,814072,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +",hypophosphatemia,fanconi syndrome
725480636,5/25/2015 10:10:21,1642957385,5/25/2015 10:09:42,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,12,45,,,28,61,HYPOPHOSPHATEMIA,FANCONI SYNDROME,c Familial HYPOPHOSPHATEMIA,0-3-12,45-53,FANCONI SYNDROME,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +.",12,45 53,12,45,1,28,61,TWrex-cause,814072,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +",hypophosphatemia,fanconi syndrome
725480636,5/25/2015 10:13:00,1642957893,5/25/2015 10:12:42,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,12,45,,,28,61,HYPOPHOSPHATEMIA,FANCONI SYNDROME,c Familial HYPOPHOSPHATEMIA,0-3-12,45-53,FANCONI SYNDROME,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +.",12,45 53,12,45,1,28,61,TWrex-cause,814072,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +",hypophosphatemia,fanconi syndrome
725480636,5/25/2015 10:24:07,1642960529,5/25/2015 10:23:49,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,12,45,,,28,61,HYPOPHOSPHATEMIA,FANCONI SYNDROME,Familial HYPOPHOSPHATEMIA,3-12,45-53,FANCONI SYNDROME,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +.",12,45 53,12,45,1,28,61,TWrex-cause,814072,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +",hypophosphatemia,fanconi syndrome
725480636,5/25/2015 10:38:10,1642969303,5/25/2015 10:37:44,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,12,45,,,28,61,HYPOPHOSPHATEMIA,FANCONI SYNDROME,Familial HYPOPHOSPHATEMIA,3-12,45-53,FANCONI SYNDROME,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +.",12,45 53,12,45,1,28,61,TWrex-cause,814072,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +",hypophosphatemia,fanconi syndrome
725480636,5/25/2015 10:39:53,1642970930,5/25/2015 10:39:40,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,12,45,,,28,61,HYPOPHOSPHATEMIA,FANCONI SYNDROME,c Familial HYPOPHOSPHATEMIA,0-3-12,45-53-72,FANCONI SYNDROME used,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +.",12,45 53,12,45,1,28,61,TWrex-cause,814072,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +",hypophosphatemia,fanconi syndrome
725480636,5/25/2015 10:44:05,1642974004,5/25/2015 10:43:51,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,12,45,,,28,61,HYPOPHOSPHATEMIA,FANCONI SYNDROME,Familial HYPOPHOSPHATEMIA,3-12,45-53,FANCONI SYNDROME,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +.",12,45 53,12,45,1,28,61,TWrex-cause,814072,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +",hypophosphatemia,fanconi syndrome
725480636,5/25/2015 10:44:33,1642974249,5/25/2015 10:44:20,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,12,45,,,28,61,HYPOPHOSPHATEMIA,FANCONI SYNDROME,"c Familial HYPOPHOSPHATEMIA associated with Fanconi acidosis, manage hypophosphatemia Fanconi syndrome",0-3-12-29-40-45-95-108-115-148-156,12-29-40-45-53-63-67-72-115-148-156,Hypophosphatemia associated with FANCONI SYNDROME Has been used hypophosphatemia Fanconi syndrome,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +.",12,45 53,12,45,1,28,61,TWrex-cause,814072,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +",hypophosphatemia,fanconi syndrome
725480636,5/25/2015 10:46:21,1642974819,5/25/2015 10:45:58,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,12,45,,,28,61,HYPOPHOSPHATEMIA,FANCONI SYNDROME,c Familial HYPOPHOSPHATEMIA,0-3-12,45-53,FANCONI SYNDROME,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +.",12,45 53,12,45,1,28,61,TWrex-cause,814072,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +",hypophosphatemia,fanconi syndrome
725480636,5/25/2015 10:48:11,1642975137,5/25/2015 10:47:44,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,12,45,,,28,61,HYPOPHOSPHATEMIA,FANCONI SYNDROME,Familial HYPOPHOSPHATEMIA associated with Fanconi syndrome,3-12-29-40-45-53,12-29-40-45-53,Hypophosphatemia associated with FANCONI SYNDROME,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +.",12,45 53,12,45,1,28,61,TWrex-cause,814072,"c  Familial Hypophosphatemia associated with Fanconi syndrome  Has been used with treatment of acidosis, to manage hypophosphatemia associated with Fanconi syndrome   +",hypophosphatemia,fanconi syndrome
725480637,5/25/2015 08:15:09,1642938602,5/25/2015 08:14:50,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,150,118,,,165,134,TYPE 1 DIABETES,INSULIN GLARGINE,TYPE 1 DIABETES.,150-155-157,118-126,INSULIN GLARGINE,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.",150 155 157,118 126,150,118,-1,165,134,TWrex-cause,800424,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes",type 1 diabetes,insulin glargine
725480637,5/25/2015 08:20:01,1642939561,5/25/2015 08:19:48,false,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,150,118,,,165,134,TYPE 1 DIABETES,INSULIN GLARGINE,insulin glargine in people with TYPE 1 DIABETES.,118-135-138-145-150-155-157-126,102-106-114-118-126-135-138-145-150-155-157,NPH insulin and INSULIN GLARGINE in people with type 1 diabetes.,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.",150 155 157,118 126,150,118,-1,165,134,TWrex-cause,800424,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes",type 1 diabetes,insulin glargine
725480637,5/25/2015 08:38:40,1642942913,5/25/2015 08:38:24,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,150,118,,,165,134,TYPE 1 DIABETES,INSULIN GLARGINE,TYPE 1 DIABETES.,150-155-157,118-126,INSULIN GLARGINE,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.",150 155 157,118 126,150,118,-1,165,134,TWrex-cause,800424,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes",type 1 diabetes,insulin glargine
725480637,5/25/2015 08:44:29,1642943825,5/25/2015 08:44:11,false,elite,1.0,26544151,GBR,"","",213.205.252.245,150,118,,,165,134,TYPE 1 DIABETES,INSULIN GLARGINE,TYPE 1 DIABETES.,150-155-157,118-126,INSULIN GLARGINE,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.",150 155 157,118 126,150,118,-1,165,134,TWrex-cause,800424,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes",type 1 diabetes,insulin glargine
725480637,5/25/2015 08:52:21,1642945252,5/25/2015 08:51:52,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,150,118,,,165,134,TYPE 1 DIABETES,INSULIN GLARGINE,TYPE 1 DIABETES.,150-155-157,118-126,INSULIN GLARGINE,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.",150 155 157,118 126,150,118,-1,165,134,TWrex-cause,800424,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes",type 1 diabetes,insulin glargine
725480637,5/25/2015 08:56:19,1642945847,5/25/2015 08:55:57,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,150,118,,,165,134,TYPE 1 DIABETES,INSULIN GLARGINE,TYPE 1 DIABETES.,150-155-157,118-126,INSULIN GLARGINE,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.",150 155 157,118 126,150,118,-1,165,134,TWrex-cause,800424,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes",type 1 diabetes,insulin glargine
725480637,5/25/2015 09:01:10,1642946584,5/25/2015 09:00:31,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,150,118,,,165,134,TYPE 1 DIABETES,INSULIN GLARGINE,Lower within - subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with TYPE 1 DIABETES.,33-39-45-46-54-66-69-77-85-88-99-102-106-114-118-135-138-145-150-155-157-126,33-39-45-46-54-66-69-77-85-88-99-102-106-114-118-126-135-138-145-150-155-157,Lower within - subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with type 1 diabetes.,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.",150 155 157,118 126,150,118,-1,165,134,TWrex-cause,800424,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes",type 1 diabetes,insulin glargine
725480637,5/25/2015 09:04:47,1642947054,5/25/2015 09:04:04,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,150,118,,,165,134,TYPE 1 DIABETES,INSULIN GLARGINE,TYPE 1 DIABETES.,150-155-157,118-126,INSULIN GLARGINE,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.",150 155 157,118 126,150,118,-1,165,134,TWrex-cause,800424,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes",type 1 diabetes,insulin glargine
725480637,5/25/2015 09:24:06,1642949856,5/25/2015 09:23:52,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,150,118,,,165,134,TYPE 1 DIABETES,INSULIN GLARGINE,TYPE 1 DIABETES.,150-155-157,118-126-138,INSULIN GLARGINE people,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.",150 155 157,118 126,150,118,-1,165,134,TWrex-cause,800424,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes",type 1 diabetes,insulin glargine
725480637,5/25/2015 09:27:28,1642950555,5/25/2015 09:27:16,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,150,118,,,165,134,TYPE 1 DIABETES,INSULIN GLARGINE,TYPE 1 DIABETES.,150-155-157,118-126,INSULIN GLARGINE,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.",150 155 157,118 126,150,118,-1,165,134,TWrex-cause,800424,"Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes",type 1 diabetes,insulin glargine
725480638,5/25/2015 08:16:48,1642938919,5/25/2015 08:16:23,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,137,90,,,148,101,CANDIDIASIS,FLUCONAZOLE,recurrent vulvovaginal CANDIDIASIS.,114-124-137,90-102,FLUCONAZOLE therapy,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.",137,90,137,90,-1,148,101,TWrex-cause,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis",candidiasis,fluconazole
725480638,5/25/2015 08:21:12,1642939844,5/25/2015 08:21:02,false,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,137,90,,,148,101,CANDIDIASIS,FLUCONAZOLE,Maintenance fluconazole therapy for recurrent vulvovaginal CANDIDIASIS.,78-90-102-114-124-137-110,71-74-78-90-102-110-114-124-137,et al. Maintenance FLUCONAZOLE therapy for recurrent vulvovaginal candidiasis.,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.",137,90,137,90,-1,148,101,TWrex-cause,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis",candidiasis,fluconazole
725480638,5/25/2015 08:40:44,1642943271,5/25/2015 08:40:26,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,137,90,,,148,101,CANDIDIASIS,FLUCONAZOLE,vulvovaginal CANDIDIASIS.,124-137,90,FLUCONAZOLE,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.",137,90,137,90,-1,148,101,TWrex-cause,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis",candidiasis,fluconazole
725480638,5/25/2015 08:46:37,1642944181,5/25/2015 08:46:17,false,elite,1.0,26544151,GBR,"","",213.205.252.245,137,90,,,148,101,CANDIDIASIS,FLUCONAZOLE,CANDIDIASIS.,137,90,FLUCONAZOLE,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.",137,90,137,90,-1,148,101,TWrex-cause,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis",candidiasis,fluconazole
725480638,5/25/2015 08:53:57,1642945516,5/25/2015 08:53:43,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,137,90,,,148,101,CANDIDIASIS,FLUCONAZOLE,vulvovaginal CANDIDIASIS.,124-137,90,FLUCONAZOLE,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.",137,90,137,90,-1,148,101,TWrex-cause,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis",candidiasis,fluconazole
725480638,5/25/2015 08:58:53,1642946229,5/25/2015 08:58:37,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,137,90,,,148,101,CANDIDIASIS,FLUCONAZOLE,recurrent vulvovaginal CANDIDIASIS.,114-124-137,90,FLUCONAZOLE,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.",137,90,137,90,-1,148,101,TWrex-cause,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis",candidiasis,fluconazole
725480638,5/25/2015 09:05:52,1642947284,5/25/2015 09:05:39,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,137,90,,,148,101,CANDIDIASIS,FLUCONAZOLE,Maintenance fluconazole therapy for recurrent vulvovaginal CANDIDIASIS.,78-90-110-114-124-137-102,78-90-102-110-114-124-137,Maintenance FLUCONAZOLE therapy for recurrent vulvovaginal candidiasis.,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.",137,90,137,90,-1,148,101,TWrex-cause,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis",candidiasis,fluconazole
725480638,5/25/2015 09:09:26,1642947817,5/25/2015 09:08:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,137,90,,,148,101,CANDIDIASIS,FLUCONAZOLE,recurrent vulvovaginal CANDIDIASIS.,114-124-137,78-90-102,Maintenance FLUCONAZOLE therapy,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.",137,90,137,90,-1,148,101,TWrex-cause,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis",candidiasis,fluconazole
725480638,5/25/2015 09:28:53,1642950773,5/25/2015 09:28:38,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,137,90,,,148,101,CANDIDIASIS,FLUCONAZOLE,CANDIDIASIS.,137,90,FLUCONAZOLE,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.",137,90,137,90,-1,148,101,TWrex-cause,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis",candidiasis,fluconazole
725480638,5/25/2015 09:33:34,1642951580,5/25/2015 09:33:20,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,137,90,,,148,101,CANDIDIASIS,FLUCONAZOLE,recurrent vulvovaginal CANDIDIASIS.,114-124-137,90-102,FLUCONAZOLE therapy,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.",137,90,137,90,-1,148,101,TWrex-cause,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis",candidiasis,fluconazole
725480639,5/25/2015 11:39:34,1642984539,5/25/2015 11:39:21,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,202,186,,,208,190,ANEMIA,IRON,iron deficiency ANEMIA,186-191-202,186-191-202,IRON deficiency anemia,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1.",202,186,202,186,-1,208,190,TWrex-cause,804439,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1",anemia,iron
725480639,5/25/2015 11:56:20,1642987864,5/25/2015 11:56:07,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,202,186,,,208,190,ANEMIA,IRON,ANEMIA,202,186,IRON,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1.",202,186,202,186,-1,208,190,TWrex-cause,804439,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1",anemia,iron
725480639,5/25/2015 12:01:13,1642988687,5/25/2015 12:00:56,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,202,186,,,208,190,ANEMIA,IRON,iron deficiency ANEMIA,186-191-202,186-191-202,IRON deficiency anemia,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1.",202,186,202,186,-1,208,190,TWrex-cause,804439,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1",anemia,iron
725480639,5/25/2015 12:24:53,1642994115,5/25/2015 12:24:25,false,instagc,1,26024737,GBR,A9,Blackpool,2.97.97.40,202,186,,,208,190,ANEMIA,IRON,ANEMIA,202,186,IRON,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1.",202,186,202,186,-1,208,190,TWrex-cause,804439,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1",anemia,iron
725480639,5/25/2015 12:41:47,1642997639,5/25/2015 12:41:25,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,202,186,,,208,190,ANEMIA,IRON,iron deficiency ANEMIA,186-191-202,186,IRON,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1.",202,186,202,186,-1,208,190,TWrex-cause,804439,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1",anemia,iron
725480639,5/25/2015 12:41:51,1642997643,5/25/2015 12:41:25,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,202,186,,,208,190,ANEMIA,IRON,of iron deficiency ANEMIA,183-186-191-202,166-172-183-186-191-202,lower prevalence of IRON deficiency anemia,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1.",202,186,202,186,-1,208,190,TWrex-cause,804439,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1",anemia,iron
725480639,5/25/2015 12:48:36,1642998890,5/25/2015 12:47:38,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,202,186,,,208,190,ANEMIA,IRON,iron deficiency ANEMIA,186-202-191,186-191-202,IRON deficiency anemia,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1.",202,186,202,186,-1,208,190,TWrex-cause,804439,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1",anemia,iron
725480639,5/25/2015 12:49:17,1642999041,5/25/2015 12:49:09,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,202,186,,,208,190,ANEMIA,IRON,iron deficiency ANEMIA,186-191-202,186-191-202,IRON deficiency anemia,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1.",202,186,202,186,-1,208,190,TWrex-cause,804439,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1",anemia,iron
725480639,5/25/2015 12:50:34,1642999228,5/25/2015 12:50:01,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,202,186,,,208,190,ANEMIA,IRON,iron deficiency ANEMIA,186-191-202,186-191-202,IRON deficiency anemia,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1.",202,186,202,186,-1,208,190,TWrex-cause,804439,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1",anemia,iron
725480639,5/25/2015 12:55:29,1643000154,5/25/2015 12:55:17,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,202,186,,,208,190,ANEMIA,IRON,iron deficiency ANEMIA,186-191-202,186-191-202,IRON deficiency anemia,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1.",202,186,202,186,-1,208,190,TWrex-cause,804439,"• A review of placebo-controlled trials of iron treatment in pregnant women revealed that iron-treated women had greater iron reserves, higher hemoglobin levels, and lower prevalence of iron deficiency anemia ( 1",anemia,iron
725480640,5/25/2015 10:15:23,1642958331,5/25/2015 10:15:06,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,0,156,,,18,164,SYSTEMIC INFECTION,CEFEPIME,SYSTEMIC INFECTION:,0-9,156,"CEFEPIME,","Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem.",0 9,156,0,156,-1,18,164,TWrex-cause,804796,"Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem",systemic infection,cefepime
725480640,5/25/2015 10:18:37,1642958891,5/25/2015 10:18:14,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,0,156,,,18,164,SYSTEMIC INFECTION,CEFEPIME,SYSTEMIC INFECTION:,0-9,156,"CEFEPIME,","Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem.",0 9,156,0,156,-1,18,164,TWrex-cause,804796,"Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem",systemic infection,cefepime
725480640,5/25/2015 10:20:11,1642959301,5/25/2015 10:19:20,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,0,156,,,18,164,SYSTEMIC INFECTION,CEFEPIME,SYSTEMIC INFECTION:,0-9,156,"CEFEPIME,","Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem.",0 9,156,0,156,-1,18,164,TWrex-cause,804796,"Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem",systemic infection,cefepime
725480640,5/25/2015 10:28:22,1642962172,5/25/2015 10:28:07,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,0,156,,,18,164,SYSTEMIC INFECTION,CEFEPIME,SYSTEMIC INFECTION:,0-9,156,"CEFEPIME,","Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem.",0 9,156,0,156,-1,18,164,TWrex-cause,804796,"Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem",systemic infection,cefepime
725480640,5/25/2015 10:44:44,1642974346,5/25/2015 10:44:25,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,0,156,,,18,164,SYSTEMIC INFECTION,CEFEPIME,SYSTEMIC INFECTION:,0-9,156-166,"CEFEPIME, cefoperazone),","Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem.",0 9,156,0,156,-1,18,164,TWrex-cause,804796,"Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem",systemic infection,cefepime
725480640,5/25/2015 10:46:03,1642974759,5/25/2015 10:45:25,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,0,156,,,18,164,SYSTEMIC INFECTION,CEFEPIME,SYSTEMIC INFECTION:,0-9,156-166,"CEFEPIME, cefoperazone),","Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem.",0 9,156,0,156,-1,18,164,TWrex-cause,804796,"Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem",systemic infection,cefepime
725480640,5/25/2015 10:51:35,1642975646,5/25/2015 10:51:20,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,0,156,,,18,164,SYSTEMIC INFECTION,CEFEPIME,SYSTEMIC INFECTION:,0-9,151-156,"(eg, CEFEPIME,","Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem.",0 9,156,0,156,-1,18,164,TWrex-cause,804796,"Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem",systemic infection,cefepime
725480640,5/25/2015 10:56:26,1642976414,5/25/2015 10:56:03,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,0,156,,,18,164,SYSTEMIC INFECTION,CEFEPIME,"SYSTEMIC INFECTION: Parenteral therapy is required,",0-9-21-32-40-43,125-137-151-156-166-181-184-120,"anti pseudomonal cephalosporin (eg, CEFEPIME, cefoperazone), or meropenem.","Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem.",0 9,156,0,156,-1,18,164,TWrex-cause,804796,"Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem",systemic infection,cefepime
725480640,5/25/2015 11:34:02,1642983559,5/25/2015 11:33:41,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,0,156,,,18,164,SYSTEMIC INFECTION,CEFEPIME,SYSTEMIC INFECTION:,0-9,125-137-151-156-166-120,"anti pseudomonal cephalosporin (eg, CEFEPIME, cefoperazone),","Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem.",0 9,156,0,156,-1,18,164,TWrex-cause,804796,"Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem",systemic infection,cefepime
725480640,5/25/2015 11:42:43,1642985234,5/25/2015 11:41:54,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,0,156,,,18,164,SYSTEMIC INFECTION,CEFEPIME,SYSTEMIC INFECTION:,0-9,94-120-125-137-151-156-166-181-184-112,"antipseudomonal lactam, anti pseudomonal cephalosporin (eg, CEFEPIME, cefoperazone), or meropenem.","Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem.",0 9,156,0,156,-1,18,164,TWrex-cause,804796,"Systemic infection:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β-lactam, anti-pseudomonal cephalosporin (eg, cefepime, cefoperazone), or meropenem",systemic infection,cefepime
725480641,5/25/2015 11:39:20,1642984521,5/25/2015 11:39:08,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,190,103,,,197,132,ANXIETY,POSTTRAUMATIC STRESS DISORDER,ANXIETY.,190,103-117-124,POSTTRAUMATIC STRESS DISORDER,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.",190,103 117 124,190,103,1,197,132,TWrex-cause,814420,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety",anxiety,posttraumatic stress disorder
725480641,5/25/2015 11:56:07,1642987841,5/25/2015 11:55:55,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,190,103,,,197,132,ANXIETY,POSTTRAUMATIC STRESS DISORDER,ANXIETY.,190,103-117-124,POSTTRAUMATIC STRESS DISORDER,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.",190,103 117 124,190,103,1,197,132,TWrex-cause,814420,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety",anxiety,posttraumatic stress disorder
725480641,5/25/2015 12:00:48,1642988535,5/25/2015 12:00:19,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,190,103,,,197,132,ANXIETY,POSTTRAUMATIC STRESS DISORDER,ANXIETY.,190,103-117-124,POSTTRAUMATIC STRESS DISORDER,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.",190,103 117 124,190,103,1,197,132,TWrex-cause,814420,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety",anxiety,posttraumatic stress disorder
725480641,5/25/2015 12:24:23,1642994033,5/25/2015 12:23:05,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,190,103,,,197,132,ANXIETY,POSTTRAUMATIC STRESS DISORDER,ANXIETY.,190,103-117-124,POSTTRAUMATIC STRESS DISORDER,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.",190,103 117 124,190,103,1,197,132,TWrex-cause,814420,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety",anxiety,posttraumatic stress disorder
725480641,5/25/2015 12:41:23,1642997567,5/25/2015 12:40:38,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,190,103,,,197,132,ANXIETY,POSTTRAUMATIC STRESS DISORDER,Depression and ANXIETY.,175-186-190,80-90-100-103-117-124-133-138-142,Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.",190,103 117 124,190,103,1,197,132,TWrex-cause,814420,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety",anxiety,posttraumatic stress disorder
725480641,5/25/2015 12:41:24,1642997571,5/25/2015 12:40:56,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,190,103,,,197,132,ANXIETY,POSTTRAUMATIC STRESS DISORDER,Depression and ANXIETY.,175-186-190,103-117-124,POSTTRAUMATIC STRESS DISORDER,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.",190,103 117 124,190,103,1,197,132,TWrex-cause,814420,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety",anxiety,posttraumatic stress disorder
725480641,5/25/2015 12:46:40,1642998493,5/25/2015 12:46:04,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,190,103,,,197,132,ANXIETY,POSTTRAUMATIC STRESS DISORDER,ANXIETY.,190,103-117-124,POSTTRAUMATIC STRESS DISORDER,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.",190,103 117 124,190,103,1,197,132,TWrex-cause,814420,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety",anxiety,posttraumatic stress disorder
725480641,5/25/2015 12:47:37,1642998673,5/25/2015 12:47:25,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,190,103,,,197,132,ANXIETY,POSTTRAUMATIC STRESS DISORDER,ANXIETY.,190,103-117-124,POSTTRAUMATIC STRESS DISORDER,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.",190,103 117 124,190,103,1,197,132,TWrex-cause,814420,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety",anxiety,posttraumatic stress disorder
725480641,5/25/2015 12:49:08,1642999004,5/25/2015 12:48:58,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,190,103,,,197,132,ANXIETY,POSTTRAUMATIC STRESS DISORDER,ANXIETY.,190,103-117-124,POSTTRAUMATIC STRESS DISORDER,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.",190,103 117 124,190,103,1,197,132,TWrex-cause,814420,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety",anxiety,posttraumatic stress disorder
725480641,5/25/2015 12:50:00,1642999148,5/25/2015 12:49:21,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,190,103,,,197,132,ANXIETY,POSTTRAUMATIC STRESS DISORDER,ANXIETY.,190,103-117-124,POSTTRAUMATIC STRESS DISORDER,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.",190,103 117 124,190,103,1,197,132,TWrex-cause,814420,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety",anxiety,posttraumatic stress disorder
725480642,5/25/2015 08:23:53,1642940457,5/25/2015 08:23:30,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,60,93,,,71,96,CONDYLOMA,HPV,(CONDYLOMATA acuminata),59-72,93,HPV.,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,,93,60,93,1,71,96,TWrex-cause,810520,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV,condyloma,HPV
725480642,5/25/2015 08:52:37,1642945321,5/25/2015 08:52:22,false,elite,1.0,26544151,GBR,"","",213.205.252.245,60,93,,,71,96,CONDYLOMA,HPV,(CONDYLOMATA,59,93,HPV.,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,,93,60,93,1,71,96,TWrex-cause,810520,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV,condyloma,HPV
725480642,5/25/2015 08:52:41,1642945339,5/25/2015 08:52:21,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,60,93,,,71,96,CONDYLOMA,HPV,(CONDYLOMATA acuminata),59-72,93,HPV.,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,,93,60,93,1,71,96,TWrex-cause,810520,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV,condyloma,HPV
725480642,5/25/2015 09:00:37,1642946445,5/25/2015 09:00:21,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,60,93,,,71,96,CONDYLOMA,HPV,exophytic warts (CONDYLOMATA acuminata),43-53-59-72,93,HPV.,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,,93,60,93,1,71,96,TWrex-cause,810520,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV,condyloma,HPV
725480642,5/25/2015 09:06:31,1642947377,5/25/2015 09:06:19,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,60,93,,,71,96,CONDYLOMA,HPV,(CONDYLOMATA acuminata),59-72,93,HPV.,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,,93,60,93,1,71,96,TWrex-cause,810520,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV,condyloma,HPV
725480642,5/25/2015 09:22:19,1642949673,5/25/2015 09:22:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,60,93,,,71,96,CONDYLOMA,HPV,Treatment of external genital and perianal exophytic warts (CONDYLOMATA acuminata) caused by HPV.,0-10-13-22-30-34-43-53-59-72-83-90-93,0-10-13-22-30-34-43-53-72-83-90-93-59,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,,93,60,93,1,71,96,TWrex-cause,810520,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV,condyloma,HPV
725480642,5/25/2015 09:30:30,1642950996,5/25/2015 09:29:53,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,60,93,,,71,96,CONDYLOMA,HPV,exophytic warts (CONDYLOMATA acuminata),43-53-59-72,93,HPV.,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,,93,60,93,1,71,96,TWrex-cause,810520,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV,condyloma,HPV
725480642,5/25/2015 09:36:00,1642952051,5/25/2015 09:35:21,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,60,93,,,71,96,CONDYLOMA,HPV,(CONDYLOMATA,59,93,HPV.,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,,93,60,93,1,71,96,TWrex-cause,810520,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV,condyloma,HPV
725480642,5/25/2015 09:50:31,1642954218,5/25/2015 09:50:18,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,60,93,,,71,96,CONDYLOMA,HPV,(CONDYLOMATA acuminata),59-72,93,HPV.,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,,93,60,93,1,71,96,TWrex-cause,810520,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV,condyloma,HPV
725480642,5/25/2015 09:59:03,1642955676,5/25/2015 09:58:21,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,60,93,,,71,96,CONDYLOMA,HPV,exophytic warts (CONDYLOMATA acuminata),43-53-59-72,93,HPV.,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV.,,93,60,93,1,71,96,TWrex-cause,810520,Treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by HPV,condyloma,HPV
725480643,5/25/2015 09:51:47,1642954425,5/25/2015 09:51:32,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,291,211,,,304,228,HYPOCALCIURIA,GITELMAN SYNDROME,HYPOCALCIURIA.,291,211-220,GITELMAN SYNDROME,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria.",291,211 220,291,211,1,304,228,TWrex-cause,812847,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria",hypocalciuria,gitelman syndrome
725480643,5/25/2015 10:00:46,1642955922,5/25/2015 10:00:36,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,291,211,,,304,228,HYPOCALCIURIA,GITELMAN SYNDROME,HYPOCALCIURIA.,291,211-220,GITELMAN SYNDROME,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria.",291,211 220,291,211,1,304,228,TWrex-cause,812847,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria",hypocalciuria,gitelman syndrome
725480643,5/25/2015 10:01:43,1642956163,5/25/2015 10:01:06,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,291,211,,,304,228,HYPOCALCIURIA,GITELMAN SYNDROME,HYPOCALCIURIA.,291,211-220,GITELMAN SYNDROME,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria.",291,211 220,291,211,1,304,228,TWrex-cause,812847,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria",hypocalciuria,gitelman syndrome
725480643,5/25/2015 10:07:40,1642957005,5/25/2015 10:07:28,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,291,211,,,304,228,HYPOCALCIURIA,GITELMAN SYNDROME,HYPOCALCIURIA.,291,211-220,GITELMAN SYNDROME,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria.",291,211 220,291,211,1,304,228,TWrex-cause,812847,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria",hypocalciuria,gitelman syndrome
725480643,5/25/2015 10:08:04,1642957089,5/25/2015 10:07:37,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,291,211,,,304,228,HYPOCALCIURIA,GITELMAN SYNDROME,HYPOCALCIURIA.,291,211-220,GITELMAN SYNDROME,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria.",291,211 220,291,211,1,304,228,TWrex-cause,812847,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria",hypocalciuria,gitelman syndrome
725480643,5/25/2015 10:21:03,1642959551,5/25/2015 10:20:47,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,291,211,,,304,228,HYPOCALCIURIA,GITELMAN SYNDROME,HYPOCALCIURIA.,291,211-220,GITELMAN SYNDROME,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria.",291,211 220,291,211,1,304,228,TWrex-cause,812847,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria",hypocalciuria,gitelman syndrome
725480643,5/25/2015 10:24:55,1642960843,5/25/2015 10:24:43,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,291,211,,,304,228,HYPOCALCIURIA,GITELMAN SYNDROME,HYPOCALCIURIA.,291,211-220,GITELMAN SYNDROME,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria.",291,211 220,291,211,1,304,228,TWrex-cause,812847,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria",hypocalciuria,gitelman syndrome
725480643,5/25/2015 10:29:57,1642962876,5/25/2015 10:27:40,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,291,211,,,304,228,HYPOCALCIURIA,GITELMAN SYNDROME,HYPOCALCIURIA.,291,211-220,GITELMAN SYNDROME,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria.",291,211 220,291,211,1,304,228,TWrex-cause,812847,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria",hypocalciuria,gitelman syndrome
725480643,5/25/2015 10:36:23,1642967561,5/25/2015 10:36:06,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,291,211,,,304,228,HYPOCALCIURIA,GITELMAN SYNDROME,and HYPOCALCIURIA.,282-291,211-220,GITELMAN SYNDROME,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria.",291,211 220,291,211,1,304,228,TWrex-cause,812847,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria",hypocalciuria,gitelman syndrome
725480643,5/25/2015 10:41:52,1642972578,5/25/2015 10:41:42,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,291,211,,,304,228,HYPOCALCIURIA,GITELMAN SYNDROME,HYPOCALCIURIA.,291,211-220,GITELMAN SYNDROME,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria.",291,211 220,291,211,1,304,228,TWrex-cause,812847,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with Gitelman syndrome can demonstrate normal urinary concentrating ability and have hypocalciuria",hypocalciuria,gitelman syndrome
725480644,5/25/2015 11:41:15,1642984878,5/25/2015 11:40:59,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,234,281,,,238,288,EYE,UVEITIS,dry EYES;,230-234,281,UVEITIS,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis.",234,281,234,281,-1,238,288,TWrex-cause,802053,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis",eye,uveitis
725480644,5/25/2015 11:57:40,1642988066,5/25/2015 11:57:28,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,234,281,,,238,288,EYE,UVEITIS,EYES;,234,281,UVEITIS,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis.",234,281,234,281,-1,238,288,TWrex-cause,802053,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis",eye,uveitis
725480644,5/25/2015 12:05:17,1642989561,5/25/2015 12:04:30,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,234,281,,,238,288,EYE,UVEITIS,dry EYES;,230-234,240-246-281-273,other symptoms suggest UVEITIS,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis.",234,281,234,281,-1,238,288,TWrex-cause,802053,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis",eye,uveitis
725480644,5/25/2015 12:43:56,1642998057,5/25/2015 12:43:39,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,234,281,,,238,288,EYE,UVEITIS,dry EYES;,230-234,281,UVEITIS,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis.",234,281,234,281,-1,238,288,TWrex-cause,802053,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis",eye,uveitis
725480644,5/25/2015 12:44:23,1642998092,5/25/2015 12:44:07,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,234,281,,,238,288,EYE,UVEITIS,sensation suggests dry EYES;,211-221-230-234,255-260-273-281-289-292,"(eg, photophobia) suggest UVEITIS or keratitis.","Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis.",234,281,234,281,-1,238,288,TWrex-cause,802053,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis",eye,uveitis
725480644,5/25/2015 12:51:17,1642999378,5/25/2015 12:50:47,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,234,281,,,238,288,EYE,UVEITIS,dry EYES;,230-234,281,UVEITIS,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis.",234,281,234,281,-1,238,288,TWrex-cause,802053,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis",eye,uveitis
725480644,5/25/2015 12:57:33,1643000567,5/25/2015 12:56:37,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,234,281,,,238,288,EYE,UVEITIS,dry EYES;,230-234,281-289-292,UVEITIS or keratitis.,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis.",234,281,234,281,-1,238,288,TWrex-cause,802053,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis",eye,uveitis
725480644,5/25/2015 12:58:46,1643000746,5/25/2015 12:58:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,234,281,,,238,288,EYE,UVEITIS,dry EYES;,230-234,281,UVEITIS,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis.",234,281,234,281,-1,238,288,TWrex-cause,802053,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis",eye,uveitis
725480644,5/25/2015 13:10:27,1643002788,5/25/2015 13:09:54,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,234,281,,,238,288,EYE,UVEITIS,EYES;,234,281,UVEITIS,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis.",234,281,234,281,-1,238,288,TWrex-cause,802053,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis",eye,uveitis
725480644,5/25/2015 13:16:01,1643003783,5/25/2015 13:15:49,false,bitcoinget,1,21614812,USA,NJ,Blackwood,50.153.127.136,234,281,,,238,288,EYE,UVEITIS,dry EYES;,230-234,281,UVEITIS,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis.",234,281,234,281,-1,238,288,TWrex-cause,802053,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests dry eyes; other symptoms (eg, photophobia) suggest uveitis or keratitis",eye,uveitis
725480645,5/25/2015 08:20:10,1642939638,5/25/2015 08:19:54,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,594,576,,,598,580,SITE,PAIN,pain at injection SITE,576-581-584-594,576-581-584-594,PAIN at injection site,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction.",594,576,594,576,-1,598,580,TWrex-cause,802010,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction",site,pain
725480645,5/25/2015 08:49:44,1642944767,5/25/2015 08:49:26,false,elite,1.0,26544151,GBR,"","",213.205.252.245,594,576,,,598,580,SITE,PAIN,SITE,594,576,PAIN,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction.",594,576,594,576,-1,598,580,TWrex-cause,802010,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction",site,pain
725480645,5/25/2015 08:50:03,1642944845,5/25/2015 08:49:06,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,594,576,,,598,580,SITE,PAIN,Mild erythema and pain at injection SITE,558-563-572-576-581-594-584,558-563-572-576-581-584-594,Mild erythema and PAIN at injection site,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction.",594,576,594,576,-1,598,580,TWrex-cause,802010,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction",site,pain
725480645,5/25/2015 08:57:15,1642945968,5/25/2015 08:56:54,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,594,576,,,598,580,SITE,PAIN,injection SITE,584-594,576,PAIN,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction.",594,576,594,576,-1,598,580,TWrex-cause,802010,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction",site,pain
725480645,5/25/2015 09:03:04,1642946793,5/25/2015 09:02:31,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,594,576,,,598,580,SITE,PAIN,pain at injection SITE,576-584-594-581,576-584-594-581,PAIN at injection site,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction.",594,576,594,576,-1,598,580,TWrex-cause,802010,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction",site,pain
725480645,5/25/2015 09:13:47,1642948368,5/25/2015 09:11:31,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,594,576,,,598,580,SITE,PAIN,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine Develops antibodies to these bacteria 0.5 mL sc Prevents overwhelming sepsis syndrome Infrequent erythema at injection site Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine Develops antibodies to these bacteria 0.5 mL im Prevents overwhelming sepsis Mild erythema and pain at injection SITE in 10% Most important in patients who are asplenic or have splenic dysfunction.",0-10-26-29-34-42-55-59-63-71-75-83-93-100-109-123-138-147-156-167-170-176-186-190-193-197-206-219-226-236-247-256-259-269-275-280-290-293-302-306-310-319-322-327-335-348-353-363-366-376-384-390-401-405-410-417-420-424-430-442-452-457-459-469-478-487-498-501-507-517-521-524-528-537-550-558-563-572-576-581-584-594-599-602-607-612-622-625-634-638-642-651-654-659-667,0-10-26-29-34-42-55-59-63-71-75-83-93-100-109-123-138-147-156-167-170-176-186-190-193-197-206-219-226-236-247-256-259-269-275-280-290-293-302-306-310-319-322-327-335-348-353-363-366-376-384-390-401-405-410-417-420-424-430-442-452-457-459-469-478-487-498-501-507-517-521-524-528-537-550-558-563-572-576-581-584-594-599-602-607-612-622-625-634-638-642-651-654-659-667,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine Develops antibodies to these bacteria 0.5 mL sc Prevents overwhelming sepsis syndrome Infrequent erythema at injection site Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine Develops antibodies to these bacteria 0.5 mL im Prevents overwhelming sepsis Mild erythema and PAIN at injection site in 10% Most important in patients who are asplenic or have splenic dysfunction.","important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction.",594,576,594,576,-1,598,580,TWrex-cause,802010,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction",site,pain
725480645,5/25/2015 09:20:19,1642949389,5/25/2015 09:19:00,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,594,576,,,598,580,SITE,PAIN,injection SITE,584-594,576,PAIN,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction.",594,576,594,576,-1,598,580,TWrex-cause,802010,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction",site,pain
725480645,5/25/2015 09:32:09,1642951255,5/25/2015 09:31:24,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,594,576,,,598,580,SITE,PAIN,SITE,594,576,PAIN,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction.",594,576,594,576,-1,598,580,TWrex-cause,802010,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction",site,pain
725480645,5/25/2015 09:48:06,1642953844,5/25/2015 09:47:53,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,594,576,,,598,580,SITE,PAIN,injection SITE,594-584,576,PAIN,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction.",594,576,594,576,-1,598,580,TWrex-cause,802010,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction",site,pain
725480645,5/25/2015 09:54:40,1642954770,5/25/2015 09:54:27,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,594,576,,,598,580,SITE,PAIN,SITE,594,576,PAIN,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction.",594,576,594,576,-1,598,580,TWrex-cause,802010,"important postsplenectomy or with splenic dysfunction, but may benefit all chronic hemolytic anemia patients Meningococcal polysaccharide vaccine  Develops antibodies to these bacteria  0.5 mL sc  Prevents overwhelming sepsis syndrome  Infrequent erythema at injection site  Most important in patients who are asplenic or have splenic dysfunction; very important in children, because these infections are more common in the young Haemophilus influenza type B conjugate vaccine  Develops antibodies to these bacteria  0.5 mL im  Prevents overwhelming sepsis  Mild erythema and pain at injection site in 10%  Most important in patients who are asplenic or have splenic dysfunction",site,pain
725480646,5/25/2015 11:40:39,1642984782,5/25/2015 11:40:11,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,127,69,,,135,80,ACIDOSIS,TRIS BUFFER,ACIDOSIS Prevention,127-137,69-74-82,TRIS BUFFER; Tris(hydroxymethyl)aminomethane;,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery.",127,69 74,127,69,-1,135,80,TWrex-cause,804784,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery",acidosis,tris buffer
725480646,5/25/2015 11:57:10,1642987984,5/25/2015 11:56:54,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,127,69,,,135,80,ACIDOSIS,TRIS BUFFER,ACIDOSIS,127,69-74,TRIS BUFFER;,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery.",127,69 74,127,69,-1,135,80,TWrex-cause,804784,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery",acidosis,tris buffer
725480646,5/25/2015 12:03:35,1642989241,5/25/2015 12:02:23,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,127,69,,,135,80,ACIDOSIS,TRIS BUFFER,ACIDOSIS Prevention,127-137,69-74-82,TRIS BUFFER; Tris(hydroxymethyl)aminomethane;,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery.",127,69 74,127,69,-1,135,80,TWrex-cause,804784,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery",acidosis,tris buffer
725480646,5/25/2015 12:43:10,1642997974,5/25/2015 12:42:33,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,127,69,,,135,80,ACIDOSIS,TRIS BUFFER,ACIDOSIS,127,69-74,TRIS BUFFER;,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery.",127,69 74,127,69,-1,135,80,TWrex-cause,804784,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery",acidosis,tris buffer
725480646,5/25/2015 12:43:43,1642998031,5/25/2015 12:43:07,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,127,69,,,135,80,ACIDOSIS,TRIS BUFFER,Uses ACIDOSIS Prevention and correction,121-127-137-148-152,46-52-58-69-74-82-115-121,TN900 (VA) Synonyms: TRIS BUFFER; Tris(hydroxymethyl)aminomethane; Tham Uses,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery.",127,69 74,127,69,-1,135,80,TWrex-cause,804784,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery",acidosis,tris buffer
725480646,5/25/2015 12:50:25,1642999199,5/25/2015 12:49:41,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,127,69,,,135,80,ACIDOSIS,TRIS BUFFER,ACIDOSIS,127,69-74,TRIS BUFFER;,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery.",127,69 74,127,69,-1,135,80,TWrex-cause,804784,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery",acidosis,tris buffer
725480646,5/25/2015 12:56:22,1643000359,5/25/2015 12:56:04,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,127,69,,,135,80,ACIDOSIS,TRIS BUFFER,ACIDOSIS Prevention and correction of metabolic acidosis,127-137-148-152-163-166-176,69-74-82,TRIS BUFFER; Tris(hydroxymethyl)aminomethane;,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery.",127,69 74,127,69,-1,135,80,TWrex-cause,804784,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery",acidosis,tris buffer
725480646,5/25/2015 12:57:06,1643000508,5/25/2015 12:56:57,false,clixsense,1.0,6352682,GBR,H9,London,2.122.19.138,127,69,,,135,80,ACIDOSIS,TRIS BUFFER,Tris(hydroxymethyl)aminomethane; Tham Uses ACIDOSIS Prevention and correction acidosis,82-115-121-127-137-148-152-176,46-52-58-69-74-82-115-121-176,TN900 (VA) Synonyms: TRIS BUFFER; Tris(hydroxymethyl)aminomethane; Tham Uses acidosis,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery.",127,69 74,127,69,-1,135,80,TWrex-cause,804784,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery",acidosis,tris buffer
725480646,5/25/2015 12:57:23,1643000548,5/25/2015 12:55:51,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,127,69,,,135,80,ACIDOSIS,TRIS BUFFER,ACIDOSIS,127,69-74,TRIS BUFFER;,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery.",127,69 74,127,69,-1,135,80,TWrex-cause,804784,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery",acidosis,tris buffer
725480646,5/25/2015 13:09:01,1643002497,5/25/2015 13:06:52,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,127,69,,,135,80,ACIDOSIS,TRIS BUFFER,ACIDOSIS,127,69-74-82,TRIS BUFFER; Tris(hydroxymethyl)aminomethane;,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery.",127,69 74,127,69,-1,135,80,TWrex-cause,804784,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  Tris Buffer; Tris(hydroxymethyl)aminomethane; Tham  Uses  Acidosis  Prevention and correction of metabolic acidosis associated with cardiac bypass surgery",acidosis,tris buffer
725480647,5/25/2015 11:39:51,1642984585,5/25/2015 11:39:35,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,36,95,,,51,106,SCHISTOSOMIASIS,SCHISTOSOMA,SCHISTOSOMIASIS,36,95,SCHISTOSOMA,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries.,36,95,36,95,1,51,106,TWrex-cause,811748,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries,schistosomiasis,schistosoma
725480647,5/25/2015 11:56:37,1642987899,5/25/2015 11:56:22,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,36,95,,,51,106,SCHISTOSOMIASIS,SCHISTOSOMA,SCHISTOSOMIASIS,36,95,SCHISTOSOMA,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries.,36,95,36,95,1,51,106,TWrex-cause,811748,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries,schistosomiasis,schistosoma
725480647,5/25/2015 12:01:50,1642988844,5/25/2015 12:01:14,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,36,95,,,51,106,SCHISTOSOMIASIS,SCHISTOSOMA,SCHISTOSOMIASIS in individuals who travel to or reside in Schistosoma endemic countries.,36-52-55-67-71-78-81-84-91-95-108-116,55-67-71-81-84-91-95-108-116-78,individuals who travel to or reside in SCHISTOSOMA endemic countries.,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries.,36,95,36,95,1,51,106,TWrex-cause,811748,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries,schistosomiasis,schistosoma
725480647,5/25/2015 12:42:11,1642997733,5/25/2015 12:41:48,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,36,95,,,51,106,SCHISTOSOMIASIS,SCHISTOSOMA,SCHISTOSOMIASIS,36,95-108-116,SCHISTOSOMA endemic countries.,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries.,36,95,36,95,1,51,106,TWrex-cause,811748,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries,schistosomiasis,schistosoma
725480647,5/25/2015 12:42:33,1642997799,5/25/2015 12:41:53,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,36,95,,,51,106,SCHISTOSOMIASIS,SCHISTOSOMA,Introduction Screen for SCHISTOSOMIASIS,11-25-32-36,81-84-91-95-108-116,or reside in SCHISTOSOMA endemic countries.,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries.,36,95,36,95,1,51,106,TWrex-cause,811748,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries,schistosomiasis,schistosoma
725480647,5/25/2015 12:49:06,1642999003,5/25/2015 12:48:37,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,36,95,,,51,106,SCHISTOSOMIASIS,SCHISTOSOMA,SCHISTOSOMIASIS,36,95,SCHISTOSOMA,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries.,36,95,36,95,1,51,106,TWrex-cause,811748,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries,schistosomiasis,schistosoma
725480647,5/25/2015 12:51:19,1642999387,5/25/2015 12:50:34,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,36,95,,,51,106,SCHISTOSOMIASIS,SCHISTOSOMA,SCHISTOSOMIASIS,36,95-108,SCHISTOSOMA endemic,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries.,36,95,36,95,1,51,106,TWrex-cause,811748,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries,schistosomiasis,schistosoma
725480647,5/25/2015 12:55:47,1643000202,5/25/2015 12:55:29,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,36,95,,,51,106,SCHISTOSOMIASIS,SCHISTOSOMA,SCHISTOSOMIASIS,36,95-108-116,SCHISTOSOMA endemic countries.,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries.,36,95,36,95,1,51,106,TWrex-cause,811748,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries,schistosomiasis,schistosoma
725480647,5/25/2015 12:56:37,1643000402,5/25/2015 12:56:27,false,clixsense,1.0,6352682,GBR,H9,London,2.122.19.138,36,95,,,51,106,SCHISTOSOMIASIS,SCHISTOSOMA,Introduction Screen for SCHISTOSOMIASIS in individuals who Schistosoma,11-25-32-36-52-55-67-95,81-84-91-95-108-116-36,schistosomiasis or reside in SCHISTOSOMA endemic countries.,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries.,36,95,36,95,1,51,106,TWrex-cause,811748,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries,schistosomiasis,schistosoma
725480647,5/25/2015 13:06:22,1643002074,5/25/2015 13:05:20,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,36,95,,,51,106,SCHISTOSOMIASIS,SCHISTOSOMA,SCHISTOSOMIASIS,36,95,SCHISTOSOMA,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries.,36,95,36,95,1,51,106,TWrex-cause,811748,SCREENING  Introduction  Screen for schistosomiasis in individuals who travel to or reside in  Schistosoma -endemic countries,schistosomiasis,schistosoma
725480648,5/25/2015 10:53:43,1642975946,5/25/2015 10:53:30,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,52,73,,,56,86,PAIN,ENDOMETRIOSIS,PAIN,52,73,ENDOMETRIOSIS.,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis.,52,73,52,73,1,56,86,TWrex-cause,813422,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis,pain,endometriosis
725480648,5/25/2015 10:59:00,1642976863,5/25/2015 10:58:40,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,52,73,,,56,86,PAIN,ENDOMETRIOSIS,oral contraceptives for PAIN associated with endometriosis.,28-33-48-52-57-68-73,12-28-52-57-68-73-33,Modern oral contraceptives pain associated with ENDOMETRIOSIS.,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis.,52,73,52,73,1,56,86,TWrex-cause,813422,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis,pain,endometriosis
725480648,5/25/2015 11:35:39,1642983902,5/25/2015 11:35:28,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,52,73,,,56,86,PAIN,ENDOMETRIOSIS,PAIN,52,73,ENDOMETRIOSIS.,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis.,52,73,52,73,1,56,86,TWrex-cause,813422,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis,pain,endometriosis
725480648,5/25/2015 11:44:43,1642985655,5/25/2015 11:44:33,false,dailyrewardsca,1.0,32438879,CAN,NB,Fredericton,156.57.46.234,52,73,,,56,86,PAIN,ENDOMETRIOSIS,PAIN,52,73,ENDOMETRIOSIS.,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis.,52,73,52,73,1,56,86,TWrex-cause,813422,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis,pain,endometriosis
725480648,5/25/2015 11:52:39,1642987357,5/25/2015 11:52:20,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,52,73,,,56,86,PAIN,ENDOMETRIOSIS,PAIN associated with endometriosis.,52-57-68-73,73,ENDOMETRIOSIS.,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis.,52,73,52,73,1,56,86,TWrex-cause,813422,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis,pain,endometriosis
725480648,5/25/2015 11:52:43,1642987374,5/25/2015 11:52:32,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,52,73,,,56,86,PAIN,ENDOMETRIOSIS,PAIN,52,73,ENDOMETRIOSIS.,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis.,52,73,52,73,1,56,86,TWrex-cause,813422,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis,pain,endometriosis
725480648,5/25/2015 11:56:27,1642987879,5/25/2015 11:56:09,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,52,73,,,56,86,PAIN,ENDOMETRIOSIS,PAIN associated with endometriosis.,52-57-68-73,73,ENDOMETRIOSIS.,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis.,52,73,52,73,1,56,86,TWrex-cause,813422,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis,pain,endometriosis
725480648,5/25/2015 12:10:45,1642990624,5/25/2015 12:10:35,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,52,73,,,56,86,PAIN,ENDOMETRIOSIS,PAIN,52,73,ENDOMETRIOSIS.,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis.,52,73,52,73,1,56,86,TWrex-cause,813422,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis,pain,endometriosis
725480648,5/25/2015 12:30:15,1642995192,5/25/2015 12:27:49,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,52,73,,,56,86,PAIN,ENDOMETRIOSIS,oral contraceptives for PAIN with endometriosis.,28-33-48-52-68-73,52-57-68-73,pain associated with ENDOMETRIOSIS.,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis.,52,73,52,73,1,56,86,TWrex-cause,813422,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis,pain,endometriosis
725480648,5/25/2015 12:33:24,1642995934,5/25/2015 12:33:06,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,52,73,,,56,86,PAIN,ENDOMETRIOSIS,oral contraceptives PAIN endometriosis.,28-33-52-73,52-57-73,pain associated ENDOMETRIOSIS.,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis.,52,73,52,73,1,56,86,TWrex-cause,813422,2000-04-01  Modern combined oral contraceptives for pain associated with endometriosis,pain,endometriosis
725480649,5/25/2015 08:15:43,1642938721,5/25/2015 08:15:29,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,92,127,,,98,141,ATAXIA,CELIAC DISEASE,Cerebellar ATAXIA,81-92,115-127-134,subclinical CELIAC DISEASE,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.",92,127 134,92,127,1,98,141,TWrex-cause,813978,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet",ataxia,celiac disease
725480649,5/25/2015 08:20:26,1642939674,5/25/2015 08:20:14,false,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,92,127,,,98,141,ATAXIA,CELIAC DISEASE,et al. Cerebellar ATAXIA associated with subclinical celiac disease,74-77-81-92-99-110-115-127-134,92-99-110-115-127-134-142-153-156-163-168,ataxia associated with subclinical CELIAC DISEASE responding to gluten free diet.,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.",92,127 134,92,127,1,98,141,TWrex-cause,813978,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet",ataxia,celiac disease
725480649,5/25/2015 08:39:46,1642943142,5/25/2015 08:39:21,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,92,127,,,98,141,ATAXIA,CELIAC DISEASE,Cerebellar ATAXIA,92-81,127-134,CELIAC DISEASE,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.",92,127 134,92,127,1,98,141,TWrex-cause,813978,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet",ataxia,celiac disease
725480649,5/25/2015 08:45:13,1642944018,5/25/2015 08:44:52,false,elite,1.0,26544151,GBR,"","",213.205.252.245,92,127,,,98,141,ATAXIA,CELIAC DISEASE,ATAXIA,92,127-134,CELIAC DISEASE,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.",92,127 134,92,127,1,98,141,TWrex-cause,813978,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet",ataxia,celiac disease
725480649,5/25/2015 08:53:06,1642945409,5/25/2015 08:52:43,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,92,127,,,98,141,ATAXIA,CELIAC DISEASE,Cerebellar ATAXIA,81-92,127-134,CELIAC DISEASE,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.",92,127 134,92,127,1,98,141,TWrex-cause,813978,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet",ataxia,celiac disease
725480649,5/25/2015 08:58:03,1642946145,5/25/2015 08:56:44,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,92,127,,,98,141,ATAXIA,CELIAC DISEASE,Cerebellar ATAXIA,81-92,127-134,CELIAC DISEASE,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.",92,127 134,92,127,1,98,141,TWrex-cause,813978,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet",ataxia,celiac disease
725480649,5/25/2015 09:03:11,1642946801,5/25/2015 09:02:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,92,127,,,98,141,ATAXIA,CELIAC DISEASE,Cerebellar ATAXIA associated with subclinical celiac disease responding to gluten - free,81-92-99-110-115-127-134-142-153-156-162-163,81-92-99-110-115-127-134-142-153-156-162-163-168,Cerebellar ataxia associated with subclinical CELIAC DISEASE responding to gluten - free diet.,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.",92,127 134,92,127,1,98,141,TWrex-cause,813978,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet",ataxia,celiac disease
725480649,5/25/2015 09:06:37,1642947386,5/25/2015 09:05:47,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,92,127,,,98,141,ATAXIA,CELIAC DISEASE,Cerebellar ATAXIA,81-92,115-127-134,subclinical CELIAC DISEASE,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.",92,127 134,92,127,1,98,141,TWrex-cause,813978,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet",ataxia,celiac disease
725480649,5/25/2015 09:24:38,1642949929,5/25/2015 09:24:21,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,92,127,,,98,141,ATAXIA,CELIAC DISEASE,ATAXIA,92,127-134,CELIAC DISEASE,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.",92,127 134,92,127,1,98,141,TWrex-cause,813978,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet",ataxia,celiac disease
725480649,5/25/2015 09:28:07,1642950650,5/25/2015 09:27:48,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,92,127,,,98,141,ATAXIA,CELIAC DISEASE,ATAXIA,92,127-134,CELIAC DISEASE,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.",92,127 134,92,127,1,98,141,TWrex-cause,813978,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet",ataxia,celiac disease
725480650,5/25/2015 10:12:09,1642957690,5/25/2015 10:11:58,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,0,30,,,10,38,BACTEREMIA,BACTERIUM,BACTEREMIA,0,30,BACTERIA,Bacteremia is the presence of bacteria in the bloodstream.,0,30,0,30,1,10,38,TWrex-cause,812049,Bacteremia is the presence of bacteria in the bloodstream,bacteremia,bacterium
725480650,5/25/2015 10:13:44,1642958037,5/25/2015 10:13:22,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,0,30,,,10,38,BACTEREMIA,BACTERIUM,BACTEREMIA,0,30,BACTERIA,Bacteremia is the presence of bacteria in the bloodstream.,0,30,0,30,1,10,38,TWrex-cause,812049,Bacteremia is the presence of bacteria in the bloodstream,bacteremia,bacterium
725480650,5/25/2015 10:15:16,1642958294,5/25/2015 10:14:54,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,0,30,,,10,38,BACTEREMIA,BACTERIUM,BACTEREMIA,0,30,BACTERIA,Bacteremia is the presence of bacteria in the bloodstream.,0,30,0,30,1,10,38,TWrex-cause,812049,Bacteremia is the presence of bacteria in the bloodstream,bacteremia,bacterium
725480650,5/25/2015 10:25:53,1642961188,5/25/2015 10:25:36,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,0,30,,,10,38,BACTEREMIA,BACTERIUM,BACTEREMIA,0,30,BACTERIA,Bacteremia is the presence of bacteria in the bloodstream.,0,30,0,30,1,10,38,TWrex-cause,812049,Bacteremia is the presence of bacteria in the bloodstream,bacteremia,bacterium
725480650,5/25/2015 10:40:54,1642971812,5/25/2015 10:40:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,0,30,,,10,38,BACTEREMIA,BACTERIUM,BACTEREMIA,0,30,BACTERIA,Bacteremia is the presence of bacteria in the bloodstream.,0,30,0,30,1,10,38,TWrex-cause,812049,Bacteremia is the presence of bacteria in the bloodstream,bacteremia,bacterium
725480650,5/25/2015 10:41:49,1642972536,5/25/2015 10:41:33,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,0,30,,,10,38,BACTEREMIA,BACTERIUM,BACTEREMIA,0,30,BACTERIA,Bacteremia is the presence of bacteria in the bloodstream.,0,30,0,30,1,10,38,TWrex-cause,812049,Bacteremia is the presence of bacteria in the bloodstream,bacteremia,bacterium
725480650,5/25/2015 10:45:36,1642974705,5/25/2015 10:45:25,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,0,30,,,10,38,BACTEREMIA,BACTERIUM,BACTEREMIA,0,30,BACTERIA,Bacteremia is the presence of bacteria in the bloodstream.,0,30,0,30,1,10,38,TWrex-cause,812049,Bacteremia is the presence of bacteria in the bloodstream,bacteremia,bacterium
725480650,5/25/2015 10:46:06,1642974787,5/25/2015 10:45:54,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,0,30,,,10,38,BACTEREMIA,BACTERIUM,BACTEREMIA is the presence,0-11-14-18,0-14-18-27-30,Bacteremia the presence of BACTERIA,Bacteremia is the presence of bacteria in the bloodstream.,0,30,0,30,1,10,38,TWrex-cause,812049,Bacteremia is the presence of bacteria in the bloodstream,bacteremia,bacterium
725480650,5/25/2015 10:48:46,1642975254,5/25/2015 10:48:30,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,0,30,,,10,38,BACTEREMIA,BACTERIUM,BACTEREMIA,0,30,BACTERIA,Bacteremia is the presence of bacteria in the bloodstream.,0,30,0,30,1,10,38,TWrex-cause,812049,Bacteremia is the presence of bacteria in the bloodstream,bacteremia,bacterium
725480650,5/25/2015 10:51:11,1642975575,5/25/2015 10:50:54,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,0,30,,,10,38,BACTEREMIA,BACTERIUM,BACTEREMIA bacteria in the bloodstream.,0-30-39-42-46,14-18-27-30-39-42-46-0,Bacteremia the presence of BACTERIA in the bloodstream.,Bacteremia is the presence of bacteria in the bloodstream.,0,30,0,30,1,10,38,TWrex-cause,812049,Bacteremia is the presence of bacteria in the bloodstream,bacteremia,bacterium
725480651,5/25/2015 11:59:20,1642988371,5/25/2015 11:59:09,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,84,41,,,98,54,HYPOTHYROIDISM,LEVOTHYROXINE,HYPOTHYROIDISM.,84,41,LEVOTHYROXINE,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.,84,41,84,41,-1,98,54,TWrex-cause,800221,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,hypothyroidism,levothyroxine
725480651,5/25/2015 12:46:29,1642998445,5/25/2015 12:46:09,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,84,41,,,98,54,HYPOTHYROIDISM,LEVOTHYROXINE,HYPOTHYROIDISM.,84,41,LEVOTHYROXINE,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.,84,41,84,41,-1,98,54,TWrex-cause,800221,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,hypothyroidism,levothyroxine
725480651,5/25/2015 12:56:33,1643000379,5/25/2015 12:55:51,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,84,41,,,98,54,HYPOTHYROIDISM,LEVOTHYROXINE,HYPOTHYROIDISM.,84,41,LEVOTHYROXINE,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.,84,41,84,41,-1,98,54,TWrex-cause,800221,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,hypothyroidism,levothyroxine
725480651,5/25/2015 13:02:21,1643001334,5/25/2015 13:02:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,84,41,,,98,54,HYPOTHYROIDISM,LEVOTHYROXINE,HYPOTHYROIDISM.,84,41,LEVOTHYROXINE,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.,84,41,84,41,-1,98,54,TWrex-cause,800221,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,hypothyroidism,levothyroxine
725480651,5/25/2015 13:14:10,1643003391,5/25/2015 13:13:50,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,84,41,,,98,54,HYPOTHYROIDISM,LEVOTHYROXINE,HYPOTHYROIDISM.,84,41,LEVOTHYROXINE,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.,84,41,84,41,-1,98,54,TWrex-cause,800221,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,hypothyroidism,levothyroxine
725480651,5/25/2015 13:17:05,1643004080,5/25/2015 13:16:43,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,84,41,,,98,54,HYPOTHYROIDISM,LEVOTHYROXINE,treatment of HYPOTHYROIDISM.,71-81-84,30-36-41,brand name LEVOTHYROXINE,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.,84,41,84,41,-1,98,54,TWrex-cause,800221,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,hypothyroidism,levothyroxine
725480651,5/25/2015 13:18:12,1643004260,5/25/2015 13:17:58,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,84,41,,,98,54,HYPOTHYROIDISM,LEVOTHYROXINE,HYPOTHYROIDISM.,84,41,LEVOTHYROXINE,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.,84,41,84,41,-1,98,54,TWrex-cause,800221,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,hypothyroidism,levothyroxine
725480651,5/25/2015 13:22:08,1643005013,5/25/2015 13:21:56,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,84,41,,,98,54,HYPOTHYROIDISM,LEVOTHYROXINE,HYPOTHYROIDISM.,84,30-36-41,brand name LEVOTHYROXINE,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.,84,41,84,41,-1,98,54,TWrex-cause,800221,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,hypothyroidism,levothyroxine
725480651,5/25/2015 13:22:26,1643005058,5/25/2015 13:22:12,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,84,41,,,98,54,HYPOTHYROIDISM,LEVOTHYROXINE,levothyroxine HYPOTHYROIDISM.,41-84,41-84,LEVOTHYROXINE hypothyroidism.,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.,84,41,84,41,-1,98,54,TWrex-cause,800221,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,hypothyroidism,levothyroxine
725480651,5/25/2015 13:22:29,1643005062,5/25/2015 13:22:08,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,84,41,,,98,54,HYPOTHYROIDISM,LEVOTHYROXINE,HYPOTHYROIDISM.,84,41,LEVOTHYROXINE,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.,84,41,84,41,-1,98,54,TWrex-cause,800221,Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,hypothyroidism,levothyroxine
725480652,5/25/2015 08:17:26,1642939011,5/25/2015 08:17:09,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,82,126,,,88,134,STROKE,WARFARIN,"STROKE,",82,126,WARFARIN,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation.",82,126,82,126,-1,88,134,TWrex-cause,804645,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation",stroke,warfarin
725480652,5/25/2015 08:42:31,1642943532,5/25/2015 08:42:01,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,82,126,,,88,134,STROKE,WARFARIN,"STROKE,",82,126,WARFARIN,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation.",82,126,82,126,-1,88,134,TWrex-cause,804645,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation",stroke,warfarin
725480652,5/25/2015 08:47:20,1642944275,5/25/2015 08:47:03,false,elite,1.0,26544151,GBR,"","",213.205.252.245,82,126,,,88,134,STROKE,WARFARIN,"STROKE,",82,126,WARFARIN,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation.",82,126,82,126,-1,88,134,TWrex-cause,804645,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation",stroke,warfarin
725480652,5/25/2015 08:54:37,1642945607,5/25/2015 08:54:19,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,82,126,,,88,134,STROKE,WARFARIN,"STROKE,",82,126,WARFARIN,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation.",82,126,82,126,-1,88,134,TWrex-cause,804645,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation",stroke,warfarin
725480652,5/25/2015 08:59:49,1642946308,5/25/2015 08:59:11,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,82,126,,,88,134,STROKE,WARFARIN,"STROKE,",82,126,WARFARIN,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation.",82,126,82,126,-1,88,134,TWrex-cause,804645,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation",stroke,warfarin
725480652,5/25/2015 09:06:45,1642947401,5/25/2015 09:06:13,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,82,126,,,88,134,STROKE,WARFARIN,"Therapeutics Higher - dose dabigatran reduced STROKE, but not major hemorrhage, more than warfarin in atrial fibrillation.",37-51-57-58-63-74-82-90-94-98-104-116-121-126-135-138-145,37-51-57-58-63-74-82-90-94-104-116-121-126-135-138-145-98,"Therapeutics Higher - dose dabigatran reduced stroke, but not major hemorrhage, more than WARFARIN in atrial fibrillation.","January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation.",82,126,82,126,-1,88,134,TWrex-cause,804645,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation",stroke,warfarin
725480652,5/25/2015 09:11:25,1642948019,5/25/2015 09:10:49,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,82,126,,,88,134,STROKE,WARFARIN,"STROKE,",82,126,WARFARIN,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation.",82,126,82,126,-1,88,134,TWrex-cause,804645,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation",stroke,warfarin
725480652,5/25/2015 09:29:35,1642950862,5/25/2015 09:29:09,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,82,126,,,88,134,STROKE,WARFARIN,"STROKE,",82,126,WARFARIN,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation.",82,126,82,126,-1,88,134,TWrex-cause,804645,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation",stroke,warfarin
725480652,5/25/2015 09:34:10,1642951694,5/25/2015 09:33:56,false,elite,1,31856422,GBR,C9,Carlisle,92.19.36.179,82,126,,,88,134,STROKE,WARFARIN,"STROKE,",82,126,WARFARIN,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation.",82,126,82,126,-1,88,134,TWrex-cause,804645,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation",stroke,warfarin
725480652,5/25/2015 09:43:53,1642953244,5/25/2015 09:43:42,false,cointasker,1,21783324,NLD,"","",31.151.239.133,82,126,,,88,134,STROKE,WARFARIN,"STROKE,",82,126,WARFARIN,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation.",82,126,82,126,-1,88,134,TWrex-cause,804645,"January 2010 - Volume 152, Number 1  Therapeutics  Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation",stroke,warfarin
725480653,5/25/2015 08:18:38,1642939264,5/25/2015 08:18:24,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,0,74,,,11,84,NEUTROPENIA,VANCOMYCIN,NEUTROPENIA,0,74,VANCOMYCIN.,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin.",0,74,0,74,-1,11,84,TWrex-cause,800555,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin",neutropenia,vancomycin
725480653,5/25/2015 08:48:16,1642944448,5/25/2015 08:48:06,false,elite,1.0,26544151,GBR,"","",213.205.252.245,0,74,,,11,84,NEUTROPENIA,VANCOMYCIN,NEUTROPENIA,0,74,VANCOMYCIN.,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin.",0,74,0,74,-1,11,84,TWrex-cause,800555,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin",neutropenia,vancomycin
725480653,5/25/2015 08:48:18,1642944459,5/25/2015 08:47:59,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,0,74,,,11,84,NEUTROPENIA,VANCOMYCIN,NEUTROPENIA,0,74,VANCOMYCIN.,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin.",0,74,0,74,-1,11,84,TWrex-cause,800555,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin",neutropenia,vancomycin
725480653,5/25/2015 08:55:36,1642945731,5/25/2015 08:55:22,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,0,74,,,11,84,NEUTROPENIA,VANCOMYCIN,NEUTROPENIA,0,74,VANCOMYCIN.,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin.",0,74,0,74,-1,11,84,TWrex-cause,800555,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin",neutropenia,vancomycin
725480653,5/25/2015 09:00:51,1642946498,5/25/2015 09:00:37,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,0,74,,,11,84,NEUTROPENIA,VANCOMYCIN,NEUTROPENIA,0,74,VANCOMYCIN.,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin.",0,74,0,74,-1,11,84,TWrex-cause,800555,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin",neutropenia,vancomycin
725480653,5/25/2015 09:08:21,1642947658,5/25/2015 09:08:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,0,74,,,11,84,NEUTROPENIA,VANCOMYCIN,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or vancomycin.",0-12-16-22-29-37-42-55-71-74,0-12-16-22-29-42-55-71-74-37,"Neutropenia can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN.","Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin.",0,74,0,74,-1,11,84,TWrex-cause,800555,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin",neutropenia,vancomycin
725480653,5/25/2015 09:14:59,1642948499,5/25/2015 09:13:50,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,0,74,,,11,84,NEUTROPENIA,VANCOMYCIN,NEUTROPENIA,0,74,VANCOMYCIN.,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin.",0,74,0,74,-1,11,84,TWrex-cause,800555,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin",neutropenia,vancomycin
725480653,5/25/2015 09:30:26,1642950982,5/25/2015 09:30:16,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,0,74,,,11,84,NEUTROPENIA,VANCOMYCIN,NEUTROPENIA,0,74,VANCOMYCIN.,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin.",0,74,0,74,-1,11,84,TWrex-cause,800555,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin",neutropenia,vancomycin
725480653,5/25/2015 09:34:47,1642951830,5/25/2015 09:34:38,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,0,74,,,11,84,NEUTROPENIA,VANCOMYCIN,NEUTROPENIA,0,74,VANCOMYCIN.,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin.",0,74,0,74,-1,11,84,TWrex-cause,800555,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin",neutropenia,vancomycin
725480653,5/25/2015 09:45:28,1642953465,5/25/2015 09:45:15,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,0,74,,,11,84,NEUTROPENIA,VANCOMYCIN,NEUTROPENIA,0,74,VANCOMYCIN.,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin.",0,74,0,74,-1,11,84,TWrex-cause,800555,"Neutropenia can occur during therapy with penicillins, cephalosporins, or vancomycin",neutropenia,vancomycin
725480654,5/25/2015 10:15:05,1642958256,5/25/2015 10:14:52,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,57,17,,,69,20,SPLENOMEGALY,HCL,"SPLENOMEGALY,",57,17,HCL,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection.",57,17,57,17,1,69,20,TWrex-cause,812638,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection",splenomegaly,HCL
725480654,5/25/2015 10:18:12,1642958833,5/25/2015 10:17:53,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,57,17,,,69,20,SPLENOMEGALY,HCL,"SPLENOMEGALY,",57,17,HCL,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection.",57,17,57,17,1,69,20,TWrex-cause,812638,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection",splenomegaly,HCL
725480654,5/25/2015 10:19:17,1642959039,5/25/2015 10:18:51,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,57,17,,,69,20,SPLENOMEGALY,HCL,"SPLENOMEGALY,",57,17,HCL,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection.",57,17,57,17,1,69,20,TWrex-cause,812638,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection",splenomegaly,HCL
725480654,5/25/2015 10:28:05,1642962036,5/25/2015 10:27:50,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,57,17,,,69,20,SPLENOMEGALY,HCL,"SPLENOMEGALY,",57,17,HCL,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection.",57,17,57,17,1,69,20,TWrex-cause,812638,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection",splenomegaly,HCL
725480654,5/25/2015 10:44:24,1642974196,5/25/2015 10:44:05,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,57,17,,,69,20,SPLENOMEGALY,HCL,"SPLENOMEGALY,",57,17,HCL,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection.",57,17,57,17,1,69,20,TWrex-cause,812638,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection",splenomegaly,HCL
725480654,5/25/2015 10:45:20,1642974603,5/25/2015 10:44:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,57,17,,,69,20,SPLENOMEGALY,HCL,"SPLENOMEGALY,",57,17,HCL,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection.",57,17,57,17,1,69,20,TWrex-cause,812638,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection",splenomegaly,HCL
725480654,5/25/2015 10:51:19,1642975624,5/25/2015 10:51:04,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,57,17,,,69,20,SPLENOMEGALY,HCL,"SPLENOMEGALY,",57,17,HCL,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection.",57,17,57,17,1,69,20,TWrex-cause,812638,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection",splenomegaly,HCL
725480654,5/25/2015 10:56:01,1642976374,5/25/2015 10:54:47,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,57,17,,,69,20,SPLENOMEGALY,HCL,"HCL presents as pancytopenia, SPLENOMEGALY, and opportunistic infection.",31-40-43-57-71-75-89-17,17-21-31-40-43-57-75-89,"HCL typically presents as pancytopenia, splenomegaly, opportunistic infection.","68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection.",57,17,57,17,1,69,20,TWrex-cause,812638,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection",splenomegaly,HCL
725480654,5/25/2015 11:33:41,1642983497,5/25/2015 11:33:27,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,57,17,,,69,20,SPLENOMEGALY,HCL,"SPLENOMEGALY,",57,0-17,68 HCL,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection.",57,17,57,17,1,69,20,TWrex-cause,812638,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection",splenomegaly,HCL
725480654,5/25/2015 11:41:55,1642984996,5/25/2015 11:41:41,false,dailyrewardsca,1.0,32438879,CAN,NB,Fredericton,156.57.46.234,57,17,,,69,20,SPLENOMEGALY,HCL,"SPLENOMEGALY,",57,17,HCL,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection.",57,17,57,17,1,69,20,TWrex-cause,812638,"68   Clinically, HCL typically presents as pancytopenia, splenomegaly, and opportunistic infection",splenomegaly,HCL
725480655,5/25/2015 10:12:47,1642957881,5/25/2015 10:12:29,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,95,56,,,112,68,PERNICIOUS ANEMIA,VITAMIN B 12,PERNICIOUS ANEMIA,95-106,56-64-66-70-82,VITAMIN B 12 Deficiency Treatment,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states.,95 106,56 64 66,95,56,-1,112,68,TWrex-cause,803419,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states,pernicious anemia,vitamin b 12
725480655,5/25/2015 10:15:09,1642958261,5/25/2015 10:14:33,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,95,56,,,112,68,PERNICIOUS ANEMIA,VITAMIN B 12,PERNICIOUS ANEMIA,95-106,56-64-66-70,VITAMIN B 12 Deficiency,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states.,95 106,56 64 66,95,56,-1,112,68,TWrex-cause,803419,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states,pernicious anemia,vitamin b 12
725480655,5/25/2015 10:16:10,1642958491,5/25/2015 10:15:51,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,95,56,,,112,68,PERNICIOUS ANEMIA,VITAMIN B 12,PERNICIOUS ANEMIA,95-106,56-64-66-70-82,VITAMIN B 12 Deficiency Treatment,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states.,95 106,56 64 66,95,56,-1,112,68,TWrex-cause,803419,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states,pernicious anemia,vitamin b 12
725480655,5/25/2015 10:26:37,1642961447,5/25/2015 10:26:13,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,95,56,,,112,68,PERNICIOUS ANEMIA,VITAMIN B 12,PERNICIOUS ANEMIA,95-106,56-64-66,VITAMIN B 12,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states.,95 106,56 64 66,95,56,-1,112,68,TWrex-cause,803419,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states,pernicious anemia,vitamin b 12
725480655,5/25/2015 10:41:43,1642972479,5/25/2015 10:41:19,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,95,56,,,112,68,PERNICIOUS ANEMIA,VITAMIN B 12,PERNICIOUS ANEMIA,95-106,56-64-66-70,VITAMIN B 12 Deficiency,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states.,95 106,56 64 66,95,56,-1,112,68,TWrex-cause,803419,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states,pernicious anemia,vitamin b 12
725480655,5/25/2015 10:42:49,1642973303,5/25/2015 10:42:16,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,95,56,,,112,68,PERNICIOUS ANEMIA,VITAMIN B 12,PERNICIOUS ANEMIA,95-106,56-64-66-70-82,VITAMIN B 12 Deficiency Treatment,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states.,95 106,56 64 66,95,56,-1,112,68,TWrex-cause,803419,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states,pernicious anemia,vitamin b 12
725480655,5/25/2015 10:46:06,1642974770,5/25/2015 10:45:52,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,95,56,,,112,68,PERNICIOUS ANEMIA,VITAMIN B 12,PERNICIOUS ANEMIA,95-106,56-64-66,VITAMIN B 12,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states.,95 106,56 64 66,95,56,-1,112,68,TWrex-cause,803419,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states,pernicious anemia,vitamin b 12
725480655,5/25/2015 10:46:45,1642974878,5/25/2015 10:46:34,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,95,56,,,112,68,PERNICIOUS ANEMIA,VITAMIN B 12,Vitamin Deficiency Treatment of PERNICIOUS ANEMIA and other vitamin,70-82-92-95-106-113-117-123-13,38-44-50-56-64-66-70-82-92-106-13,Vitamin VT100 (VA) Uses VITAMIN B 12 Deficiency Treatment of anemia,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states.,95 106,56 64 66,95,56,-1,112,68,TWrex-cause,803419,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states,pernicious anemia,vitamin b 12
725480655,5/25/2015 10:49:38,1642975368,5/25/2015 10:49:10,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,95,56,,,112,68,PERNICIOUS ANEMIA,VITAMIN B 12,PERNICIOUS ANEMIA,95-106,56-64-66-70-82,VITAMIN B 12 Deficiency Treatment,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states.,95 106,56 64 66,95,56,-1,112,68,TWrex-cause,803419,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states,pernicious anemia,vitamin b 12
725480655,5/25/2015 10:52:12,1642975790,5/25/2015 10:51:48,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,95,56,,,112,68,PERNICIOUS ANEMIA,VITAMIN B 12,Vitamin B 12 Deficiency Treatment of PERNICIOUS ANEMIA,56-64-66-70-82-92-95-106,38-44-50-56-64-66-70-82-92-95-106,VT100 (VA) Uses VITAMIN B 12 Deficiency Treatment of pernicious anemia,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states.,95 106,56 64 66,95,56,-1,112,68,TWrex-cause,803419,104  Class:  Vitamin B Complex 88:08; VT100 (VA)  Uses  Vitamin B 12  Deficiency  Treatment of pernicious anemia and other vitamin B 12  deficiency states,pernicious anemia,vitamin b 12
725480656,5/25/2015 08:17:53,1642939100,5/25/2015 08:17:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,186,136,,,193,146,COLITIS,MESALAMINE,active ulcerative COLITIS.,168-175-186,125-132-135,Asacol ® (MESALAMINE),"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis.",186,,186,136,-1,193,146,TWrex-cause,800903,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis",colitis,mesalamine
725480656,5/25/2015 08:47:30,1642944280,5/25/2015 08:47:08,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,186,136,,,193,146,COLITIS,MESALAMINE,COLITIS.,186,152-157-175-186-168,mild moderately active ulcerative colitis.,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis.",186,,186,136,-1,193,146,TWrex-cause,800903,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis",colitis,mesalamine
725480656,5/25/2015 08:47:47,1642944332,5/25/2015 08:47:22,false,elite,1.0,26544151,GBR,"","",213.205.252.245,186,136,,,193,146,COLITIS,MESALAMINE,COLITIS.,186,135,(MESALAMINE),"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis.",186,,186,136,-1,193,146,TWrex-cause,800903,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis",colitis,mesalamine
725480656,5/25/2015 08:54:57,1642945666,5/25/2015 08:54:39,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,186,136,,,193,146,COLITIS,MESALAMINE,ulcerative COLITIS.,175-186,125-132-135,Asacol ® (MESALAMINE),"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis.",186,,186,136,-1,193,146,TWrex-cause,800903,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis",colitis,mesalamine
725480656,5/25/2015 09:00:15,1642946389,5/25/2015 08:59:51,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,186,136,,,193,146,COLITIS,MESALAMINE,ulcerative COLITIS.,175-186,135,(MESALAMINE),"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis.",186,,186,136,-1,193,146,TWrex-cause,800903,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis",colitis,mesalamine
725480656,5/25/2015 09:07:41,1642947555,5/25/2015 09:06:46,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,186,136,,,193,146,COLITIS,MESALAMINE,A multi - center double - blind dose - response trial of Colazide (balsalazide disodium) and Asacol (mesalamine) for mild - moderately active ulcerative COLITIS.,35-37-42-43-50-57-63-67-68-77-83-86-98-111-121-125-135-148-152-156-157-168-175-186-56,35-37-42-43-50-56-57-63-67-68-77-83-86-98-111-121-125-135-148-152-156-157-168-175-186,A multi - center double - blind dose - response trial of Colazide (balsalazide disodium) and Asacol (MESALAMINE) for mild - moderately active ulcerative colitis.,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis.",186,,186,136,-1,193,146,TWrex-cause,800903,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis",colitis,mesalamine
725480656,5/25/2015 09:12:45,1642948236,5/25/2015 09:11:27,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,186,136,,,193,146,COLITIS,MESALAMINE,ulcerative COLITIS.,175-186,175-186,ulcerative colitis.,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis.",186,,186,136,-1,193,146,TWrex-cause,800903,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis",colitis,mesalamine
725480656,5/25/2015 09:29:57,1642950896,5/25/2015 09:29:36,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,186,136,,,193,146,COLITIS,MESALAMINE,COLITIS.,186,135,(MESALAMINE),"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis.",186,,186,136,-1,193,146,TWrex-cause,800903,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis",colitis,mesalamine
725480656,5/25/2015 09:34:26,1642951719,5/25/2015 09:34:12,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,186,136,,,193,146,COLITIS,MESALAMINE,ulcerative COLITIS.,175-186,125-132-135,Asacol ® (MESALAMINE),"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis.",186,,186,136,-1,193,146,TWrex-cause,800903,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis",colitis,mesalamine
725480656,5/25/2015 09:44:04,1642953256,5/25/2015 09:43:54,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,186,136,,,193,146,COLITIS,MESALAMINE,ulcerative COLITIS.,175-186,125-132-135,Asacol ® (MESALAMINE),"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis.",186,,186,136,-1,193,146,TWrex-cause,800903,"Levine DS, Pruitt R, Riff D et al. A multi-center double-blind dose-response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (mesalamine) for mild-moderately active ulcerative colitis",colitis,mesalamine
725480657,5/25/2015 08:22:17,1642940051,5/25/2015 08:22:03,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,110,63,,,118,70,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,100-110,63,HEPARIN,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.",110,63,110,63,-1,118,70,TWrex-cause,803804,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism",embolism,heparin
725480657,5/25/2015 08:51:30,1642945081,5/25/2015 08:51:17,false,elite,1.0,26544151,GBR,"","",213.205.252.245,110,63,,,118,70,EMBOLISM,HEPARIN,EMBOLISM.,110,63,HEPARIN,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.",110,63,110,63,-1,118,70,TWrex-cause,803804,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism",embolism,heparin
725480657,5/25/2015 08:51:29,1642945084,5/25/2015 08:51:17,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,110,63,,,118,70,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,100-110,63,HEPARIN,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.",110,63,110,63,-1,118,70,TWrex-cause,803804,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism",embolism,heparin
725480657,5/25/2015 08:59:05,1642946246,5/25/2015 08:58:47,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,110,63,,,118,70,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,100-110,63,HEPARIN,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.",110,63,110,63,-1,118,70,TWrex-cause,803804,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism",embolism,heparin
725480657,5/25/2015 09:05:00,1642947072,5/25/2015 09:04:49,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,110,63,,,118,70,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,100-110,63,HEPARIN,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.",110,63,110,63,-1,118,70,TWrex-cause,803804,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism",embolism,heparin
725480657,5/25/2015 09:18:24,1642949086,5/25/2015 09:18:10,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,110,63,,,118,70,EMBOLISM,HEPARIN,Thrombolysis compared with heparin for the initial treatment of pulmonary EMBOLISM.,36-49-58-63-71-75-87-97-100-110-79,36-49-58-63-71-75-79-87-97-100-110,Thrombolysis compared with HEPARIN for the initial treatment of pulmonary embolism.,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.",110,63,110,63,-1,118,70,TWrex-cause,803804,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism",embolism,heparin
725480657,5/25/2015 09:25:29,1642950036,5/25/2015 09:25:09,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,110,63,,,118,70,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,100-110,63,HEPARIN,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.",110,63,110,63,-1,118,70,TWrex-cause,803804,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism",embolism,heparin
725480657,5/25/2015 09:33:50,1642951613,5/25/2015 09:33:29,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,110,63,,,118,70,EMBOLISM,HEPARIN,EMBOLISM.,110,63,HEPARIN,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.",110,63,110,63,-1,118,70,TWrex-cause,803804,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism",embolism,heparin
725480657,5/25/2015 09:49:29,1642954023,5/25/2015 09:49:18,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,110,63,,,118,70,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,110-100,63,HEPARIN,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.",110,63,110,63,-1,118,70,TWrex-cause,803804,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism",embolism,heparin
725480657,5/25/2015 09:55:37,1642954978,5/25/2015 09:55:27,false,clixsense,1.0,24763049,GBR,Y8,Welshpool,81.135.56.139,110,63,,,118,70,EMBOLISM,HEPARIN,EMBOLISM.,110,63,HEPARIN,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.",110,63,110,63,-1,118,70,TWrex-cause,803804,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism",embolism,heparin
725480658,5/25/2015 10:05:47,1642956780,5/25/2015 10:04:48,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,86,24,,,94,37,FISTULA,CROHN DISEASE,anal FISTULAS.,81-86,24-30,CROHN DISEASE,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas.,86,24 30,86,24,1,94,37,TWrex-cause,814914,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas,fistula,crohn disease
725480658,5/25/2015 10:09:03,1642957194,5/25/2015 10:08:51,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,86,24,,,94,37,FISTULA,CROHN DISEASE,anal FISTULAS.,81-86,24-30,CROHN DISEASE,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas.,86,24 30,86,24,1,94,37,TWrex-cause,814914,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas,fistula,crohn disease
725480658,5/25/2015 10:11:28,1642957566,5/25/2015 10:10:53,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,86,24,,,94,37,FISTULA,CROHN DISEASE,anal FISTULAS.,81-86,24-30,CROHN DISEASE,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas.,86,24 30,86,24,1,94,37,TWrex-cause,814914,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas,fistula,crohn disease
725480658,5/25/2015 10:13:50,1642958047,5/25/2015 10:13:41,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,86,24,,,94,37,FISTULA,CROHN DISEASE,anal FISTULAS.,81-86,24-30,CROHN DISEASE,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas.,86,24 30,86,24,1,94,37,TWrex-cause,814914,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas,fistula,crohn disease
725480658,5/25/2015 10:22:53,1642960125,5/25/2015 10:22:40,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,86,24,,,94,37,FISTULA,CROHN DISEASE,anal FISTULAS.,81-86,24-30,CROHN DISEASE,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas.,86,24 30,86,24,1,94,37,TWrex-cause,814914,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas,fistula,crohn disease
725480658,5/25/2015 10:27:32,1642961807,5/25/2015 10:27:18,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,86,24,,,94,37,FISTULA,CROHN DISEASE,anal FISTULAS.,81-86,24-30,CROHN DISEASE,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas.,86,24 30,86,24,1,94,37,TWrex-cause,814914,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas,fistula,crohn disease
725480658,5/25/2015 10:35:16,1642966594,5/25/2015 10:34:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,86,24,,,94,37,FISTULA,CROHN DISEASE,anal FISTULAS.,81-86,24-30,CROHN DISEASE,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas.,86,24 30,86,24,1,94,37,TWrex-cause,814914,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas,fistula,crohn disease
725480658,5/25/2015 10:38:41,1642969809,5/25/2015 10:38:18,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,86,24,,,94,37,FISTULA,CROHN DISEASE,anal FISTULAS.,81-86,24-30,CROHN DISEASE,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas.,86,24 30,86,24,1,94,37,TWrex-cause,814914,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas,fistula,crohn disease
725480658,5/25/2015 10:43:01,1642973432,5/25/2015 10:42:50,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,86,24,,,94,37,FISTULA,CROHN DISEASE,anal FISTULAS.,81-86,24-30,CROHN DISEASE,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas.,86,24 30,86,24,1,94,37,TWrex-cause,814914,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas,fistula,crohn disease
725480658,5/25/2015 10:43:16,1642973609,5/25/2015 10:43:03,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,86,24,,,94,37,FISTULA,CROHN DISEASE,Crohn disease sinuses and anal FISTULAS.,24-69-77-81-86-30,0-6-21-24-30-38-46-55-69-81-86,Other manifestations of CROHN DISEASE include inguinal abscesses sinuses anal fistulas.,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas.,86,24 30,86,24,1,94,37,TWrex-cause,814914,Other manifestations of Crohn disease include inguinal abscesses and sinuses and anal fistulas,fistula,crohn disease
725480659,5/25/2015 08:23:12,1642940306,5/25/2015 08:22:48,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,84,166,,,96,174,HYPERTENSION,LOSARTAN,HYPERTENSION,84,166,LOSARTAN,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP.",84,166,84,166,-1,96,174,TWrex-cause,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP",hypertension,losartan
725480659,5/25/2015 08:52:04,1642945202,5/25/2015 08:51:50,false,elite,1.0,26544151,GBR,"","",213.205.252.245,84,166,,,96,174,HYPERTENSION,LOSARTAN,HYPERTENSION,84,166,LOSARTAN,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP.",84,166,84,166,-1,96,174,TWrex-cause,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP",hypertension,losartan
725480659,5/25/2015 08:52:05,1642945205,5/25/2015 08:51:50,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,84,166,,,96,174,HYPERTENSION,LOSARTAN,HYPERTENSION,84,166,LOSARTAN,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP.",84,166,84,166,-1,96,174,TWrex-cause,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP",hypertension,losartan
725480659,5/25/2015 08:59:58,1642946320,5/25/2015 08:59:28,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,84,166,,,96,174,HYPERTENSION,LOSARTAN,HYPERTENSION,84,166,LOSARTAN,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP.",84,166,84,166,-1,96,174,TWrex-cause,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP",hypertension,losartan
725480659,5/25/2015 09:05:52,1642947285,5/25/2015 09:05:30,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,84,166,,,96,174,HYPERTENSION,LOSARTAN,HYPERTENSION,84,166,LOSARTAN,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP.",84,166,84,166,-1,96,174,TWrex-cause,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP",hypertension,losartan
725480659,5/25/2015 09:21:19,1642949558,5/25/2015 09:20:07,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,84,166,,,96,174,HYPERTENSION,LOSARTAN,"The LIFE study prospectively randomized &gt;9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β - blocker atenolol, with additional therapy using a diuretic of a calcium - channel blocker as needed to control BP.",2-6-11-17-31-42-48-57-60-63-66-72-75-79-84-97-101-106-118-130-133-137-149-158-166-175-178-182-183-184-192-202-207-218-226-232-234-243-246-248-255-256-264-272-275-282-285-293,2-6-11-17-31-42-48-57-60-63-66-72-75-79-84-97-101-106-118-130-133-137-149-158-166-175-178-182-183-184-192-202-207-218-226-232-234-243-246-248-255-256-264-272-275-282-285-293,"The LIFE study prospectively randomized &gt;9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β - blocker atenolol, with additional therapy using a diuretic of a calcium - channel blocker as needed to control BP.","• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP.",84,166,84,166,-1,96,174,TWrex-cause,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP",hypertension,losartan
725480659,5/25/2015 09:28:35,1642950720,5/25/2015 09:27:53,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,84,166,,,96,174,HYPERTENSION,LOSARTAN,HYPERTENSION,84,137-149-158-166,angiotensin receptor blocker LOSARTAN,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP.",84,166,84,166,-1,96,174,TWrex-cause,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP",hypertension,losartan
725480659,5/25/2015 09:34:44,1642951803,5/25/2015 09:34:21,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,84,166,,,96,174,HYPERTENSION,LOSARTAN,HYPERTENSION,84,166,LOSARTAN,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP.",84,166,84,166,-1,96,174,TWrex-cause,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP",hypertension,losartan
725480659,5/25/2015 09:50:01,1642954153,5/25/2015 09:49:47,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,84,166,,,96,174,HYPERTENSION,LOSARTAN,HYPERTENSION,84,166,LOSARTAN,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP.",84,166,84,166,-1,96,174,TWrex-cause,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP",hypertension,losartan
725480659,5/25/2015 09:58:08,1642955476,5/25/2015 09:57:52,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,84,166,,,96,174,HYPERTENSION,LOSARTAN,HYPERTENSION,84,137-149-158-166,angiotensin receptor blocker LOSARTAN,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP.",84,166,84,166,-1,96,174,TWrex-cause,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with hypertension and left ventricular hypertrophy to the angiotensin receptor blocker losartan or the β-blocker atenolol, with additional therapy using a diuretic of a calcium-channel blocker as needed to control BP",hypertension,losartan
725480660,5/25/2015 13:02:22,1643001336,5/25/2015 13:02:11,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,0,26,,,5,40,WART,PAPILLOMAVIRUS,WARTS,0,20-26,human PAPILLOMAVIRUS,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions.,0,26,0,26,1,5,40,TWrex-cause,810676,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions,wart,papillomavirus
725480660,5/25/2015 13:06:18,1643002046,5/25/2015 13:06:02,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,0,26,,,5,40,WART,PAPILLOMAVIRUS,WARTS,0,20-26-41-47,human PAPILLOMAVIRUS (HPV) infection;,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions.,0,26,0,26,1,5,40,TWrex-cause,810676,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions,wart,papillomavirus
725480660,5/25/2015 13:18:29,1643004339,5/25/2015 13:18:14,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,0,26,,,5,40,WART,PAPILLOMAVIRUS,WARTS,0,20-26-47,human PAPILLOMAVIRUS infection;,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions.,0,26,0,26,1,5,40,TWrex-cause,810676,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions,wart,papillomavirus
725480660,5/25/2015 13:25:00,1643005734,5/25/2015 13:24:46,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,0,26,,,5,40,WART,PAPILLOMAVIRUS,WARTS are caused by human papillomavirus (HPV) infection;,0-6-10-17-20-26-41-47,0-10-17-20-26-41-47-58-6,Warts are caused by human PAPILLOMAVIRUS (HPV) infection; at,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions.,0,26,0,26,1,5,40,TWrex-cause,810676,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions,wart,papillomavirus
725480660,5/25/2015 13:25:16,1643005810,5/25/2015 13:24:57,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,0,26,,,5,40,WART,PAPILLOMAVIRUS,WARTS human papillomavirus (HPV) infection; HPV skin lesions.,0-20-26-41-47-94-99-70,0-20-26-41-47-58-70-99-94,Warts human PAPILLOMAVIRUS (HPV) infection; at HPV skin lesions.,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions.,0,26,0,26,1,5,40,TWrex-cause,810676,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions,wart,papillomavirus
725480660,5/25/2015 13:25:53,1643005941,5/25/2015 13:25:41,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,0,26,,,5,40,WART,PAPILLOMAVIRUS,WARTS,0,20-26,human PAPILLOMAVIRUS,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions.,0,26,0,26,1,5,40,TWrex-cause,810676,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions,wart,papillomavirus
725480660,5/25/2015 13:26:38,1643006087,5/25/2015 13:26:23,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,0,26,,,5,40,WART,PAPILLOMAVIRUS,WARTS,0,20-26-41-47,human PAPILLOMAVIRUS (HPV) infection;,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions.,0,26,0,26,1,5,40,TWrex-cause,810676,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions,wart,papillomavirus
725480660,5/25/2015 13:28:48,1643006509,5/25/2015 13:27:51,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,0,26,,,5,40,WART,PAPILLOMAVIRUS,WARTS,0,20-26-41-47,human PAPILLOMAVIRUS (HPV) infection;,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions.,0,26,0,26,1,5,40,TWrex-cause,810676,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions,wart,papillomavirus
725480660,5/25/2015 13:28:50,1643006511,5/25/2015 13:27:44,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,0,26,,,5,40,WART,PAPILLOMAVIRUS,WARTS,0,26,PAPILLOMAVIRUS,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions.,0,26,0,26,1,5,40,TWrex-cause,810676,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions,wart,papillomavirus
725480660,5/25/2015 14:00:57,1643013412,5/25/2015 14:00:35,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,0,26,,,5,40,WART,PAPILLOMAVIRUS,WARTS,0,26-47-41,PAPILLOMAVIRUS (HPV) infection;,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions.,0,26,0,26,1,5,40,TWrex-cause,810676,Warts are caused by human papillomavirus (HPV) infection; at least 70 HPV types are linked to skin lesions,wart,papillomavirus
725480661,5/25/2015 08:13:56,1642938380,5/25/2015 08:13:34,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,182,93,,,193,107,NEUTROPENIA,AMPHOTERICIN B,NEUTROPENIA.,182,93-106,AMPHOTERICIN B,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.",182,93 106,182,93,-1,193,107,TWrex-cause,800740,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia",neutropenia,amphotericin b
725480661,5/25/2015 08:17:51,1642939095,5/25/2015 08:17:26,false,instagc,1,31130954,USA,IL,Glen Ellyn,99.135.172.175,182,93,,,193,107,NEUTROPENIA,AMPHOTERICIN B,NEUTROPENIA.,182,93-106,AMPHOTERICIN B,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.",182,93 106,182,93,-1,193,107,TWrex-cause,800740,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia",neutropenia,amphotericin b
725480661,5/25/2015 08:19:02,1642939320,5/25/2015 08:18:47,false,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,182,93,,,193,107,NEUTROPENIA,AMPHOTERICIN B,empiric anti - fungal agents prolonged fever and NEUTROPENIA.,111-119-123-124-162-172-178-182-131,73-76-88-93-106-108-111-119-124-131,of fluconazole with AMPHOTERICIN B as empiric anti fungal agents,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.",182,93 106,182,93,-1,193,107,TWrex-cause,800740,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia",neutropenia,amphotericin b
725480661,5/25/2015 08:36:47,1642942532,5/25/2015 08:35:28,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,182,93,,,193,107,NEUTROPENIA,AMPHOTERICIN B,NEUTROPENIA.,182,93-106,AMPHOTERICIN B,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.",182,93 106,182,93,-1,193,107,TWrex-cause,800740,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia",neutropenia,amphotericin b
725480661,5/25/2015 08:42:56,1642943607,5/25/2015 08:42:47,false,neodev,1,11382239,AUS,02,Strathfield,60.241.129.81,182,93,,,193,107,NEUTROPENIA,AMPHOTERICIN B,NEUTROPENIA.,182,93-106,AMPHOTERICIN B,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.",182,93 106,182,93,-1,193,107,TWrex-cause,800740,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia",neutropenia,amphotericin b
725480661,5/25/2015 08:43:06,1642943620,5/25/2015 08:42:50,false,elite,1.0,26544151,GBR,"","",213.205.252.245,182,93,,,193,107,NEUTROPENIA,AMPHOTERICIN B,NEUTROPENIA.,182,93-106,AMPHOTERICIN B,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.",182,93 106,182,93,-1,193,107,TWrex-cause,800740,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia",neutropenia,amphotericin b
725480661,5/25/2015 08:43:21,1642943707,5/25/2015 08:43:06,false,bitcoinget,1,30546513,GBR,G6,Hull,194.42.67.50,182,93,,,193,107,NEUTROPENIA,AMPHOTERICIN B,NEUTROPENIA.,182,93-106,AMPHOTERICIN B,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.",182,93 106,182,93,-1,193,107,TWrex-cause,800740,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia",neutropenia,amphotericin b
725480661,5/25/2015 08:50:46,1642944996,5/25/2015 08:50:30,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,182,93,,,193,107,NEUTROPENIA,AMPHOTERICIN B,NEUTROPENIA.,182,93-106,AMPHOTERICIN B,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.",182,93 106,182,93,-1,193,107,TWrex-cause,800740,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia",neutropenia,amphotericin b
725480661,5/25/2015 08:54:54,1642945663,5/25/2015 08:54:36,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,182,93,,,193,107,NEUTROPENIA,AMPHOTERICIN B,NEUTROPENIA.,182,93-106,AMPHOTERICIN B,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.",182,93 106,182,93,-1,193,107,TWrex-cause,800740,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia",neutropenia,amphotericin b
725480661,5/25/2015 08:57:58,1642946122,5/25/2015 08:57:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,182,93,,,193,107,NEUTROPENIA,AMPHOTERICIN B,A randomized comparison of fluconazole with amphotericin B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA.,49-51-62-73-76-88-93-106-108-111-119-124-131-138-141-148-162-172-178-182-157,49-51-62-73-76-88-93-106-108-111-119-124-131-138-141-148-157-162-172-178-182,A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and neutropenia.,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.",182,93 106,182,93,-1,193,107,TWrex-cause,800740,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia",neutropenia,amphotericin b
725480662,5/25/2015 09:52:32,1642954563,5/25/2015 09:52:19,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,29,53,,,32,65,CNS,ENCEPHALITIS,CNS,29,53,ENCEPHALITIS,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",29,53,29,53,-1,32,65,TWrex-cause,802622,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20",CNS,encephalitis
725480662,5/25/2015 10:02:14,1642956199,5/25/2015 10:02:01,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,29,53,,,32,65,CNS,ENCEPHALITIS,CNS,29,53,ENCEPHALITIS,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",29,53,29,53,-1,32,65,TWrex-cause,802622,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20",CNS,encephalitis
725480662,5/25/2015 10:03:56,1642956499,5/25/2015 10:03:20,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,29,53,,,32,65,CNS,ENCEPHALITIS,CNS an,29-50,53-69,"ENCEPHALITIS encephalomyelitis,","• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",29,53,29,53,-1,32,65,TWrex-cause,802622,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20",CNS,encephalitis
725480662,5/25/2015 10:08:34,1642957140,5/25/2015 10:08:19,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,29,53,,,32,65,CNS,ENCEPHALITIS,CNS,29,53,ENCEPHALITIS,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",29,53,29,53,-1,32,65,TWrex-cause,802622,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20",CNS,encephalitis
725480662,5/25/2015 10:10:24,1642957390,5/25/2015 10:09:52,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,29,53,,,32,65,CNS,ENCEPHALITIS,CNS,29,53,ENCEPHALITIS,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",29,53,29,53,-1,32,65,TWrex-cause,802622,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20",CNS,encephalitis
725480662,5/25/2015 10:22:19,1642959899,5/25/2015 10:22:02,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,29,53,,,32,65,CNS,ENCEPHALITIS,CNS,29,53,ENCEPHALITIS,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",29,53,29,53,-1,32,65,TWrex-cause,802622,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20",CNS,encephalitis
725480662,5/25/2015 10:26:56,1642961534,5/25/2015 10:26:31,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,29,53,,,32,65,CNS,ENCEPHALITIS,HSV affecting the CNS,11-15-29-25,53-66-69,"ENCEPHALITIS or encephalomyelitis,","• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",29,53,29,53,-1,32,65,TWrex-cause,802622,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20",CNS,encephalitis
725480662,5/25/2015 10:33:22,1642965072,5/25/2015 10:32:22,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,29,53,,,32,65,CNS,ENCEPHALITIS,CNS,29,53,ENCEPHALITIS,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",29,53,29,53,-1,32,65,TWrex-cause,802622,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20",CNS,encephalitis
725480662,5/25/2015 10:37:48,1642968992,5/25/2015 10:37:29,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,29,53,,,32,65,CNS,ENCEPHALITIS,CNS,29,53,ENCEPHALITIS,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",29,53,29,53,-1,32,65,TWrex-cause,802622,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20",CNS,encephalitis
725480662,5/25/2015 10:42:49,1642973289,5/25/2015 10:42:35,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,29,53,,,32,65,CNS,ENCEPHALITIS,CNS,29,53,ENCEPHALITIS,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",29,53,29,53,-1,32,65,TWrex-cause,802622,"• Although HSV affecting the CNS primarily causes an encephalitis or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20",CNS,encephalitis
725480663,5/25/2015 11:58:08,1642988131,5/25/2015 11:57:55,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,13,41,,,24,72,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,PAPILLEDEMA,13,41-51-64,INCREASED INTRACRANIAL PRESSURE,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,13,41 51 64,13,41,1,24,72,TWrex-cause,811853,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF,papilledema,increased intracranial pressure
725480663,5/25/2015 12:06:28,1642989803,5/25/2015 12:05:46,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,13,41,,,24,72,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,PAPILLEDEMA,13,41-51-64-73-80-83-93-106-110-122-125-129-137-140-154,INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,13,41 51 64,13,41,1,24,72,TWrex-cause,811853,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF,papilledema,increased intracranial pressure
725480663,5/25/2015 12:44:35,1642998117,5/25/2015 12:44:16,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,13,41,,,24,72,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,PAPILLEDEMA,13,41-51-64,INCREASED INTRACRANIAL PRESSURE,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,13,41 51 64,13,41,1,24,72,TWrex-cause,811853,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF,papilledema,increased intracranial pressure
725480663,5/25/2015 12:45:02,1642998163,5/25/2015 12:44:52,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,13,41,,,24,72,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,Headache and PAPILLEDEMA may result,0-9-13-25-29,25-29-36-41-51-64-73-80-83,may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,13,41 51 64,13,41,1,24,72,TWrex-cause,811853,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF,papilledema,increased intracranial pressure
725480663,5/25/2015 12:52:21,1642999598,5/25/2015 12:51:32,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,13,41,,,24,72,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,PAPILLEDEMA,13,41-51-64,INCREASED INTRACRANIAL PRESSURE,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,13,41 51 64,13,41,1,24,72,TWrex-cause,811853,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF,papilledema,increased intracranial pressure
725480663,5/25/2015 12:58:04,1643000665,5/25/2015 12:57:51,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,13,41,,,24,72,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,PAPILLEDEMA,13,41-51-64,INCREASED INTRACRANIAL PRESSURE,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,13,41 51 64,13,41,1,24,72,TWrex-cause,811853,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF,papilledema,increased intracranial pressure
725480663,5/25/2015 12:59:49,1643000926,5/25/2015 12:59:17,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,13,41,,,24,72,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,PAPILLEDEMA,13,41-51-64,INCREASED INTRACRANIAL PRESSURE,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,13,41 51 64,13,41,1,24,72,TWrex-cause,811853,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF,papilledema,increased intracranial pressure
725480663,5/25/2015 13:11:29,1643002973,5/25/2015 13:11:01,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,13,41,,,24,72,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,PAPILLEDEMA,13,41-51-64,INCREASED INTRACRANIAL PRESSURE,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,13,41 51 64,13,41,1,24,72,TWrex-cause,811853,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF,papilledema,increased intracranial pressure
725480663,5/25/2015 13:16:54,1643004005,5/25/2015 13:16:41,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,13,41,,,24,72,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,PAPILLEDEMA,13,41-51-64,INCREASED INTRACRANIAL PRESSURE,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,13,41 51 64,13,41,1,24,72,TWrex-cause,811853,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF,papilledema,increased intracranial pressure
725480663,5/25/2015 13:19:45,1643004561,5/25/2015 13:19:17,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,13,41,,,24,72,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,Headache PAPILLEDEMA intracranial pressure meningeal infiltration obstruction of the outflow of cerebrospinal fluid (CSF.,0-13-51-64-83-93-110-125-129-137-140-154-160-122,0-13-41-51-64-83-93-110-122-125-129-137-140-154-160,Headache papilledema INCREASED INTRACRANIAL PRESSURE meningeal infiltration obstruction of the outflow of cerebrospinal fluid (CSF.,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,13,41 51 64,13,41,1,24,72,TWrex-cause,811853,Headache and papilledema may result from increased intracranial pressure caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF,papilledema,increased intracranial pressure
725480664,5/25/2015 12:49:13,1642999011,5/25/2015 12:48:45,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,127,18,,,140,24,BREAST CANCER,CANCER,BREAST CANCER,127-134,18,CANCER,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years.,127 134,18,127,18,1,140,24,TWrex-cause,813494,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years,breast cancer,cancer
725480664,5/25/2015 13:01:55,1643001266,5/25/2015 13:01:23,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,127,18,,,140,24,BREAST CANCER,CANCER,BREAST CANCER,127-134,11-18,breast CANCER,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years.,127 134,18,127,18,1,140,24,TWrex-cause,813494,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years,breast cancer,cancer
725480664,5/25/2015 13:04:52,1643001765,5/25/2015 13:04:36,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,127,18,,,140,24,BREAST CANCER,CANCER,BREAST CANCER,127-134,11-18,breast CANCER,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years.,127 134,18,127,18,1,140,24,TWrex-cause,813494,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years,breast cancer,cancer
725480664,5/25/2015 13:17:52,1643004207,5/25/2015 13:17:31,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,127,18,,,140,24,BREAST CANCER,CANCER,BREAST CANCER,127-134,11-18,breast CANCER,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years.,127 134,18,127,18,1,140,24,TWrex-cause,813494,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years,breast cancer,cancer
725480664,5/25/2015 13:24:29,1643005557,5/25/2015 13:24:16,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,127,18,,,140,24,BREAST CANCER,CANCER,BREAST CANCER,127-134,11-18,breast CANCER,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years.,127 134,18,127,18,1,140,24,TWrex-cause,813494,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years,breast cancer,cancer
725480664,5/25/2015 13:24:34,1643005581,5/25/2015 13:24:17,false,neodev,1,31326282,NLD,"","",82.169.243.65,127,18,,,140,24,BREAST CANCER,CANCER,breast cancer BREAST CANCER years.,11-18-127-134-150,18-127-134-11,breast CANCER breast cancer,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years.,127 134,18,127,18,1,140,24,TWrex-cause,813494,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years,breast cancer,cancer
725480664,5/25/2015 13:25:18,1643005809,5/25/2015 13:24:41,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,127,18,,,140,24,BREAST CANCER,CANCER,BREAST CANCER,127-134,11-18,breast CANCER,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years.,127 134,18,127,18,1,140,24,TWrex-cause,813494,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years,breast cancer,cancer
725480664,5/25/2015 13:25:31,1643005874,5/25/2015 13:25:04,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,127,18,,,140,24,BREAST CANCER,CANCER,BREAST CANCER,127-134,11-18,breast CANCER,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years.,127 134,18,127,18,1,140,24,TWrex-cause,813494,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years,breast cancer,cancer
725480664,5/25/2015 13:26:20,1643006040,5/25/2015 13:25:57,false,elite,1,31913360,USA,VA,Manassas,207.244.77.1,127,18,,,140,24,BREAST CANCER,CANCER,cause other than BREAST CANCER within 3 years.,110-116-122-127-134-141-148-150,0-6-11-18-25-29-34,Women with breast CANCER and more than,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years.,127 134,18,127,18,1,140,24,TWrex-cause,813494,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years,breast cancer,cancer
725480664,5/25/2015 13:27:10,1643006192,5/25/2015 13:26:27,false,clixsense,1,22947672,GBR,"","",88.144.127.68,127,18,,,140,24,BREAST CANCER,CANCER,BREAST CANCER,127-134,11-18,breast CANCER,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years.,127 134,18,127,18,1,140,24,TWrex-cause,813494,Women with breast cancer and more than three comorbid medical conditions are 20 times more likely to die of a cause other than breast cancer within 3 years,breast cancer,cancer
725480665,5/25/2015 10:10:49,1642957486,5/25/2015 10:10:31,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,27,82,,,43,113,THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,Primary immune THROMBOCYTOPENIA,12-20-27,82-89-106,IMMUNE THROMBOCYTOPENIC PURPURA.,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura.,27,82 89 106,27,82,1,43,113,TWrex-cause,814131,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura,thrombocytopenia,immune thrombocytopenic purpura
725480665,5/25/2015 10:11:47,1642957643,5/25/2015 10:10:54,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,27,82,,,43,113,THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,• Primary immune THROMBOCYTOPENIA,10-12-20-27,82-89-106,IMMUNE THROMBOCYTOPENIC PURPURA.,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura.,27,82 89 106,27,82,1,43,113,TWrex-cause,814131,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura,thrombocytopenia,immune thrombocytopenic purpura
725480665,5/25/2015 10:13:43,1642958033,5/25/2015 10:13:23,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,27,82,,,43,113,THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,• Primary immune THROMBOCYTOPENIA,10-12-20-27,82-89-106,IMMUNE THROMBOCYTOPENIC PURPURA.,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura.,27,82 89 106,27,82,1,43,113,TWrex-cause,814131,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura,thrombocytopenia,immune thrombocytopenic purpura
725480665,5/25/2015 10:24:43,1642960780,5/25/2015 10:24:26,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,27,82,,,43,113,THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,Primary immune THROMBOCYTOPENIA,12-20-27,82-89-106,IMMUNE THROMBOCYTOPENIC PURPURA.,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura.,27,82 89 106,27,82,1,43,113,TWrex-cause,814131,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura,thrombocytopenia,immune thrombocytopenic purpura
725480665,5/25/2015 10:39:16,1642970403,5/25/2015 10:38:30,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,27,82,,,43,113,THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,Primary immune THROMBOCYTOPENIA,12-20-27,82-89-106,IMMUNE THROMBOCYTOPENIC PURPURA.,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura.,27,82 89 106,27,82,1,43,113,TWrex-cause,814131,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura,thrombocytopenia,immune thrombocytopenic purpura
725480665,5/25/2015 10:40:33,1642971535,5/25/2015 10:40:10,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,27,82,,,43,113,THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,Primary immune THROMBOCYTOPENIA,12-20-27,82-89-106,IMMUNE THROMBOCYTOPENIC PURPURA.,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura.,27,82 89 106,27,82,1,43,113,TWrex-cause,814131,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura,thrombocytopenia,immune thrombocytopenic purpura
725480665,5/25/2015 10:44:34,1642974276,5/25/2015 10:44:22,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,27,82,,,43,113,THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,• Primary immune THROMBOCYTOPENIA,10-12-20-27,68-82-89-106-79,idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA.,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura.,27,82 89 106,27,82,1,43,113,TWrex-cause,814131,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura,thrombocytopenia,immune thrombocytopenic purpura
725480665,5/25/2015 10:45:26,1642974640,5/25/2015 10:45:06,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,27,82,,,43,113,THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,• Primary immune THROMBOCYTOPENIA was previously known idiopathic thrombocytopenic purpura.,10-12-20-27-44-48-59-89-106-68,65-68-79-82-89-106-27,thrombocytopenia as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA.,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura.,27,82 89 106,27,82,1,43,113,TWrex-cause,814131,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura,thrombocytopenia,immune thrombocytopenic purpura
725480665,5/25/2015 10:47:09,1642974967,5/25/2015 10:46:45,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,27,82,,,43,113,THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,Primary immune THROMBOCYTOPENIA,12-20-27,82-89-106,IMMUNE THROMBOCYTOPENIC PURPURA.,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura.,27,82 89 106,27,82,1,43,113,TWrex-cause,814131,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura,thrombocytopenia,immune thrombocytopenic purpura
725480665,5/25/2015 10:49:21,1642975346,5/25/2015 10:48:43,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,27,82,,,43,113,THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,Primary immune THROMBOCYTOPENIA known idiopathic or immune thrombocytopenic purpura.,12-20-27-59-68-79-82-89-106,12-20-48-59-65-68-79-82-89-106-27,Primary immune thrombocytopenia previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA.,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura.,27,82 89 106,27,82,1,43,113,TWrex-cause,814131,Comments: • Primary immune thrombocytopenia was previously known as idiopathic or immune thrombocytopenic purpura,thrombocytopenia,immune thrombocytopenic purpura
725480666,5/25/2015 09:36:58,1642952220,5/25/2015 09:36:45,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,77,41,,,92,50,EXTERNAL OTITIS,OFLOXACIN,EXTERNAL OTITIS:,77-86,41,OFLOXACIN,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.",77 86,41,77,41,-1,92,50,TWrex-cause,803726,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases",external otitis,ofloxacin
725480666,5/25/2015 09:51:30,1642954401,5/25/2015 09:51:17,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,77,41,,,92,50,EXTERNAL OTITIS,OFLOXACIN,EXTERNAL OTITIS:,77-86,36-41,Oral OFLOXACIN,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.",77 86,41,77,41,-1,92,50,TWrex-cause,803726,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases",external otitis,ofloxacin
725480666,5/25/2015 10:00:35,1642955912,5/25/2015 10:00:07,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,77,41,,,92,50,EXTERNAL OTITIS,OFLOXACIN,malignant EXTERNAL OTITIS:,67-77-86,36-41,Oral OFLOXACIN,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.",77 86,41,77,41,-1,92,50,TWrex-cause,803726,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases",external otitis,ofloxacin
725480666,5/25/2015 10:01:03,1642955984,5/25/2015 10:00:28,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,77,41,,,92,50,EXTERNAL OTITIS,OFLOXACIN,treatment of malignant EXTERNAL OTITIS: a study of,54-64-67-77-86-94-96-102,36-41,Oral OFLOXACIN,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.",77 86,41,77,41,-1,92,50,TWrex-cause,803726,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases",external otitis,ofloxacin
725480666,5/25/2015 10:07:26,1642956995,5/25/2015 10:06:58,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,77,41,,,92,50,EXTERNAL OTITIS,OFLOXACIN,EXTERNAL OTITIS:,77-86,36-41,Oral OFLOXACIN,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.",77 86,41,77,41,-1,92,50,TWrex-cause,803726,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases",external otitis,ofloxacin
725480666,5/25/2015 10:07:36,1642956999,5/25/2015 10:07:07,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,77,41,,,92,50,EXTERNAL OTITIS,OFLOXACIN,malignant EXTERNAL OTITIS:,77-86-67,36-41,Oral OFLOXACIN,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.",77 86,41,77,41,-1,92,50,TWrex-cause,803726,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases",external otitis,ofloxacin
725480666,5/25/2015 10:20:46,1642959491,5/25/2015 10:20:26,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,77,41,,,92,50,EXTERNAL OTITIS,OFLOXACIN,malignant EXTERNAL OTITIS:,67-77-86,36-41,Oral OFLOXACIN,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.",77 86,41,77,41,-1,92,50,TWrex-cause,803726,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases",external otitis,ofloxacin
725480666,5/25/2015 10:24:43,1642960758,5/25/2015 10:24:19,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,77,41,,,92,50,EXTERNAL OTITIS,OFLOXACIN,malignant EXTERNAL OTITIS:,67-77-86,36-41,Oral OFLOXACIN,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.",77 86,41,77,41,-1,92,50,TWrex-cause,803726,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases",external otitis,ofloxacin
725480666,5/25/2015 10:27:37,1642961835,5/25/2015 10:25:20,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,77,41,,,92,50,EXTERNAL OTITIS,OFLOXACIN,malignant EXTERNAL OTITIS:,67-77-86,36-41,Oral OFLOXACIN,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.",77 86,41,77,41,-1,92,50,TWrex-cause,803726,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases",external otitis,ofloxacin
725480666,5/25/2015 10:36:05,1642967250,5/25/2015 10:35:39,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,77,41,,,92,50,EXTERNAL OTITIS,OFLOXACIN,EXTERNAL OTITIS:,77-86,36-41,Oral OFLOXACIN,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.",77 86,41,77,41,-1,92,50,TWrex-cause,803726,"Levy R, Shpitzer T, Shvero J et al. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases",external otitis,ofloxacin
725480667,5/25/2015 10:53:59,1642976005,5/25/2015 10:53:45,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,13,131,,,21,152,HEADACHE,TENSION TYPE HEADACHE,HEADACHE,13,131-139-144,TENSION TYPE HEADACHE.,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache.",13,131 139 144,13,131,1,21,152,TWrex-cause,812902,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache",headache,tension type headache
725480667,5/25/2015 10:59:38,1642977006,5/25/2015 10:59:01,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,13,131,,,21,152,HEADACHE,TENSION TYPE HEADACHE,HEADACHE started suddenly can become tension - type headache.,13-22-30-120-124-131-138-139-144,13-22-30-81-85-91-111-120-124-131-139-144-102,headache started suddenly new daily persistent headache commonly can become TENSION TYPE HEADACHE.,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache.",13,131 139 144,13,131,1,21,152,TWrex-cause,812902,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache",headache,tension type headache
725480667,5/25/2015 11:35:51,1642983950,5/25/2015 11:35:41,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,13,131,,,21,152,HEADACHE,TENSION TYPE HEADACHE,HEADACHE,13,131-139-144,TENSION TYPE HEADACHE.,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache.",13,131 139 144,13,131,1,21,152,TWrex-cause,812902,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache",headache,tension type headache
725480667,5/25/2015 11:44:55,1642985676,5/25/2015 11:44:44,false,dailyrewardsca,1.0,32438879,CAN,NB,Fredericton,156.57.46.234,13,131,,,21,152,HEADACHE,TENSION TYPE HEADACHE,HEADACHE,13,131-139-144,TENSION TYPE HEADACHE.,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache.",13,131 139 144,13,131,1,21,152,TWrex-cause,812902,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache",headache,tension type headache
725480667,5/25/2015 11:52:55,1642987387,5/25/2015 11:52:45,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,13,131,,,21,152,HEADACHE,TENSION TYPE HEADACHE,HEADACHE,13,131-139-144,TENSION TYPE HEADACHE.,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache.",13,131 139 144,13,131,1,21,152,TWrex-cause,812902,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache",headache,tension type headache
725480667,5/25/2015 11:53:08,1642987406,5/25/2015 11:52:40,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,13,131,,,21,152,HEADACHE,TENSION TYPE HEADACHE,HEADACHE started suddenly,13-22-30,85-91-102-111-120-131-139-144-124,daily persistent headache commonly can become TENSION TYPE HEADACHE.,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache.",13,131 139 144,13,131,1,21,152,TWrex-cause,812902,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache",headache,tension type headache
725480667,5/25/2015 11:56:43,1642987907,5/25/2015 11:56:29,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,13,131,,,21,152,HEADACHE,TENSION TYPE HEADACHE,HEADACHE,13,131-139-144,TENSION TYPE HEADACHE.,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache.",13,131 139 144,13,131,1,21,152,TWrex-cause,812902,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache",headache,tension type headache
725480667,5/25/2015 12:13:00,1642991415,5/25/2015 12:10:46,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,13,131,,,21,152,HEADACHE,TENSION TYPE HEADACHE,HEADACHE,13,131-139-144,TENSION TYPE HEADACHE.,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache.",13,131 139 144,13,131,1,21,152,TWrex-cause,812902,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache",headache,tension type headache
725480667,5/25/2015 12:30:41,1642995312,5/25/2015 12:30:18,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,13,131,,,21,152,HEADACHE,TENSION TYPE HEADACHE,"Finally, the HEADACHE started suddenly",0-9-13-22-30,111-120-124-131-139-144,commonly can become TENSION TYPE HEADACHE.,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache.",13,131 139 144,13,131,1,21,152,TWrex-cause,812902,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache",headache,tension type headache
725480667,5/25/2015 12:33:55,1642996110,5/25/2015 12:33:30,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,13,131,,,21,152,HEADACHE,TENSION TYPE HEADACHE,HEADACHE started suddenly in,13-22-30-39,111-120-124-131-139-144,commonly can become TENSION TYPE HEADACHE.,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache.",13,131 139 144,13,131,1,21,152,TWrex-cause,812902,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent headache commonly can become tension-type headache",headache,tension type headache
725480668,5/25/2015 10:14:34,1642958170,5/25/2015 10:14:19,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,7,138,,,20,142,DRUG TOXICITY,DRUG,Direct DRUG TOXICITY,7-12-0,138,DRUG,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug.",7 12,138,7,138,1,20,142,TWrex-cause,812433,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug",drug toxicity,drug
725480668,5/25/2015 10:17:27,1642958668,5/25/2015 10:17:02,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,7,138,,,20,142,DRUG TOXICITY,DRUG,Direct DRUG TOXICITY,0-7-12,138,DRUG,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug.",7 12,138,7,138,1,20,142,TWrex-cause,812433,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug",drug toxicity,drug
725480668,5/25/2015 10:17:59,1642958769,5/25/2015 10:17:34,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,7,138,,,20,142,DRUG TOXICITY,DRUG,Direct DRUG TOXICITY,0-7-12,138,DRUG,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug.",7 12,138,7,138,1,20,142,TWrex-cause,812433,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug",drug toxicity,drug
725480668,5/25/2015 10:27:31,1642961797,5/25/2015 10:27:18,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,7,138,,,20,142,DRUG TOXICITY,DRUG,DRUG TOXICITY,7-12,138,DRUG,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug.",7 12,138,7,138,1,20,142,TWrex-cause,812433,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug",drug toxicity,drug
725480668,5/25/2015 10:43:44,1642973844,5/25/2015 10:43:25,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,7,138,,,20,142,DRUG TOXICITY,DRUG,Direct DRUG TOXICITY,0-7-12,138,DRUG,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug.",7 12,138,7,138,1,20,142,TWrex-cause,812433,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug",drug toxicity,drug
725480668,5/25/2015 10:44:19,1642974155,5/25/2015 10:43:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,7,138,,,20,142,DRUG TOXICITY,DRUG,Direct DRUG TOXICITY,0-7-12,138,DRUG,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug.",7 12,138,7,138,1,20,142,TWrex-cause,812433,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug",drug toxicity,drug
725480668,5/25/2015 10:46:48,1642974915,5/25/2015 10:46:39,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,7,138,,,20,142,DRUG TOXICITY,DRUG,DRUG TOXICITY,7-12,138,DRUG,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug.",7 12,138,7,138,1,20,142,TWrex-cause,812433,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug",drug toxicity,drug
725480668,5/25/2015 10:50:34,1642975520,5/25/2015 10:50:21,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,7,138,,,20,142,DRUG TOXICITY,DRUG,DRUG TOXICITY,7-12,138,DRUG,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug.",7 12,138,7,138,1,20,142,TWrex-cause,812433,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug",drug toxicity,drug
725480668,5/25/2015 10:54:17,1642976049,5/25/2015 10:53:53,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,7,138,,,20,142,DRUG TOXICITY,DRUG,Direct DRUG TOXICITY Although antimicrobials,0-7-12-22-31,96-106-119-126-133-138-143-146-110,potential for toxicity varies widely from DRUG to drug.,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug.",7 12,138,7,138,1,20,142,TWrex-cause,812433,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug",drug toxicity,drug
725480668,5/25/2015 11:33:06,1642983395,5/25/2015 11:32:55,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,7,138,,,20,142,DRUG TOXICITY,DRUG,DRUG TOXICITY,7-12,119-138,varies DRUG,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug.",7 12,138,7,138,1,20,142,TWrex-cause,812433,"Direct Drug Toxicity  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to drug",drug toxicity,drug
725480669,5/25/2015 10:55:56,1642976373,5/25/2015 10:55:41,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,6,41,,,15,53,PREGNANCY,TRANDOLAPRIL,PREGNANCY,6,41,TRANDOLAPRIL,"•  If pregnancy is detected, discontinue trandolapril as soon as possible.",6,41,6,41,-1,15,53,TWrex-cause,803118,"•  If pregnancy is detected, discontinue trandolapril as soon as possible",pregnancy,trandolapril
725480669,5/25/2015 11:03:20,1642977697,5/25/2015 11:03:03,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,6,41,,,15,53,PREGNANCY,TRANDOLAPRIL,"If PREGNANCY is detected, discontinue trandolapril",3-6-16-19-29-41,3-6-16-19-29-41,"If pregnancy is detected, discontinue TRANDOLAPRIL","•  If pregnancy is detected, discontinue trandolapril as soon as possible.",6,41,6,41,-1,15,53,TWrex-cause,803118,"•  If pregnancy is detected, discontinue trandolapril as soon as possible",pregnancy,trandolapril
725480669,5/25/2015 11:37:33,1642984287,5/25/2015 11:37:17,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,6,41,,,15,53,PREGNANCY,TRANDOLAPRIL,PREGNANCY,6,41,TRANDOLAPRIL,"•  If pregnancy is detected, discontinue trandolapril as soon as possible.",6,41,6,41,-1,15,53,TWrex-cause,803118,"•  If pregnancy is detected, discontinue trandolapril as soon as possible",pregnancy,trandolapril
725480669,5/25/2015 11:54:30,1642987561,5/25/2015 11:54:18,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,6,41,,,15,53,PREGNANCY,TRANDOLAPRIL,PREGNANCY,6,41,TRANDOLAPRIL,"•  If pregnancy is detected, discontinue trandolapril as soon as possible.",6,41,6,41,-1,15,53,TWrex-cause,803118,"•  If pregnancy is detected, discontinue trandolapril as soon as possible",pregnancy,trandolapril
725480669,5/25/2015 11:56:51,1642987956,5/25/2015 11:56:15,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,6,41,,,15,53,PREGNANCY,TRANDOLAPRIL,PREGNANCY,6,29-41,discontinue TRANDOLAPRIL,"•  If pregnancy is detected, discontinue trandolapril as soon as possible.",6,41,6,41,-1,15,53,TWrex-cause,803118,"•  If pregnancy is detected, discontinue trandolapril as soon as possible",pregnancy,trandolapril
725480669,5/25/2015 12:18:52,1642992894,5/25/2015 12:18:36,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,6,41,,,15,53,PREGNANCY,TRANDOLAPRIL,PREGNANCY,6,41,TRANDOLAPRIL,"•  If pregnancy is detected, discontinue trandolapril as soon as possible.",6,41,6,41,-1,15,53,TWrex-cause,803118,"•  If pregnancy is detected, discontinue trandolapril as soon as possible",pregnancy,trandolapril
725480669,5/25/2015 12:35:46,1642996494,5/25/2015 12:35:31,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,6,41,,,15,53,PREGNANCY,TRANDOLAPRIL,"• If PREGNANCY is detected, discontinue",0-3-6-16-19-29,41-54-57-62,TRANDOLAPRIL as soon as,"•  If pregnancy is detected, discontinue trandolapril as soon as possible.",6,41,6,41,-1,15,53,TWrex-cause,803118,"•  If pregnancy is detected, discontinue trandolapril as soon as possible",pregnancy,trandolapril
725480669,5/25/2015 12:36:11,1642996591,5/25/2015 12:34:31,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,6,41,,,15,53,PREGNANCY,TRANDOLAPRIL,"PREGNANCY is detected,",6-16-19,16-19-29-41-54-57-62-65,"is detected, discontinue TRANDOLAPRIL as soon as possible.","•  If pregnancy is detected, discontinue trandolapril as soon as possible.",6,41,6,41,-1,15,53,TWrex-cause,803118,"•  If pregnancy is detected, discontinue trandolapril as soon as possible",pregnancy,trandolapril
725480669,5/25/2015 12:38:07,1642996995,5/25/2015 12:37:45,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,6,41,,,15,53,PREGNANCY,TRANDOLAPRIL,PREGNANCY,6,41,TRANDOLAPRIL,"•  If pregnancy is detected, discontinue trandolapril as soon as possible.",6,41,6,41,-1,15,53,TWrex-cause,803118,"•  If pregnancy is detected, discontinue trandolapril as soon as possible",pregnancy,trandolapril
725480669,5/25/2015 12:42:05,1642997691,5/25/2015 12:41:43,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,6,41,,,15,53,PREGNANCY,TRANDOLAPRIL,PREGNANCY,6,41,TRANDOLAPRIL,"•  If pregnancy is detected, discontinue trandolapril as soon as possible.",6,41,6,41,-1,15,53,TWrex-cause,803118,"•  If pregnancy is detected, discontinue trandolapril as soon as possible",pregnancy,trandolapril
725480670,5/25/2015 08:17:08,1642938982,5/25/2015 08:16:50,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,35,104,,,45,106,DEPRESSION,MS,"DEPRESSION,",35,104,MS,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",35,104,35,104,1,45,106,TWrex-cause,812811,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable",depression,MS
725480670,5/25/2015 08:41:50,1642943376,5/25/2015 08:40:49,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,35,104,,,45,106,DEPRESSION,MS,"DEPRESSION,",35,104,MS,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",35,104,35,104,1,45,106,TWrex-cause,812811,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable",depression,MS
725480670,5/25/2015 08:47:01,1642944205,5/25/2015 08:46:43,false,elite,1.0,26544151,GBR,"","",213.205.252.245,35,104,,,45,106,DEPRESSION,MS,"DEPRESSION,",35,104,MS,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",35,104,35,104,1,45,106,TWrex-cause,812811,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable",depression,MS
725480670,5/25/2015 08:54:17,1642945562,5/25/2015 08:53:59,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,35,104,,,45,106,DEPRESSION,MS,"DEPRESSION,",35,104,MS,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",35,104,35,104,1,45,106,TWrex-cause,812811,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable",depression,MS
725480670,5/25/2015 08:59:09,1642946245,5/25/2015 08:58:55,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,35,104,,,45,106,DEPRESSION,MS,"DEPRESSION,",35,104,MS,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",35,104,35,104,1,45,106,TWrex-cause,812811,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable",depression,MS
725480670,5/25/2015 09:06:11,1642947330,5/25/2015 09:05:53,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,35,104,,,45,106,DEPRESSION,MS,"Psychiatric problems, especially DEPRESSION, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",2-14-24-35-47-56-60-71-82-91-99-104-107-111-115,2-14-24-35-47-56-60-82-91-99-104-107-111-115-71,"Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.","• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",35,104,35,104,1,45,106,TWrex-cause,812811,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable",depression,MS
725480670,5/25/2015 09:10:43,1642947944,5/25/2015 09:09:28,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,35,104,,,45,106,DEPRESSION,MS,"DEPRESSION,",35,104,MS,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",35,104,35,104,1,45,106,TWrex-cause,812811,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable",depression,MS
725480670,5/25/2015 09:29:08,1642950819,5/25/2015 09:28:54,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,35,104,,,45,106,DEPRESSION,MS,"DEPRESSION,",35,104,MS,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",35,104,35,104,1,45,106,TWrex-cause,812811,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable",depression,MS
725480670,5/25/2015 09:33:54,1642951639,5/25/2015 09:33:40,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,35,104,,,45,106,DEPRESSION,MS,"DEPRESSION,",35,104,MS,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",35,104,35,104,1,45,106,TWrex-cause,812811,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable",depression,MS
725480670,5/25/2015 09:43:35,1642953208,5/25/2015 09:43:16,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,35,104,,,45,106,DEPRESSION,MS,"DEPRESSION,",35,104,MS,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",35,104,35,104,1,45,106,TWrex-cause,812811,"• Psychiatric problems, especially depression, anxiety, and adjustment disorders, commonly coexist with MS and are treatable",depression,MS
725480671,5/25/2015 13:02:55,1643001404,5/25/2015 13:02:23,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,128,0,,,138,18,ACROMEGALY,OCTREOTIDE ACETATE,"ACROMEGALY,",128,0-11,OCTREOTIDE ACETATE,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",128,0 11,128,0,-1,138,18,TWrex-cause,803498,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding",acromegaly,octreotide acetate
725480671,5/25/2015 13:07:10,1643002251,5/25/2015 13:06:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,128,0,,,138,18,ACROMEGALY,OCTREOTIDE ACETATE,"ACROMEGALY,",128,0-11,OCTREOTIDE ACETATE,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",128,0 11,128,0,-1,138,18,TWrex-cause,803498,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding",acromegaly,octreotide acetate
725480671,5/25/2015 13:18:58,1643004409,5/25/2015 13:18:30,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,128,0,,,138,18,ACROMEGALY,OCTREOTIDE ACETATE,"ACROMEGALY, carcinoid tumors,",128-140-150,0-11,OCTREOTIDE ACETATE,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",128,0 11,128,0,-1,138,18,TWrex-cause,803498,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding",acromegaly,octreotide acetate
725480671,5/25/2015 13:25:21,1643005842,5/25/2015 13:25:01,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,128,0,,,138,18,ACROMEGALY,OCTREOTIDE ACETATE,"ACROMEGALY,",128,0-11-48-50-60,OCTREOTIDE ACETATE A synthetic drug,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",128,0 11,128,0,-1,138,18,TWrex-cause,803498,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding",acromegaly,octreotide acetate
725480671,5/25/2015 13:25:39,1643005891,5/25/2015 13:25:18,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,128,0,,,138,18,ACROMEGALY,OCTREOTIDE ACETATE,"octreotide acetate ACROMEGALY, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, gastrointestinal bleeding.",0-11-128-140-150-158-169-188-196-214-231-180,0-11-128-140-150-158-169-180-188-196-214-231,"OCTREOTIDE ACETATE acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, gastrointestinal bleeding.","octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",128,0 11,128,0,-1,138,18,TWrex-cause,803498,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding",acromegaly,octreotide acetate
725480671,5/25/2015 13:26:24,1643006044,5/25/2015 13:25:55,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,128,0,,,138,18,ACROMEGALY,OCTREOTIDE ACETATE,"ACROMEGALY,",128,0-11,OCTREOTIDE ACETATE,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",128,0 11,128,0,-1,138,18,TWrex-cause,803498,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding",acromegaly,octreotide acetate
725480671,5/25/2015 13:27:01,1643006171,5/25/2015 13:26:39,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,128,0,,,138,18,ACROMEGALY,OCTREOTIDE ACETATE,"ACROMEGALY,",128,0-11,OCTREOTIDE ACETATE,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",128,0 11,128,0,-1,138,18,TWrex-cause,803498,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding",acromegaly,octreotide acetate
725480671,5/25/2015 13:29:57,1643006777,5/25/2015 13:28:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,128,0,,,138,18,ACROMEGALY,OCTREOTIDE ACETATE,"ACROMEGALY,",128,0-11,OCTREOTIDE ACETATE,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",128,0 11,128,0,-1,138,18,TWrex-cause,803498,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding",acromegaly,octreotide acetate
725480671,5/25/2015 13:52:21,1643011549,5/25/2015 13:51:51,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,128,0,,,138,18,ACROMEGALY,OCTREOTIDE ACETATE,"treating ACROMEGALY,",119-128,0-11-39,OCTREOTIDE ACETATE audio,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",128,0 11,128,0,-1,138,18,TWrex-cause,803498,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding",acromegaly,octreotide acetate
725480671,5/25/2015 14:01:29,1643013443,5/25/2015 14:01:04,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,128,0,,,138,18,ACROMEGALY,OCTREOTIDE ACETATE,"ACROMEGALY,",128,0-11,OCTREOTIDE ACETATE,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",128,0 11,128,0,-1,138,18,TWrex-cause,803498,"octreotide acetate    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding",acromegaly,octreotide acetate
725480672,5/25/2015 12:48:10,1642998762,5/25/2015 12:47:53,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,72,47,,,78,58,TREMOR,PROPRANOLOL,essential TREMOR.,62-72,47,PROPRANOLOL,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor.",72,47,72,47,-1,78,58,TWrex-cause,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor",tremor,propranolol
725480672,5/25/2015 13:01:05,1643001151,5/25/2015 13:00:14,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,72,47,,,78,58,TREMOR,PROPRANOLOL,essential TREMOR.,62-72,47,PROPRANOLOL,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor.",72,47,72,47,-1,78,58,TWrex-cause,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor",tremor,propranolol
725480672,5/25/2015 13:04:11,1643001638,5/25/2015 13:03:51,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,72,47,,,78,58,TREMOR,PROPRANOLOL,TREMOR.,72,47,PROPRANOLOL,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor.",72,47,72,47,-1,78,58,TWrex-cause,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor",tremor,propranolol
725480672,5/25/2015 13:16:54,1643004009,5/25/2015 13:16:21,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,72,47,,,78,58,TREMOR,PROPRANOLOL,TREMOR.,72,47,PROPRANOLOL,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor.",72,47,72,47,-1,78,58,TWrex-cause,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor",tremor,propranolol
725480672,5/25/2015 13:23:49,1643005360,5/25/2015 13:23:37,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,72,47,,,78,58,TREMOR,PROPRANOLOL,propranolol on essential TREMOR.,47-59-62-72,47-59-62-72,PROPRANOLOL on essential tremor.,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor.",72,47,72,47,-1,78,58,TWrex-cause,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor",tremor,propranolol
725480672,5/25/2015 13:23:52,1643005362,5/25/2015 13:23:35,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,72,47,,,78,58,TREMOR,PROPRANOLOL,essential TREMOR.,62-72,47,PROPRANOLOL,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor.",72,47,72,47,-1,78,58,TWrex-cause,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor",tremor,propranolol
725480672,5/25/2015 13:24:02,1643005383,5/25/2015 13:23:52,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,72,47,,,78,58,TREMOR,PROPRANOLOL,propranolol on essential TREMOR.,47-59-62-72,37-44-47-59-62-72,Effect of PROPRANOLOL on essential tremor.,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor.",72,47,72,47,-1,78,58,TWrex-cause,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor",tremor,propranolol
725480672,5/25/2015 13:24:37,1643005611,5/25/2015 13:24:05,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,72,47,,,78,58,TREMOR,PROPRANOLOL,essential TREMOR.,62-72,47,PROPRANOLOL,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor.",72,47,72,47,-1,78,58,TWrex-cause,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor",tremor,propranolol
725480672,5/25/2015 13:25:20,1643005837,5/25/2015 13:24:54,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,72,47,,,78,58,TREMOR,PROPRANOLOL,essential TREMOR.,62-72,47,PROPRANOLOL,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor.",72,47,72,47,-1,78,58,TWrex-cause,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor",tremor,propranolol
725480672,5/25/2015 13:25:34,1643005880,5/25/2015 13:25:10,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,72,47,,,78,58,TREMOR,PROPRANOLOL,propranolol on essential TREMOR.,47-59-62-72,34-37-44-47-59-62-72,A. Effect of PROPRANOLOL on essential tremor.,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor.",72,47,72,47,-1,78,58,TWrex-cause,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor",tremor,propranolol
725480673,5/25/2015 08:19:06,1642939335,5/25/2015 08:18:40,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,206,79,,,214,89,DISORDER,OLANZAPINE,bipolar DISORDER,198-206,79,OLANZAPINE,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.",206,79,206,79,-1,214,89,TWrex-cause,800310,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder",disorder,olanzapine
725480673,5/25/2015 08:48:37,1642944542,5/25/2015 08:48:22,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,206,79,,,214,89,DISORDER,OLANZAPINE,schizophrenia and bipolar DISORDER,180-194-198-206,79,OLANZAPINE,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.",206,79,206,79,-1,214,89,TWrex-cause,800310,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder",disorder,olanzapine
725480673,5/25/2015 08:48:43,1642944574,5/25/2015 08:48:18,false,elite,1.0,26544151,GBR,"","",213.205.252.245,206,79,,,214,89,DISORDER,OLANZAPINE,DISORDER,206,79,OLANZAPINE,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.",206,79,206,79,-1,214,89,TWrex-cause,800310,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder",disorder,olanzapine
725480673,5/25/2015 08:55:57,1642945764,5/25/2015 08:55:37,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,206,79,,,214,89,DISORDER,OLANZAPINE,bipolar DISORDER,198-206,79,OLANZAPINE,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.",206,79,206,79,-1,214,89,TWrex-cause,800310,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder",disorder,olanzapine
725480673,5/25/2015 09:01:17,1642946596,5/25/2015 09:00:55,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,206,79,,,214,89,DISORDER,OLANZAPINE,bipolar DISORDER,198-206,79,OLANZAPINE,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.",206,79,206,79,-1,214,89,TWrex-cause,800310,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder",disorder,olanzapine
725480673,5/25/2015 09:09:26,1642947818,5/25/2015 09:08:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,206,79,,,214,89,DISORDER,OLANZAPINE,"Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",15-20-24-38-48-56-59-69-79-90-93-103-106-109-118-123-126-128-134-144-152-156-166-175-180-194-198-206-215-220-224-232-238-247-263-276-284-288-297-302-306,15-20-24-38-48-56-59-69-79-90-93-103-106-109-118-123-126-128-134-144-152-156-166-175-180-194-198-206-215-220-224-232-238-247-263-276-284-288-297-302-306,"Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.","Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.",206,79,206,79,-1,214,89,TWrex-cause,800310,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder",disorder,olanzapine
725480673,5/25/2015 09:16:52,1642948844,5/25/2015 09:15:01,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,206,79,,,214,89,DISORDER,OLANZAPINE,bipolar DISORDER,198-206,79,OLANZAPINE,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.",206,79,206,79,-1,214,89,TWrex-cause,800310,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder",disorder,olanzapine
725480673,5/25/2015 09:30:46,1642951031,5/25/2015 09:30:28,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,206,79,,,214,89,DISORDER,OLANZAPINE,DISORDER,206,79,OLANZAPINE,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.",206,79,206,79,-1,214,89,TWrex-cause,800310,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder",disorder,olanzapine
725480673,5/25/2015 09:45:42,1642953482,5/25/2015 09:45:29,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,206,79,,,214,89,DISORDER,OLANZAPINE,bipolar DISORDER,198-206,79,OLANZAPINE,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.",206,79,206,79,-1,214,89,TWrex-cause,800310,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder",disorder,olanzapine
725480673,5/25/2015 09:53:54,1642954651,5/25/2015 09:53:40,false,clixsense,1.0,24763049,GBR,Y8,Welshpool,81.135.56.139,206,79,,,214,89,DISORDER,OLANZAPINE,DISORDER,206,79,OLANZAPINE,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder.",206,79,206,79,-1,214,89,TWrex-cause,800310,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Olanzapine is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder",disorder,olanzapine
725480674,5/25/2015 08:24:36,1642940607,5/25/2015 08:24:19,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,77,17,,,92,29,SCHISTOSOMIASIS,PRAZIQUANTEL,acute SCHISTOSOMIASIS,71-77,17,PRAZIQUANTEL,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,77,17,77,17,-1,92,29,TWrex-cause,800597,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids,schistosomiasis,praziquantel
725480674,5/25/2015 08:53:14,1642945439,5/25/2015 08:53:00,false,elite,1.0,26544151,GBR,"","",213.205.252.245,77,17,,,92,29,SCHISTOSOMIASIS,PRAZIQUANTEL,SCHISTOSOMIASIS,77,17,PRAZIQUANTEL,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,77,17,77,17,-1,92,29,TWrex-cause,800597,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids,schistosomiasis,praziquantel
725480674,5/25/2015 08:53:30,1642945467,5/25/2015 08:53:00,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,77,17,,,92,29,SCHISTOSOMIASIS,PRAZIQUANTEL,acute SCHISTOSOMIASIS,71-77,17,PRAZIQUANTEL,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,77,17,77,17,-1,92,29,TWrex-cause,800597,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids,schistosomiasis,praziquantel
725480674,5/25/2015 09:01:27,1642946602,5/25/2015 09:01:08,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,77,17,,,92,29,SCHISTOSOMIASIS,PRAZIQUANTEL,SCHISTOSOMIASIS,77,17,PRAZIQUANTEL,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,77,17,77,17,-1,92,29,TWrex-cause,800597,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids,schistosomiasis,praziquantel
725480674,5/25/2015 09:07:13,1642947495,5/25/2015 09:06:53,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,77,17,,,92,29,SCHISTOSOMIASIS,PRAZIQUANTEL,acute SCHISTOSOMIASIS,71-77,17,PRAZIQUANTEL,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,77,17,77,17,-1,92,29,TWrex-cause,800597,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids,schistosomiasis,praziquantel
725480674,5/25/2015 09:23:44,1642949815,5/25/2015 09:23:18,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,77,17,,,92,29,SCHISTOSOMIASIS,PRAZIQUANTEL,Treatment with praziquantel has not been proven to effectively treat acute SCHISTOSOMIASIS but should be given together with oral corticosteroids.,2-12-17-30-34-38-43-50-53-65-71-77-93-97-104-107-113-122-127-132,2-12-17-30-34-38-43-50-53-65-71-77-93-97-104-107-113-122-127-132,Treatment with PRAZIQUANTEL has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,77,17,77,17,-1,92,29,TWrex-cause,800597,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids,schistosomiasis,praziquantel
725480674,5/25/2015 09:32:29,1642951319,5/25/2015 09:31:28,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,77,17,,,92,29,SCHISTOSOMIASIS,PRAZIQUANTEL,acute SCHISTOSOMIASIS,71-77,17,PRAZIQUANTEL,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,77,17,77,17,-1,92,29,TWrex-cause,800597,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids,schistosomiasis,praziquantel
725480674,5/25/2015 09:36:31,1642952178,5/25/2015 09:36:17,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,77,17,,,92,29,SCHISTOSOMIASIS,PRAZIQUANTEL,SCHISTOSOMIASIS,77,17,PRAZIQUANTEL,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,77,17,77,17,-1,92,29,TWrex-cause,800597,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids,schistosomiasis,praziquantel
725480674,5/25/2015 09:51:00,1642954283,5/25/2015 09:50:46,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,77,17,,,92,29,SCHISTOSOMIASIS,PRAZIQUANTEL,SCHISTOSOMIASIS,77,17,PRAZIQUANTEL,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,77,17,77,17,-1,92,29,TWrex-cause,800597,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids,schistosomiasis,praziquantel
725480674,5/25/2015 09:59:48,1642955850,5/25/2015 09:59:06,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,77,17,,,92,29,SCHISTOSOMIASIS,PRAZIQUANTEL,acute SCHISTOSOMIASIS,71-77,17,PRAZIQUANTEL,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids.,77,17,77,17,-1,92,29,TWrex-cause,800597,• Treatment with praziquantel has not been proven to effectively treat acute schistosomiasis but should be given together with oral corticosteroids,schistosomiasis,praziquantel
725480675,5/25/2015 10:14:51,1642958197,5/25/2015 10:14:37,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,161,122,,,171,129,THROMBOSIS,HEPARIN,of deep vein THROMBOSIS,148-151-156-161,109-122,subcutaneous HEPARIN,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.",161,122,161,122,-1,171,129,TWrex-cause,805151,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement",thrombosis,heparin
725480675,5/25/2015 10:17:52,1642958764,5/25/2015 10:17:28,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,161,122,,,171,129,THROMBOSIS,HEPARIN,deep vein THROMBOSIS,151-156-161,98-104-109-122,fixed dose subcutaneous HEPARIN,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.",161,122,161,122,-1,171,129,TWrex-cause,805151,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement",thrombosis,heparin
725480675,5/25/2015 10:18:48,1642958913,5/25/2015 10:18:01,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,161,122,,,171,129,THROMBOSIS,HEPARIN,deep vein THROMBOSIS,151-156-161,98-103-104-109-122,fixed - dose subcutaneous HEPARIN,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.",161,122,161,122,-1,171,129,TWrex-cause,805151,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement",thrombosis,heparin
725480675,5/25/2015 10:27:48,1642961895,5/25/2015 10:27:32,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,161,122,,,171,129,THROMBOSIS,HEPARIN,deep vein THROMBOSIS,151-156-161,109-122,subcutaneous HEPARIN,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.",161,122,161,122,-1,171,129,TWrex-cause,805151,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement",thrombosis,heparin
725480675,5/25/2015 10:44:04,1642974002,5/25/2015 10:43:45,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,161,122,,,171,129,THROMBOSIS,HEPARIN,deep vein THROMBOSIS,151-156-161,98-104-109-122,fixed dose subcutaneous HEPARIN,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.",161,122,161,122,-1,171,129,TWrex-cause,805151,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement",thrombosis,heparin
725480675,5/25/2015 10:44:41,1642974316,5/25/2015 10:44:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,161,122,,,171,129,THROMBOSIS,HEPARIN,deep vein THROMBOSIS,151-156-161,98-104-109-122,fixed dose subcutaneous HEPARIN,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.",161,122,161,122,-1,171,129,TWrex-cause,805151,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement",thrombosis,heparin
725480675,5/25/2015 10:51:03,1642975558,5/25/2015 10:50:35,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,161,122,,,171,129,THROMBOSIS,HEPARIN,deep vein THROMBOSIS,151-156-161,98-104-109-122,fixed dose subcutaneous HEPARIN,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.",161,122,161,122,-1,171,129,TWrex-cause,805151,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement",thrombosis,heparin
725480675,5/25/2015 10:54:45,1642976100,5/25/2015 10:54:19,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,161,122,,,171,129,THROMBOSIS,HEPARIN,subcutaneous heparin prevention of deep vein THROMBOSIS,109-122-148-151-156-161-137,82-91-98-104-109-122-130-133-137-151-156-161,Adjusted versus fixed dose subcutaneous HEPARIN in the prevention deep vein thrombosis,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.",161,122,161,122,-1,171,129,TWrex-cause,805151,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement",thrombosis,heparin
725480675,5/25/2015 11:33:26,1642983437,5/25/2015 11:33:07,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,161,122,,,171,129,THROMBOSIS,HEPARIN,deep vein THROMBOSIS,151-156-161,98-104-109-122,fixed dose subcutaneous HEPARIN,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.",161,122,161,122,-1,171,129,TWrex-cause,805151,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement",thrombosis,heparin
725480675,5/25/2015 11:41:53,1642984994,5/25/2015 11:41:02,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,161,122,,,171,129,THROMBOSIS,HEPARIN,deep vein THROMBOSIS,151-156-161,109-122,subcutaneous HEPARIN,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.",161,122,161,122,-1,171,129,TWrex-cause,805151,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement",thrombosis,heparin
725480676,5/25/2015 12:47:52,1642998707,5/25/2015 12:47:33,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,106,84,,,121,91,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM,106,63-67-77-84,low molecular weight HEPARIN,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.",106,84,106,84,-1,121,91,TWrex-cause,804394,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients",thromboembolism,heparin
725480676,5/25/2015 13:00:12,1643000989,5/25/2015 12:59:34,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,106,84,,,121,91,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM,106,84,HEPARIN,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.",106,84,106,84,-1,121,91,TWrex-cause,804394,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients",thromboembolism,heparin
725480676,5/25/2015 13:03:46,1643001557,5/25/2015 13:03:25,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,106,84,,,121,91,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM,106,84,HEPARIN,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.",106,84,106,84,-1,121,91,TWrex-cause,804394,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients",thromboembolism,heparin
725480676,5/25/2015 13:16:20,1643003878,5/25/2015 13:15:39,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,106,84,,,121,91,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM,106,84,HEPARIN,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.",106,84,106,84,-1,121,91,TWrex-cause,804394,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients",thromboembolism,heparin
725480676,5/25/2015 13:23:33,1643005304,5/25/2015 13:23:18,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,106,84,,,121,91,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM in trauma patients.,106-122-125-132,63-67-77-84,low molecular weight HEPARIN,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.",106,84,106,84,-1,121,91,TWrex-cause,804394,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients",thromboembolism,heparin
725480676,5/25/2015 13:23:36,1643005310,5/25/2015 13:23:19,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,106,84,,,121,91,THROMBOEMBOLISM,HEPARIN,heparin preventing THROMBOEMBOLISM,84-95-106,84-95-106,HEPARIN preventing thromboembolism,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.",106,84,106,84,-1,121,91,TWrex-cause,804394,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients",thromboembolism,heparin
725480676,5/25/2015 13:23:50,1643005361,5/25/2015 13:23:40,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,106,84,,,121,91,THROMBOEMBOLISM,HEPARIN,heparin in preventing THROMBOEMBOLISM,84-92-95-106,63-67-77-84-92-95-106,low molecular weight HEPARIN in preventing thromboembolism,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.",106,84,106,84,-1,121,91,TWrex-cause,804394,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients",thromboembolism,heparin
725480676,5/25/2015 13:24:04,1643005384,5/25/2015 13:23:34,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,106,84,,,121,91,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM,106,63-67-77-84,low molecular weight HEPARIN,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.",106,84,106,84,-1,121,91,TWrex-cause,804394,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients",thromboembolism,heparin
725480676,5/25/2015 13:25:04,1643005776,5/25/2015 13:24:31,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,106,84,,,121,91,THROMBOEMBOLISM,HEPARIN,heparin in preventing THROMBOEMBOLISM in trauma patients.,84-92-95-106-122-125-132,63-67-77-84-92-95-106,low molecular weight HEPARIN in preventing thromboembolism,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.",106,84,106,84,-1,121,91,TWrex-cause,804394,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients",thromboembolism,heparin
725480676,5/25/2015 13:25:15,1643005808,5/25/2015 13:24:10,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,106,84,,,121,91,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM,106,84,HEPARIN,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.",106,84,106,84,-1,121,91,TWrex-cause,804394,"1]  Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients",thromboembolism,heparin
725480677,5/25/2015 08:14:49,1642938524,5/25/2015 08:14:29,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,43,17,,,51,20,SEIZURE,AIP,"SEIZURES,",43,0-6-14-17,Acute attacks of AIP,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",43,17,43,17,1,51,20,TWrex-cause,814789,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH",seizure,AIP
725480677,5/25/2015 08:19:47,1642939523,5/25/2015 08:19:34,false,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,43,17,,,51,20,SEIZURE,AIP,"Acute attacks of AIP may be accompanied by SEIZURES, especially in patients",0-6-14-17-25-28-40-43-53-64-67-21,0-6-14-17-21-25-28-40-43,"Acute attacks of AIP may be accompanied by seizures,","Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",43,17,43,17,1,51,20,TWrex-cause,814789,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH",seizure,AIP
725480677,5/25/2015 08:38:15,1642942863,5/25/2015 08:37:41,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,43,17,,,51,20,SEIZURE,AIP,"SEIZURES,",43,17,AIP,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",43,17,43,17,1,51,20,TWrex-cause,814789,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH",seizure,AIP
725480677,5/25/2015 08:44:10,1642943796,5/25/2015 08:43:54,false,elite,1.0,26544151,GBR,"","",213.205.252.245,43,17,,,51,20,SEIZURE,AIP,"SEIZURES,",43,17,AIP,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",43,17,43,17,1,51,20,TWrex-cause,814789,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH",seizure,AIP
725480677,5/25/2015 08:51:50,1642945160,5/25/2015 08:51:31,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,43,17,,,51,20,SEIZURE,AIP,"SEIZURES,",43,17,AIP,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",43,17,43,17,1,51,20,TWrex-cause,814789,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH",seizure,AIP
725480677,5/25/2015 08:55:55,1642945752,5/25/2015 08:55:37,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,43,17,,,51,20,SEIZURE,AIP,"SEIZURES,",43,17,AIP,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",43,17,43,17,1,51,20,TWrex-cause,814789,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH",seizure,AIP
725480677,5/25/2015 09:00:26,1642946397,5/25/2015 08:59:38,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,43,17,,,51,20,SEIZURE,AIP,"Acute attacks of AIP may be accompanied by SEIZURES, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone",0-6-14-17-21-25-28-40-43-53-64-67-76-81-94-101-104-114-128-134-143-146-150-159-162-176-189,0-6-14-17-21-25-28-40-43-53-64-67-76-81-94-101-104-114-128-134-143-146-150-159-162-176-189,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone","Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",43,17,43,17,1,51,20,TWrex-cause,814789,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH",seizure,AIP
725480677,5/25/2015 09:03:58,1642946876,5/25/2015 09:02:40,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,43,17,,,51,20,SEIZURE,AIP,"SEIZURES,",43,17,AIP,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",43,17,43,17,1,51,20,TWrex-cause,814789,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH",seizure,AIP
725480677,5/25/2015 09:23:50,1642949840,5/25/2015 09:23:36,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,43,17,,,51,20,SEIZURE,AIP,"SEIZURES,",43,17,AIP,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",43,17,43,17,1,51,20,TWrex-cause,814789,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH",seizure,AIP
725480677,5/25/2015 09:27:15,1642950489,5/25/2015 09:27:02,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,43,17,,,51,20,SEIZURE,AIP,"SEIZURES,",43,17,AIP,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",43,17,43,17,1,51,20,TWrex-cause,814789,"Acute attacks of AIP may be accompanied by seizures, especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH",seizure,AIP
725480678,5/25/2015 08:15:27,1642938627,5/25/2015 08:15:10,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,58,8,,,82,14,TYPE 1 DIABETES MELLITUS,LISPRO,TYPE 1 DIABETES MELLITUS,58-63-65-74,8,LISPRO,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin.",58 63 65 74,8,58,8,-1,82,14,TWrex-cause,800006,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin",type 1 diabetes mellitus,lispro
725480678,5/25/2015 08:20:13,1642939653,5/25/2015 08:20:02,false,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,58,8,,,82,14,TYPE 1 DIABETES MELLITUS,LISPRO,hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to tight glycemic control,33-46-55-58-63-65-74-83-88-93-104-110-119,0-8-15-23-33-58-63-65-74,Insulin LISPRO reduced nocturnal hypoglycemic type 1 diabetes mellitus,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin.",58 63 65 74,8,58,8,-1,82,14,TWrex-cause,800006,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin",type 1 diabetes mellitus,lispro
725480678,5/25/2015 08:39:08,1642943000,5/25/2015 08:38:42,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,58,8,,,82,14,TYPE 1 DIABETES MELLITUS,LISPRO,TYPE 1 DIABETES MELLITUS,58-63-65-74,8,LISPRO,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin.",58 63 65 74,8,58,8,-1,82,14,TWrex-cause,800006,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin",type 1 diabetes mellitus,lispro
725480678,5/25/2015 08:44:50,1642943893,5/25/2015 08:44:32,false,elite,1.0,26544151,GBR,"","",213.205.252.245,58,8,,,82,14,TYPE 1 DIABETES MELLITUS,LISPRO,TYPE 1 DIABETES MELLITUS,58-63-65-74,8,LISPRO,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin.",58 63 65 74,8,58,8,-1,82,14,TWrex-cause,800006,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin",type 1 diabetes mellitus,lispro
725480678,5/25/2015 08:52:41,1642945333,5/25/2015 08:52:22,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,58,8,,,82,14,TYPE 1 DIABETES MELLITUS,LISPRO,TYPE 1 DIABETES MELLITUS,58-63-65-74,8-0,Insulin LISPRO,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin.",58 63 65 74,8,58,8,-1,82,14,TWrex-cause,800006,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin",type 1 diabetes mellitus,lispro
725480678,5/25/2015 08:56:42,1642945912,5/25/2015 08:56:21,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,58,8,,,82,14,TYPE 1 DIABETES MELLITUS,LISPRO,TYPE 1 DIABETES MELLITUS,58-63-65-74,0-8,Insulin LISPRO,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin.",58 63 65 74,8,58,8,-1,82,14,TWrex-cause,800006,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin",type 1 diabetes mellitus,lispro
725480678,5/25/2015 09:02:16,1642946712,5/25/2015 09:01:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,58,8,,,82,14,TYPE 1 DIABETES MELLITUS,LISPRO,"Insulin lispro reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control Keywords: Blood glucose Diabetes mellitus, insulin - dependent Hypoglycemia Hypoglycemic agents Insulin.",0-8-15-23-33-46-55-58-63-65-74-83-88-93-96-104-110-119-128-138-144-152-161-171-178-179-189-202-215-222,0-8-15-23-33-46-55-58-63-65-74-83-88-93-96-104-110-119-128-138-144-152-161-171-178-179-189-202-215-222,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control Keywords: Blood glucose Diabetes mellitus, insulin - dependent Hypoglycemia Hypoglycemic agents Insulin.","Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin.",58 63 65 74,8,58,8,-1,82,14,TWrex-cause,800006,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin",type 1 diabetes mellitus,lispro
725480678,5/25/2015 09:05:45,1642947239,5/25/2015 09:04:49,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,58,8,,,82,14,TYPE 1 DIABETES MELLITUS,LISPRO,TYPE 1 DIABETES MELLITUS,58-63-65-74,0-8,Insulin LISPRO,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin.",58 63 65 74,8,58,8,-1,82,14,TWrex-cause,800006,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin",type 1 diabetes mellitus,lispro
725480678,5/25/2015 09:24:20,1642949893,5/25/2015 09:24:07,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,58,8,,,82,14,TYPE 1 DIABETES MELLITUS,LISPRO,TYPE 1 DIABETES MELLITUS,58-63-65-74,8,LISPRO,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin.",58 63 65 74,8,58,8,-1,82,14,TWrex-cause,800006,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin",type 1 diabetes mellitus,lispro
725480678,5/25/2015 09:27:47,1642950616,5/25/2015 09:27:29,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,58,8,,,82,14,TYPE 1 DIABETES MELLITUS,LISPRO,TYPE 1 DIABETES MELLITUS,58-63-65-74,8,LISPRO,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin.",58 63 65 74,8,58,8,-1,82,14,TWrex-cause,800006,"Insulin lispro reduced nocturnal hypoglycemic episodes in type 1 diabetes mellitus when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin-dependent Hypoglycemia Hypoglycemic agents Insulin",type 1 diabetes mellitus,lispro
725480679,5/25/2015 11:38:51,1642984421,5/25/2015 11:38:36,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,82,37,,,90,45,HEADACHE,MIGRAINE,HEADACHE,82,37,MIGRAINE,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam.,82,37,82,37,1,90,45,TWrex-cause,814476,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam,headache,migraine
725480679,5/25/2015 11:55:39,1642987761,5/25/2015 11:55:22,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,82,37,,,90,45,HEADACHE,MIGRAINE,HEADACHE,82,37,MIGRAINE,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam.,82,37,82,37,1,90,45,TWrex-cause,814476,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam,headache,migraine
725480679,5/25/2015 11:59:30,1642988387,5/25/2015 11:58:49,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,82,37,,,90,45,HEADACHE,MIGRAINE,HEADACHE,82,37,MIGRAINE,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam.,82,37,82,37,1,90,45,TWrex-cause,814476,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam,headache,migraine
725480679,5/25/2015 12:21:42,1642993399,5/25/2015 12:21:19,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,82,37,,,90,45,HEADACHE,MIGRAINE,HEADACHE,82,37,MIGRAINE,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam.,82,37,82,37,1,90,45,TWrex-cause,814476,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam,headache,migraine
725480679,5/25/2015 12:37:14,1642996838,5/25/2015 12:36:58,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,82,37,,,90,45,HEADACHE,MIGRAINE,HEADACHE in patients with,82-91-94-103,13-22-25-37-46-51-59,symptoms to distinguish MIGRAINE from tension type,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam.,82,37,82,37,1,90,45,TWrex-cause,814476,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam,headache,migraine
725480679,5/25/2015 12:39:42,1642997275,5/25/2015 12:39:26,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,82,37,,,90,45,HEADACHE,MIGRAINE,other types of HEADACHE in patients,67-73-79-82-91-94,13-22-25-37-46-51-59,symptoms to distinguish MIGRAINE from tension type,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam.,82,37,82,37,1,90,45,TWrex-cause,814476,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam,headache,migraine
725480679,5/25/2015 12:40:18,1642997369,5/25/2015 12:39:46,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,82,37,,,90,45,HEADACHE,MIGRAINE,HEADACHE,82,37,MIGRAINE,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam.,82,37,82,37,1,90,45,TWrex-cause,814476,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam,headache,migraine
725480679,5/25/2015 12:45:39,1642998237,5/25/2015 12:44:50,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,82,37,,,90,45,HEADACHE,MIGRAINE,HEADACHE,82,37,MIGRAINE,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam.,82,37,82,37,1,90,45,TWrex-cause,814476,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam,headache,migraine
725480679,5/25/2015 12:46:55,1642998527,5/25/2015 12:46:44,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,82,37,,,90,45,HEADACHE,MIGRAINE,HEADACHE,82,37,MIGRAINE,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam.,82,37,82,37,1,90,45,TWrex-cause,814476,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam,headache,migraine
725480679,5/25/2015 12:48:56,1642998948,5/25/2015 12:48:45,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,82,37,,,90,45,HEADACHE,MIGRAINE,HEADACHE,82,37,MIGRAINE,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam.,82,37,82,37,1,90,45,TWrex-cause,814476,3.2 Evaluate symptoms to distinguish migraine from tension-type or other types of headache in patients with a normal neurologic exam,headache,migraine
725480680,5/25/2015 08:22:02,1642940010,5/25/2015 08:21:22,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,163,107,,,172,117,CIRRHOSIS,COLCHICINE,biliary CIRRHOSIS:,155-163,107,COLCHICINE,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",163,107,163,107,-1,172,117,TWrex-cause,800140,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile",cirrhosis,colchicine
725480680,5/25/2015 08:51:16,1642945033,5/25/2015 08:51:01,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,163,107,,,172,117,CIRRHOSIS,COLCHICINE,CIRRHOSIS:,163,107,COLCHICINE,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",163,107,163,107,-1,172,117,TWrex-cause,800140,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile",cirrhosis,colchicine
725480680,5/25/2015 08:51:14,1642945034,5/25/2015 08:50:52,false,elite,1.0,26544151,GBR,"","",213.205.252.245,163,107,,,172,117,CIRRHOSIS,COLCHICINE,CIRRHOSIS:,163,107,COLCHICINE,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",163,107,163,107,-1,172,117,TWrex-cause,800140,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile",cirrhosis,colchicine
725480680,5/25/2015 08:58:45,1642946226,5/25/2015 08:58:27,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,163,107,,,172,117,CIRRHOSIS,COLCHICINE,primary biliary CIRRHOSIS:,147-155-163,107,COLCHICINE,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",163,107,163,107,-1,172,117,TWrex-cause,800140,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile",cirrhosis,colchicine
725480680,5/25/2015 09:04:47,1642947055,5/25/2015 09:04:29,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,163,107,,,172,117,CIRRHOSIS,COLCHICINE,CIRRHOSIS:,163,107,COLCHICINE,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",163,107,163,107,-1,172,117,TWrex-cause,800140,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile",cirrhosis,colchicine
725480680,5/25/2015 09:18:07,1642949045,5/25/2015 09:16:28,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,163,107,,,172,117,CIRRHOSIS,COLCHICINE,"ADDITIONAL RESOURCES Article Alimentary Pharmacology &amp; Therapeutics Ten year combination treatment with colchicine and ursodeoxycholic acid for primary biliary CIRRHOSIS: a double blind, placebo controlled trial on symptomatic patients American Journal of Gastroenterology Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",0-11-22-31-42-55-57-71-75-80-92-102-107-118-122-138-143-147-155-163-174-176-183-190-198-209-215-218-230-240-249-257-260-278-289-298-301-317-322-325-333-341-352-355-357-364-371,0-11-22-31-42-55-57-71-75-80-92-102-107-118-122-138-143-147-155-163-174-176-183-190-198-209-215-218-230-240-249-257-260-278-289-298-301-317-322-325-333-341-352-355-357-364-371,"ADDITIONAL RESOURCES Article Alimentary Pharmacology &amp; Therapeutics Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients American Journal of Gastroenterology Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.","ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",163,107,163,107,-1,172,117,TWrex-cause,800140,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile",cirrhosis,colchicine
725480680,5/25/2015 09:25:07,1642949984,5/25/2015 09:24:08,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,163,107,,,172,117,CIRRHOSIS,COLCHICINE,primary biliary CIRRHOSIS:,147-155-163,107,COLCHICINE,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",163,107,163,107,-1,172,117,TWrex-cause,800140,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile",cirrhosis,colchicine
725480680,5/25/2015 09:33:21,1642951560,5/25/2015 09:32:57,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,163,107,,,172,117,CIRRHOSIS,COLCHICINE,CIRRHOSIS:,163,107,COLCHICINE,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",163,107,163,107,-1,172,117,TWrex-cause,800140,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile",cirrhosis,colchicine
725480680,5/25/2015 09:49:16,1642954022,5/25/2015 09:49:01,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,163,107,,,172,117,CIRRHOSIS,COLCHICINE,biliary CIRRHOSIS:,155-163,107,COLCHICINE,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",163,107,163,107,-1,172,117,TWrex-cause,800140,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile",cirrhosis,colchicine
725480680,5/25/2015 09:57:32,1642955360,5/25/2015 09:55:23,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,163,107,,,172,117,CIRRHOSIS,COLCHICINE,primary biliary CIRRHOSIS:,147-163-155,107-122-138,COLCHICINE ursodeoxycholic acid,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile.",163,107,163,107,-1,172,117,TWrex-cause,800140,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile",cirrhosis,colchicine
725480681,5/25/2015 10:06:41,1642956902,5/25/2015 10:05:49,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,110,129,,,117,139,MALARIA,PLASMODIUM,(prophylaxis) of MALARIA,93-107-110,129,PLASMODIUM,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P..",110,129,110,129,1,117,139,TWrex-cause,811012,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P.",malaria,plasmodium
725480681,5/25/2015 10:09:22,1642957223,5/25/2015 10:09:04,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,110,129,,,117,139,MALARIA,PLASMODIUM,MALARIA,110,129-140,PLASMODIUM malariae,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P..",110,129,110,129,1,117,139,TWrex-cause,811012,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P.",malaria,plasmodium
725480681,5/25/2015 10:11:54,1642957663,5/25/2015 10:11:29,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,110,129,,,117,139,MALARIA,PLASMODIUM,MALARIA caused by Plasmodium malariae,110-118-125-129-140,110-118-125-129-140,malaria caused by PLASMODIUM malariae,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P..",110,129,110,129,1,117,139,TWrex-cause,811012,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P.",malaria,plasmodium
725480681,5/25/2015 10:14:12,1642958108,5/25/2015 10:13:52,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,110,129,,,117,139,MALARIA,PLASMODIUM,MALARIA,110,129-140,PLASMODIUM malariae,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P..",110,129,110,129,1,117,139,TWrex-cause,811012,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P.",malaria,plasmodium
725480681,5/25/2015 10:23:13,1642960244,5/25/2015 10:22:55,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,110,129,,,117,139,MALARIA,PLASMODIUM,MALARIA,110,129-140,PLASMODIUM malariae,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P..",110,129,110,129,1,117,139,TWrex-cause,811012,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P.",malaria,plasmodium
725480681,5/25/2015 10:27:51,1642961921,5/25/2015 10:27:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,110,129,,,117,139,MALARIA,PLASMODIUM,MALARIA,110,129-140,PLASMODIUM malariae,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P..",110,129,110,129,1,117,139,TWrex-cause,811012,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P.",malaria,plasmodium
725480681,5/25/2015 10:36:20,1642967511,5/25/2015 10:35:19,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,110,129,,,117,139,MALARIA,PLASMODIUM,MALARIA,110,129-140,PLASMODIUM malariae,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P..",110,129,110,129,1,117,139,TWrex-cause,811012,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P.",malaria,plasmodium
725480681,5/25/2015 10:39:04,1642970186,5/25/2015 10:38:42,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,110,129,,,117,139,MALARIA,PLASMODIUM,MALARIA,110,129-140,PLASMODIUM malariae,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P..",110,129,110,129,1,117,139,TWrex-cause,811012,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P.",malaria,plasmodium
725480681,5/25/2015 10:43:18,1642973634,5/25/2015 10:43:04,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,110,129,,,117,139,MALARIA,PLASMODIUM,MALARIA,110,129-140,PLASMODIUM malariae,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P..",110,129,110,129,1,117,139,TWrex-cause,811012,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P.",malaria,plasmodium
725480681,5/25/2015 10:43:37,1642973796,5/25/2015 10:43:17,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,110,129,,,117,139,MALARIA,PLASMODIUM,Antimalarials Aralen Malaria Prevention (prophylaxis) of MALARIA caused by Plasmodium malariae,13-59-73-82-93-107-110-118-125-129-140,13-73-82-110-118-125-129-140-152-155-93,Antimalarials Malaria Prevention (prophylaxis) malaria caused by PLASMODIUM malariae P. ovale,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P..",110,129,110,129,1,117,139,TWrex-cause,811012,"136  Class:  Antimalarials 8:30.08; AP101 (VA)  Synonyms:  Aralen  Uses  Malaria  Prevention (prophylaxis) of malaria caused by  Plasmodium malariae ,  P. ovale , chloroquine-susceptible  P.",malaria,plasmodium
725480682,5/25/2015 08:23:30,1642940339,5/25/2015 08:23:13,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,60,35,,,74,45,PANIC DISORDER,PAROXETINE,PANIC DISORDER,60-66,35,"PAROXETINE,","• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92.",60 66,35,60,35,-1,74,45,TWrex-cause,800469,"• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92",panic disorder,paroxetine
725480682,5/25/2015 08:52:20,1642945241,5/25/2015 08:52:06,false,elite,1.0,26544151,GBR,"","",213.205.252.245,60,35,,,74,45,PANIC DISORDER,PAROXETINE,PANIC DISORDER,60-66,35,"PAROXETINE,","• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92.",60 66,35,60,35,-1,74,45,TWrex-cause,800469,"• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92",panic disorder,paroxetine
725480682,5/25/2015 08:52:20,1642945250,5/25/2015 08:52:06,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,60,35,,,74,45,PANIC DISORDER,PAROXETINE,PANIC DISORDER,60-66,35,"PAROXETINE,","• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92.",60 66,35,60,35,-1,74,45,TWrex-cause,800469,"• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92",panic disorder,paroxetine
725480682,5/25/2015 09:00:19,1642946393,5/25/2015 08:59:59,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,60,35,,,74,45,PANIC DISORDER,PAROXETINE,PANIC DISORDER,60-66,35,"PAROXETINE,","• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92.",60 66,35,60,35,-1,74,45,TWrex-cause,800469,"• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92",panic disorder,paroxetine
725480682,5/25/2015 09:06:17,1642947361,5/25/2015 09:05:54,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,60,35,,,74,45,PANIC DISORDER,PAROXETINE,PANIC DISORDER,60-66,35,"PAROXETINE,","• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92.",60 66,35,60,35,-1,74,45,TWrex-cause,800469,"• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92",panic disorder,paroxetine
725480682,5/25/2015 09:21:58,1642949643,5/25/2015 09:21:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,60,35,,,74,45,PANIC DISORDER,PAROXETINE,"patients treated with paroxetine, 10 mg d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit",13-22-30-35-47-50-53-56-60-66-75-84-91-98-103-118-123-127-138-143-152,13-22-30-35-47-50-53-56-60-66-75-84-91-98-103-118-123-127-138-143-152,"patients treated with PAROXETINE, 10 mg d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit","• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92.",60 66,35,60,35,-1,74,45,TWrex-cause,800469,"• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92",panic disorder,paroxetine
725480682,5/25/2015 09:29:52,1642950880,5/25/2015 09:28:37,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,60,35,,,74,45,PANIC DISORDER,PAROXETINE,PANIC DISORDER,60-66,35-47-50-53,"PAROXETINE, 10 mg d,","• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92.",60 66,35,60,35,-1,74,45,TWrex-cause,800469,"• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92",panic disorder,paroxetine
725480682,5/25/2015 09:35:20,1642951900,5/25/2015 09:34:45,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,60,35,,,74,45,PANIC DISORDER,PAROXETINE,PANIC DISORDER,60-66,35,"PAROXETINE,","• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92.",60 66,35,60,35,-1,74,45,TWrex-cause,800469,"• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92",panic disorder,paroxetine
725480682,5/25/2015 09:50:17,1642954173,5/25/2015 09:50:03,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,60,35,,,74,45,PANIC DISORDER,PAROXETINE,PANIC DISORDER,60-66,35,"PAROXETINE,","• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92.",60 66,35,60,35,-1,74,45,TWrex-cause,800469,"• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92",panic disorder,paroxetine
725480682,5/25/2015 09:58:24,1642955547,5/25/2015 09:58:11,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,60,35,,,74,45,PANIC DISORDER,PAROXETINE,PANIC DISORDER,60-66,35,"PAROXETINE,","• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92.",60 66,35,60,35,-1,74,45,TWrex-cause,800469,"• A study of patients treated with paroxetine, 10 mg/d, for panic disorder reported higher plasma drug concentrations were not associated with improved benefit ( 92",panic disorder,paroxetine
725480683,5/25/2015 10:16:34,1642958540,5/25/2015 10:15:52,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,69,113,,,94,128,ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,ASCENDING AORTIC ANEURYSM,69-79-86,113-120,MARFAN SYNDROME,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower.",69 79 86,113 120,69,113,1,94,128,TWrex-cause,813266,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower",ascending aortic aneurysm,marfan syndrome
725480683,5/25/2015 10:19:43,1642959165,5/25/2015 10:19:20,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,69,113,,,94,128,ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,ASCENDING AORTIC ANEURYSM,69-79-86,113-120,MARFAN SYNDROME,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower.",69 79 86,113 120,69,113,1,94,128,TWrex-cause,813266,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower",ascending aortic aneurysm,marfan syndrome
725480683,5/25/2015 10:29:12,1642962561,5/25/2015 10:28:55,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,69,113,,,94,128,ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,ASCENDING AORTIC ANEURYSM,69-79-86,113-120,MARFAN SYNDROME,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower.",69 79 86,113 120,69,113,1,94,128,TWrex-cause,813266,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower",ascending aortic aneurysm,marfan syndrome
725480683,5/25/2015 10:45:45,1642974726,5/25/2015 10:45:27,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,69,113,,,94,128,ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,ASCENDING AORTIC ANEURYSM,69-79-86,113-120-133,MARFAN SYNDROME be,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower.",69 79 86,113 120,69,113,1,94,128,TWrex-cause,813266,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower",ascending aortic aneurysm,marfan syndrome
725480683,5/25/2015 10:50:09,1642975433,5/25/2015 10:49:54,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,69,113,,,94,128,ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,ASCENDING AORTIC ANEURYSM,69-79-86,113-120,MARFAN SYNDROME,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower.",69 79 86,113 120,69,113,1,94,128,TWrex-cause,813266,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower",ascending aortic aneurysm,marfan syndrome
725480683,5/25/2015 10:52:44,1642975836,5/25/2015 10:52:27,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,69,113,,,94,128,ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,ASCENDING AORTIC ANEURYSM,69-79-86,113-120,MARFAN SYNDROME,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower.",69 79 86,113 120,69,113,1,94,128,TWrex-cause,813266,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower",ascending aortic aneurysm,marfan syndrome
725480683,5/25/2015 10:57:47,1642976589,5/25/2015 10:57:16,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,69,113,,,94,128,ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,repair of an ASCENDING AORTIC ANEURYSM in a patient with Marfan syndrome,56-63-66-69-79-86-95-98-100-108-113-120,47-56-69-79-86-95-98-100-108-113-120-129-133-136-141,elective repair ascending aortic aneurysm in a patient with MARFAN SYNDROME may be even lower.,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower.",69 79 86,113 120,69,113,1,94,128,TWrex-cause,813266,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower",ascending aortic aneurysm,marfan syndrome
725480683,5/25/2015 11:34:53,1642983746,5/25/2015 11:34:37,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,69,113,,,94,128,ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,ASCENDING AORTIC ANEURYSM,69-79-86,113-120,MARFAN SYNDROME,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower.",69 79 86,113 120,69,113,1,94,128,TWrex-cause,813266,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower",ascending aortic aneurysm,marfan syndrome
725480683,5/25/2015 11:42:42,1642985236,5/25/2015 11:42:28,false,dailyrewardsca,1.0,32438879,CAN,NB,Fredericton,156.57.46.234,69,113,,,94,128,ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,ASCENDING AORTIC ANEURYSM,69-79-86,113-120,MARFAN SYNDROME,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower.",69 79 86,113 120,69,113,1,94,128,TWrex-cause,813266,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower",ascending aortic aneurysm,marfan syndrome
725480683,5/25/2015 11:44:18,1642985544,5/25/2015 11:43:43,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,69,113,,,94,128,ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,ASCENDING AORTIC ANEURYSM,69-79-86,113-120,MARFAN SYNDROME,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower.",69 79 86,113 120,69,113,1,94,128,TWrex-cause,813266,"At some high-volume centers, the threshold for elective repair of an ascending aortic aneurysm in a patient with Marfan syndrome may be even lower",ascending aortic aneurysm,marfan syndrome
725480684,5/25/2015 10:16:46,1642958594,5/25/2015 10:16:35,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,159,103,,,167,115,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,139-147-159,103,CHLORAMBUCIL,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",159,103,159,103,-1,167,115,TWrex-cause,803854,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
725480684,5/25/2015 10:20:05,1642959281,5/25/2015 10:19:44,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,159,103,,,167,115,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,139-147-159,103,CHLORAMBUCIL,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",159,103,159,103,-1,167,115,TWrex-cause,803854,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
725480684,5/25/2015 10:29:29,1642962710,5/25/2015 10:29:14,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,159,103,,,167,115,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,139-147-159,103,CHLORAMBUCIL,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",159,103,159,103,-1,167,115,TWrex-cause,803854,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
725480684,5/25/2015 10:46:01,1642974756,5/25/2015 10:45:47,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,159,103,,,167,115,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,139-147-159,103,CHLORAMBUCIL,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",159,103,159,103,-1,167,115,TWrex-cause,803854,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
725480684,5/25/2015 10:50:28,1642975513,5/25/2015 10:50:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,159,103,,,167,115,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,139-147-159,103,CHLORAMBUCIL,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",159,103,159,103,-1,167,115,TWrex-cause,803854,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
725480684,5/25/2015 10:53:01,1642975872,5/25/2015 10:52:45,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,159,103,,,167,115,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,139-147-159,103,CHLORAMBUCIL,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",159,103,159,103,-1,167,115,TWrex-cause,803854,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
725480684,5/25/2015 10:58:15,1642976663,5/25/2015 10:57:48,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,159,103,,,167,115,LEUKEMIA,CHLORAMBUCIL,Fludarabine chlorambucil as primary therapy for chronic lymphocytic LEUKEMIA.,77-103-119-127-135-139-147-159-116,77-89-98-103-116-119-127-135-139-147-159,Fludarabine compared with CHLORAMBUCIL as primary therapy for chronic lymphocytic leukemia.,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",159,103,159,103,-1,167,115,TWrex-cause,803854,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
725480684,5/25/2015 11:35:08,1642983777,5/25/2015 11:34:55,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,159,103,,,167,115,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,139-147-159,103,CHLORAMBUCIL,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",159,103,159,103,-1,167,115,TWrex-cause,803854,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
725480684,5/25/2015 11:42:57,1642985282,5/25/2015 11:42:43,false,dailyrewardsca,1.0,32438879,CAN,NB,Fredericton,156.57.46.234,159,103,,,167,115,LEUKEMIA,CHLORAMBUCIL,LEUKEMIA.,159,103,CHLORAMBUCIL,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",159,103,159,103,-1,167,115,TWrex-cause,803854,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
725480684,5/25/2015 11:44:45,1642985656,5/25/2015 11:44:20,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,159,103,,,167,115,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,139-147-159,103-119-127-135-139-147-159,CHLORAMBUCIL primary therapy for chronic lymphocytic leukemia.,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",159,103,159,103,-1,167,115,TWrex-cause,803854,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
725480685,5/25/2015 13:05:31,1643001842,5/25/2015 13:02:57,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,57,87,,,65,93,GLANDERS,MALLEUS,GLANDERS,57,87-84,B. MALLEI.,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei.",57,87,57,87,1,65,93,TWrex-cause,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei",glanders,malleus
725480685,5/25/2015 13:08:57,1643002494,5/25/2015 13:07:13,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,57,87,,,65,93,GLANDERS,MALLEUS,GLANDERS,57,84-87,B. MALLEI.,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei.",57,87,57,87,1,65,93,TWrex-cause,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei",glanders,malleus
725480685,5/25/2015 13:19:14,1643004433,5/25/2015 13:18:59,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,57,87,,,65,93,GLANDERS,MALLEUS,for GLANDERS,40-57,84-87,B. MALLEI.,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei.",57,87,57,87,1,65,93,TWrex-cause,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei",glanders,malleus
725480685,5/25/2015 13:25:35,1643005882,5/25/2015 13:25:22,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,57,87,,,65,93,GLANDERS,MALLEUS,GLANDERS + caused by B. mallei.,57-68-73-80-84-87,57-73-80-84-87-68,glanders + caused by B. MALLEI.,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei.",57,87,57,87,1,65,93,TWrex-cause,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei",glanders,malleus
725480685,5/25/2015 13:25:52,1643005937,5/25/2015 13:25:40,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,57,87,,,65,93,GLANDERS,MALLEUS,GLANDERS B.,57-84,57-84-87,glanders B. MALLEI.,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei.",57,87,57,87,1,65,93,TWrex-cause,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei",glanders,malleus
725480685,5/25/2015 13:26:39,1643006095,5/25/2015 13:26:26,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,57,87,,,65,93,GLANDERS,MALLEUS,GLANDERS,57,84-87,B. MALLEI.,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei.",57,87,57,87,1,65,93,TWrex-cause,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei",glanders,malleus
725480685,5/25/2015 13:27:30,1643006271,5/25/2015 13:27:08,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,57,87,,,65,93,GLANDERS,MALLEUS,GLANDERS,57,84-87,B. MALLEI.,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei.",57,87,57,87,1,65,93,TWrex-cause,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei",glanders,malleus
725480685,5/25/2015 13:31:06,1643007040,5/25/2015 13:30:01,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,57,87,,,65,93,GLANDERS,MALLEUS,GLANDERS,57,84-87,B. MALLEI.,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei.",57,87,57,87,1,65,93,TWrex-cause,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei",glanders,malleus
725480685,5/25/2015 13:52:54,1643011682,5/25/2015 13:52:28,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,57,87,,,65,93,GLANDERS,MALLEUS,treatment of GLANDERS,44-54-57,84-87,B. MALLEI.,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei.",57,87,57,87,1,65,93,TWrex-cause,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei",glanders,malleus
725480685,5/25/2015 14:02:02,1643013611,5/25/2015 14:01:37,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,57,87,,,65,93,GLANDERS,MALLEUS,of GLANDERS,54-57,84-87,B. MALLEI.,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei.",57,87,57,87,1,65,93,TWrex-cause,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of glanders   +    caused by  B. mallei",glanders,malleus
725480686,5/25/2015 10:11:57,1642957668,5/25/2015 10:11:43,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,81,0,,,87,22,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA.,81,0-12-23,FLUTICASONE PROPIONATE aerosol,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma.,81,0 12,81,0,-1,87,22,TWrex-cause,803472,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma,asthma,fluticasone propionate
725480686,5/25/2015 10:13:19,1642957938,5/25/2015 10:12:49,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,81,0,,,87,22,ASTHMA,FLUTICASONE PROPIONATE,moderate ASTHMA.,72-81,0-12,FLUTICASONE PROPIONATE,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma.,81,0 12,81,0,-1,87,22,TWrex-cause,803472,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma,asthma,fluticasone propionate
725480686,5/25/2015 10:14:53,1642958199,5/25/2015 10:14:38,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,81,0,,,87,22,ASTHMA,FLUTICASONE PROPIONATE,moderate ASTHMA.,72-81,0-12-23,FLUTICASONE PROPIONATE aerosol,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma.,81,0 12,81,0,-1,87,22,TWrex-cause,803472,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma,asthma,fluticasone propionate
725480686,5/25/2015 10:25:35,1642961094,5/25/2015 10:25:21,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,81,0,,,87,22,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA.,81,0-12-23,FLUTICASONE PROPIONATE aerosol,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma.,81,0 12,81,0,-1,87,22,TWrex-cause,803472,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma,asthma,fluticasone propionate
725480686,5/25/2015 10:40:29,1642971482,5/25/2015 10:40:10,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,81,0,,,87,22,ASTHMA,FLUTICASONE PROPIONATE,mild to moderate ASTHMA.,64-72-81-69,0-12-23,FLUTICASONE PROPIONATE aerosol,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma.,81,0 12,81,0,-1,87,22,TWrex-cause,803472,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma,asthma,fluticasone propionate
725480686,5/25/2015 10:41:32,1642972310,5/25/2015 10:41:16,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,81,0,,,87,22,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA.,81,0-12-23,FLUTICASONE PROPIONATE aerosol,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma.,81,0 12,81,0,-1,87,22,TWrex-cause,803472,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma,asthma,fluticasone propionate
725480686,5/25/2015 10:45:05,1642974530,5/25/2015 10:44:54,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,81,0,,,87,22,ASTHMA,FLUTICASONE PROPIONATE,Fluticasone aerosol mild to moderate ASTHMA.,0-64-69-72-81-23,0-12-23-31-35-81,FLUTICASONE PROPIONATE aerosol for the asthma.,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma.,81,0 12,81,0,-1,87,22,TWrex-cause,803472,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma,asthma,fluticasone propionate
725480686,5/25/2015 10:45:23,1642974609,5/25/2015 10:45:10,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,81,0,,,87,22,ASTHMA,FLUTICASONE PROPIONATE,mild to moderate ASTHMA.,69-72-81-64,0-12-23,FLUTICASONE PROPIONATE aerosol,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma.,81,0 12,81,0,-1,87,22,TWrex-cause,803472,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma,asthma,fluticasone propionate
725480686,5/25/2015 10:48:29,1642975205,5/25/2015 10:48:04,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,81,0,,,87,22,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA.,81,0-12,FLUTICASONE PROPIONATE,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma.,81,0 12,81,0,-1,87,22,TWrex-cause,803472,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma,asthma,fluticasone propionate
725480686,5/25/2015 10:50:52,1642975548,5/25/2015 10:50:25,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,81,0,,,87,22,ASTHMA,FLUTICASONE PROPIONATE,Fluticasone propionate aerosol for treatment mild to moderate ASTHMA.,0-12-23-31-64-69-72-81-39,0-12-23-31-35-39-64-69-72-81,FLUTICASONE PROPIONATE aerosol for the treatment mild to moderate asthma.,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma.,81,0 12,81,0,-1,87,22,TWrex-cause,803472,Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma,asthma,fluticasone propionate
725480687,5/25/2015 11:38:12,1642984369,5/25/2015 11:37:55,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,170,154,,,176,158,ANEMIA,IRON,iron deficiency ANEMIA,154-159-170,143-154-159-170,• IRON deficiency anemia,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process.",170,154,170,154,-1,176,158,TWrex-cause,804649,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process",anemia,iron
725480687,5/25/2015 11:55:03,1642987621,5/25/2015 11:54:47,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,170,154,,,176,158,ANEMIA,IRON,ANEMIA,170,154,IRON,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process.",170,154,170,154,-1,176,158,TWrex-cause,804649,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process",anemia,iron
725480687,5/25/2015 11:58:17,1642988171,5/25/2015 11:57:40,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,170,154,,,176,158,ANEMIA,IRON,iron deficiency ANEMIA serum,154-159-170-184,154-159-170,IRON deficiency anemia,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process.",170,154,170,154,-1,176,158,TWrex-cause,804649,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process",anemia,iron
725480687,5/25/2015 12:20:12,1642993190,5/25/2015 12:19:26,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,170,154,,,176,158,ANEMIA,IRON,ANEMIA,170,154,IRON,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process.",170,154,170,154,-1,176,158,TWrex-cause,804649,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process",anemia,iron
725480687,5/25/2015 12:36:33,1642996664,5/25/2015 12:36:10,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,170,154,,,176,158,ANEMIA,IRON,Diagnose iron deficiency ANEMIA if the serum,145-154-159-170-177-180-184,129-143-154-159-170-177,concentration • IRON deficiency anemia if,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process.",170,154,170,154,-1,176,158,TWrex-cause,804649,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process",anemia,iron
725480687,5/25/2015 12:38:02,1642996992,5/25/2015 12:37:11,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,170,154,,,176,158,ANEMIA,IRON,Diagnose iron deficiency ANEMIA,145-154-159-170,145-154-159-170-177-180-184-190-199-213-217-221-224,Diagnose IRON deficiency anemia if the serum ferritin concentration is 100 ng mL,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process.",170,154,170,154,-1,176,158,TWrex-cause,804649,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process",anemia,iron
725480687,5/25/2015 12:39:14,1642997148,5/25/2015 12:38:49,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,170,154,,,176,158,ANEMIA,IRON,iron deficiency ANEMIA,154-159-170,143-154,• IRON,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process.",170,154,170,154,-1,176,158,TWrex-cause,804649,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process",anemia,iron
725480687,5/25/2015 12:44:23,1642998095,5/25/2015 12:43:35,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,170,154,,,176,158,ANEMIA,IRON,iron deficiency ANEMIA,154-159-170,154-159-170,IRON deficiency anemia,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process.",170,154,170,154,-1,176,158,TWrex-cause,804649,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process",anemia,iron
725480687,5/25/2015 12:45:34,1642998229,5/25/2015 12:45:29,false,neodev,1,31789301,USA,NY,New York,192.241.140.200,170,154,,,176,158,ANEMIA,IRON,Diagnose iron deficiency ANEMIA if the serum,145-154-159-170-177-180-184,129-143-145-154-159-170-177,concentration • Diagnose IRON deficiency anemia if,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process.",170,154,170,154,-1,176,158,TWrex-cause,804649,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process",anemia,iron
725480687,5/25/2015 12:46:13,1642998347,5/25/2015 12:44:57,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,170,154,,,176,158,ANEMIA,IRON,iron deficiency ANEMIA,154-159-170,154-159-170,IRON deficiency anemia,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process.",170,154,170,154,-1,176,158,TWrex-cause,804649,"B]  Specific recommendation: • In patients with suspected microcytic anemia, obtain: ◊ CBC ◊ Reticulocyte count ◊ Serum ferritin concentration • Diagnose iron deficiency anemia if the serum ferritin concentration is  100 ng/mL and iron deficiency has been thereby excluded, request an ESR and a CRP to look for evidence of an inflammatory process",anemia,iron
725480688,5/25/2015 12:47:31,1642998665,5/25/2015 12:47:16,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,28,118,,,45,125,TYPHOID INFECTION,VACCINE,acute TYPHOID INFECTION,22-28-36,110-118,typhoid VACCINE.,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine.,28 36,118,28,118,-1,45,125,TWrex-cause,805299,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine,typhoid infection,vaccine
725480688,5/25/2015 12:59:33,1643000880,5/25/2015 12:59:16,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,28,118,,,45,125,TYPHOID INFECTION,VACCINE,TYPHOID INFECTION,28-36,110-118,typhoid VACCINE.,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine.,28 36,118,28,118,-1,45,125,TWrex-cause,805299,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine,typhoid infection,vaccine
725480688,5/25/2015 13:03:22,1643001489,5/25/2015 13:02:59,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,28,118,,,45,125,TYPHOID INFECTION,VACCINE,acute TYPHOID INFECTION,22-28-36,110-118,typhoid VACCINE.,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine.,28 36,118,28,118,-1,45,125,TWrex-cause,805299,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine,typhoid infection,vaccine
725480688,5/25/2015 13:15:22,1643003613,5/25/2015 13:15:06,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,28,118,,,45,125,TYPHOID INFECTION,VACCINE,acute TYPHOID INFECTION,22-28-36,110-118,typhoid VACCINE.,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine.,28 36,118,28,118,-1,45,125,TWrex-cause,805299,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine,typhoid infection,vaccine
725480688,5/25/2015 13:17:46,1643004194,5/25/2015 13:17:34,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,28,118,,,45,125,TYPHOID INFECTION,VACCINE,TYPHOID INFECTION,28-36,118,VACCINE.,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine.,28 36,118,28,118,-1,45,125,TWrex-cause,805299,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine,typhoid infection,vaccine
725480688,5/25/2015 13:18:53,1643004405,5/25/2015 13:18:43,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,28,118,,,45,125,TYPHOID INFECTION,VACCINE,acute TYPHOID INFECTION,22-28-36,110-118,typhoid VACCINE.,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine.,28 36,118,28,118,-1,45,125,TWrex-cause,805299,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine,typhoid infection,vaccine
725480688,5/25/2015 13:22:52,1643005186,5/25/2015 13:22:43,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,28,118,,,45,125,TYPHOID INFECTION,VACCINE,acute TYPHOID INFECTION,22-28-36,110-118,typhoid VACCINE.,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine.,28 36,118,28,118,-1,45,125,TWrex-cause,805299,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine,typhoid infection,vaccine
725480688,5/25/2015 13:23:16,1643005248,5/25/2015 13:23:01,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,28,118,,,45,125,TYPHOID INFECTION,VACCINE,acute TYPHOID INFECTION,22-28-36,110-118,typhoid VACCINE.,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine.,28 36,118,28,118,-1,45,125,TWrex-cause,805299,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine,typhoid infection,vaccine
725480688,5/25/2015 13:23:30,1643005284,5/25/2015 13:22:55,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,28,118,,,45,125,TYPHOID INFECTION,VACCINE,acute TYPHOID INFECTION,22-28-36,110-118,typhoid VACCINE.,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine.,28 36,118,28,118,-1,45,125,TWrex-cause,805299,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine,typhoid infection,vaccine
725480688,5/25/2015 13:24:25,1643005551,5/25/2015 13:23:53,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,28,118,,,45,125,TYPHOID INFECTION,VACCINE,Individuals with acute TYPHOID INFECTION and those who,5-17-22-28-36-46-50-56,97-102-110-118,not receive typhoid VACCINE.,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine.,28 36,118,28,118,-1,45,125,TWrex-cause,805299,131  Individuals with acute typhoid infection and those who are chronic typhoid carriers should  not  receive typhoid vaccine,typhoid infection,vaccine
725480689,5/25/2015 11:59:35,1642988397,5/25/2015 11:59:21,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,94,31,,,104,39,HEMORRHAGE,WARFARIN,"HEMORRHAGE,",94,31,"WARFARIN,","COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1).",94,31,94,31,1,104,39,TWrex-cause,810133,"COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1)",hemorrhage,warfarin
725480689,5/25/2015 12:46:53,1642998515,5/25/2015 12:46:30,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,94,31,,,104,39,HEMORRHAGE,WARFARIN,"intracerebral HEMORRHAGE,",80-94,31,"WARFARIN,","COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1).",94,31,94,31,1,104,39,TWrex-cause,810133,"COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1)",hemorrhage,warfarin
725480689,5/25/2015 12:58:50,1643000749,5/25/2015 12:56:34,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,94,31,,,104,39,HEMORRHAGE,WARFARIN,"HEMORRHAGE,",94,31,"WARFARIN,","COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1).",94,31,94,31,1,104,39,TWrex-cause,810133,"COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1)",hemorrhage,warfarin
725480689,5/25/2015 13:02:40,1643001377,5/25/2015 13:02:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,94,31,,,104,39,HEMORRHAGE,WARFARIN,"intracerebral HEMORRHAGE,",80-94,31,"WARFARIN,","COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1).",94,31,94,31,1,104,39,TWrex-cause,810133,"COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1)",hemorrhage,warfarin
725480689,5/25/2015 13:14:38,1643003468,5/25/2015 13:14:11,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,94,31,,,104,39,HEMORRHAGE,WARFARIN,"intracerebral HEMORRHAGE,",80-94,31,"WARFARIN,","COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1).",94,31,94,31,1,104,39,TWrex-cause,810133,"COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1)",hemorrhage,warfarin
725480689,5/25/2015 13:17:18,1643004108,5/25/2015 13:17:06,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,94,31,,,104,39,HEMORRHAGE,WARFARIN,"intracerebral HEMORRHAGE,",80-94,31,"WARFARIN,","COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1).",94,31,94,31,1,104,39,TWrex-cause,810133,"COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1)",hemorrhage,warfarin
725480689,5/25/2015 13:18:27,1643004330,5/25/2015 13:18:12,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,94,31,,,104,39,HEMORRHAGE,WARFARIN,"intracerebral HEMORRHAGE,",80-94,31,"WARFARIN,","COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1).",94,31,94,31,1,104,39,TWrex-cause,810133,"COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1)",hemorrhage,warfarin
725480689,5/25/2015 13:22:23,1643005053,5/25/2015 13:22:10,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,94,31,,,104,39,HEMORRHAGE,WARFARIN,"intracerebral HEMORRHAGE,",80-94,31,"WARFARIN,","COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1).",94,31,94,31,1,104,39,TWrex-cause,810133,"COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1)",hemorrhage,warfarin
725480689,5/25/2015 13:22:46,1643005121,5/25/2015 13:22:27,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,94,31,,,104,39,HEMORRHAGE,WARFARIN,"warfarin, bleeding, including intracerebral HEMORRHAGE,",31-60-70-80-94,31-60-70-94-80,"WARFARIN, bleeding, including intracerebral hemorrhage,","COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1).",94,31,94,31,1,104,39,TWrex-cause,810133,"COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1)",hemorrhage,warfarin
725480689,5/25/2015 13:24:10,1643005424,5/25/2015 13:22:17,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,94,31,,,104,39,HEMORRHAGE,WARFARIN,"intracerebral HEMORRHAGE,",80-94,31,"WARFARIN,","COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1).",94,31,94,31,1,104,39,TWrex-cause,810133,"COMMENTARY  In patients taking warfarin, the risk for major bleeding, including intracerebral hemorrhage, increases significantly with INRs ≥ 4.5  (1)",hemorrhage,warfarin
725480690,5/25/2015 11:58:21,1642988175,5/25/2015 11:58:09,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,74,5,,,88,17,SPOROTRICHOSIS,AMPHOTERICIN,SPOROTRICHOSIS:,74,5,AMPHOTERICIN,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",74,5,74,5,-1,88,17,TWrex-cause,804299,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months",sporotrichosis,amphotericin
725480690,5/25/2015 12:44:54,1642998138,5/25/2015 12:44:37,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,74,5,,,88,17,SPOROTRICHOSIS,AMPHOTERICIN,osteoarticular SPOROTRICHOSIS:,59-74,5-18,AMPHOTERICIN B,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",74,5,74,5,-1,88,17,TWrex-cause,804299,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months",sporotrichosis,amphotericin
725480690,5/25/2015 12:52:37,1642999612,5/25/2015 12:52:22,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,74,5,,,88,17,SPOROTRICHOSIS,AMPHOTERICIN,osteoarticular SPOROTRICHOSIS:,59-74,5-18,AMPHOTERICIN B,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",74,5,74,5,-1,88,17,TWrex-cause,804299,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months",sporotrichosis,amphotericin
725480690,5/25/2015 12:58:22,1643000689,5/25/2015 12:58:05,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,74,5,,,88,17,SPOROTRICHOSIS,AMPHOTERICIN,osteoarticular SPOROTRICHOSIS:,59-74,0-5-18,429 AMPHOTERICIN B,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",74,5,74,5,-1,88,17,TWrex-cause,804299,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months",sporotrichosis,amphotericin
725480690,5/25/2015 13:00:31,1643001044,5/25/2015 12:59:50,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,74,5,,,88,17,SPOROTRICHOSIS,AMPHOTERICIN,osteoarticular SPOROTRICHOSIS:,59-74,5-18,AMPHOTERICIN B,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",74,5,74,5,-1,88,17,TWrex-cause,804299,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months",sporotrichosis,amphotericin
725480690,5/25/2015 13:12:01,1643003066,5/25/2015 13:11:30,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,74,5,,,88,17,SPOROTRICHOSIS,AMPHOTERICIN,osteoarticular SPOROTRICHOSIS:,59-74,5-18,AMPHOTERICIN B,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",74,5,74,5,-1,88,17,TWrex-cause,804299,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months",sporotrichosis,amphotericin
725480690,5/25/2015 13:17:09,1643004097,5/25/2015 13:16:55,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,74,5,,,88,17,SPOROTRICHOSIS,AMPHOTERICIN,osteoarticular SPOROTRICHOSIS:,59-74,5-18,AMPHOTERICIN B,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",74,5,74,5,-1,88,17,TWrex-cause,804299,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months",sporotrichosis,amphotericin
725480690,5/25/2015 13:20:14,1643004641,5/25/2015 13:19:47,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,74,5,,,88,17,SPOROTRICHOSIS,AMPHOTERICIN,osteoarticular SPOROTRICHOSIS: itraconazole,59-74-156,5-59-74-156,AMPHOTERICIN osteoarticular sporotrichosis: itraconazole,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",74,5,74,5,-1,88,17,TWrex-cause,804299,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months",sporotrichosis,amphotericin
725480690,5/25/2015 13:20:36,1643004741,5/25/2015 13:20:20,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,74,5,,,88,17,SPOROTRICHOSIS,AMPHOTERICIN,osteoarticular SPOROTRICHOSIS:,59-74,5-18,AMPHOTERICIN B,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",74,5,74,5,-1,88,17,TWrex-cause,804299,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months",sporotrichosis,amphotericin
725480690,5/25/2015 13:20:50,1643004787,5/25/2015 13:20:01,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,74,5,,,88,17,SPOROTRICHOSIS,AMPHOTERICIN,osteoarticular SPOROTRICHOSIS:,59-74,5-18,AMPHOTERICIN B,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",74,5,74,5,-1,88,17,TWrex-cause,804299,"429  Amphotericin B (a lipid formulation) in patients with osteoarticular sporotrichosis: 3-5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months",sporotrichosis,amphotericin
725480691,5/25/2015 11:40:57,1642984826,5/25/2015 11:40:43,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,128,88,,,161,102,POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,"POSTOPERATIVE NAUSEA AND VOMITING,",128-142-149-153,88,METOCLOPRAMIDE,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",128 142 149 153,88,128,88,-1,161,102,TWrex-cause,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure",postoperative nausea and vomiting,metoclopramide
725480691,5/25/2015 11:57:26,1642988023,5/25/2015 11:57:12,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,128,88,,,161,102,POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,"POSTOPERATIVE NAUSEA AND VOMITING,",128-142-149-153,88,METOCLOPRAMIDE,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",128 142 149 153,88,128,88,-1,161,102,TWrex-cause,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure",postoperative nausea and vomiting,metoclopramide
725480691,5/25/2015 12:04:29,1642989377,5/25/2015 12:03:36,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,128,88,,,161,102,POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,"POSTOPERATIVE NAUSEA AND VOMITING,",128-142-149-153,88-117-120-128-142-149-153,"METOCLOPRAMIDE to prevent postoperative nausea and vomiting,","11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",128 142 149 153,88,128,88,-1,161,102,TWrex-cause,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure",postoperative nausea and vomiting,metoclopramide
725480691,5/25/2015 12:43:38,1642998026,5/25/2015 12:43:12,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,128,88,,,161,102,POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,"POSTOPERATIVE NAUSEA AND VOMITING,",128-142-149-153,88,METOCLOPRAMIDE,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",128 142 149 153,88,128,88,-1,161,102,TWrex-cause,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure",postoperative nausea and vomiting,metoclopramide
725480691,5/25/2015 12:44:06,1642998066,5/25/2015 12:43:45,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,128,88,,,161,102,POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,"suction to prevent POSTOPERATIVE NAUSEA AND VOMITING,",109-117-120-128-142-149-153,73-81-84-88-103-106-109,whether to use METOCLOPRAMIDE or NG suction,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",128 142 149 153,88,128,88,-1,161,102,TWrex-cause,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure",postoperative nausea and vomiting,metoclopramide
725480691,5/25/2015 12:50:46,1642999282,5/25/2015 12:50:25,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,128,88,,,161,102,POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,"POSTOPERATIVE NAUSEA AND VOMITING,",128-142-149-153,88,METOCLOPRAMIDE,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",128 142 149 153,88,128,88,-1,161,102,TWrex-cause,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure",postoperative nausea and vomiting,metoclopramide
725480691,5/25/2015 12:56:35,1643000386,5/25/2015 12:56:22,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,128,88,,,161,102,POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,"POSTOPERATIVE NAUSEA AND VOMITING,",128-142-149-153,73-81-84-88-103-106-109,whether to use METOCLOPRAMIDE or NG suction,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",128 142 149 153,88,128,88,-1,161,102,TWrex-cause,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure",postoperative nausea and vomiting,metoclopramide
725480691,5/25/2015 12:58:06,1643000666,5/25/2015 12:57:24,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,128,88,,,161,102,POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,"POSTOPERATIVE NAUSEA AND VOMITING,",128-142-149-153,88,METOCLOPRAMIDE,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",128 142 149 153,88,128,88,-1,161,102,TWrex-cause,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure",postoperative nausea and vomiting,metoclopramide
725480691,5/25/2015 13:09:53,1643002598,5/25/2015 13:09:02,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,128,88,,,161,102,POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,"POSTOPERATIVE NAUSEA AND VOMITING,",128-142-149-153,88,METOCLOPRAMIDE,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",128 142 149 153,88,128,88,-1,161,102,TWrex-cause,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure",postoperative nausea and vomiting,metoclopramide
725480691,5/25/2015 13:15:44,1643003699,5/25/2015 13:15:24,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,128,88,,,161,102,POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,"POSTOPERATIVE NAUSEA AND VOMITING,",128-142-149-153,88,METOCLOPRAMIDE,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",128 142 149 153,88,128,88,-1,161,102,TWrex-cause,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent postoperative nausea and vomiting, consider the possibility that metoclopramide theoretically could produce increased pressure on suture lines following GI anastomosis or closure",postoperative nausea and vomiting,metoclopramide
725480692,5/25/2015 08:21:20,1642939863,5/25/2015 08:20:49,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,35,61,,,42,76,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,61-68,VIBRIO CHOLERAE,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139.",35,61 68,35,61,1,42,76,TWrex-cause,811806,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139",cholera,vibrio cholera
725480692,5/25/2015 08:50:50,1642945001,5/25/2015 08:50:31,false,elite,1.0,26544151,GBR,"","",213.205.252.245,35,61,,,42,76,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,61-68,VIBRIO CHOLERAE,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139.",35,61 68,35,61,1,42,76,TWrex-cause,811806,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139",cholera,vibrio cholera
725480692,5/25/2015 08:50:59,1642945017,5/25/2015 08:50:47,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,35,61,,,42,76,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,61-68,VIBRIO CHOLERAE,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139.",35,61 68,35,61,1,42,76,TWrex-cause,811806,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139",cholera,vibrio cholera
725480692,5/25/2015 08:58:25,1642946180,5/25/2015 08:58:06,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,35,61,,,42,76,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,61-68,VIBRIO CHOLERAE,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139.",35,61 68,35,61,1,42,76,TWrex-cause,811806,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139",cholera,vibrio cholera
725480692,5/25/2015 09:04:28,1642946908,5/25/2015 09:04:10,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,35,61,,,42,76,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,61-68,VIBRIO CHOLERAE,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139.",35,61 68,35,61,1,42,76,TWrex-cause,811806,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139",cholera,vibrio cholera
725480692,5/25/2015 09:16:27,1642948782,5/25/2015 09:16:05,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,35,61,,,42,76,CHOLERA,VIBRIO CHOLERA,Cholera Treatment of CHOLERA + caused by Vibrio cholerae 01 or 0139.,13-22-32-35-45-50-57-61-68-78-81-84,13-22-32-45-50-57-61-68-78-81-84-35,Cholera Treatment of cholera + caused by VIBRIO CHOLERAE 01 or 0139.,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139.",35,61 68,35,61,1,42,76,TWrex-cause,811806,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139",cholera,vibrio cholera
725480692,5/25/2015 09:24:06,1642949857,5/25/2015 09:22:51,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,35,61,,,42,76,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,61-68-78-81-84,VIBRIO CHOLERAE 01 or 0139.,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139.",35,61 68,35,61,1,42,76,TWrex-cause,811806,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139",cholera,vibrio cholera
725480692,5/25/2015 09:32:56,1642951499,5/25/2015 09:32:43,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,35,61,,,42,76,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,61-68,VIBRIO CHOLERAE,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139.",35,61 68,35,61,1,42,76,TWrex-cause,811806,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139",cholera,vibrio cholera
725480692,5/25/2015 09:49:00,1642954003,5/25/2015 09:48:46,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,35,61,,,42,76,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,61-68,VIBRIO CHOLERAE,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139.",35,61 68,35,61,1,42,76,TWrex-cause,811806,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139",cholera,vibrio cholera
725480692,5/25/2015 09:55:26,1642954960,5/25/2015 09:55:14,false,clixsense,1.0,24763049,GBR,Y8,Welshpool,81.135.56.139,35,61,,,42,76,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,61-68,VIBRIO CHOLERAE,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139.",35,61 68,35,61,1,42,76,TWrex-cause,811806,"297 ,   298  Cholera  Treatment of cholera   +    caused by  Vibrio cholerae  01 or 0139",cholera,vibrio cholera
725480693,5/25/2015 11:57:54,1642988079,5/25/2015 11:57:41,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,102,35,,,110,43,SEIZURE,SYNDROME,SEIZURES,102,35,SYNDROME,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis.,102,35,102,35,1,110,43,TWrex-cause,813359,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis,seizure,syndrome
725480693,5/25/2015 12:05:45,1642989683,5/25/2015 12:05:18,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,102,35,,,110,43,SEIZURE,SYNDROME,contralateral SEIZURES caused by leptomeningeal angiomatosis.,88-102-111-118-121-136,22-29-35,Sturge Weber SYNDROME,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis.,102,35,102,35,1,110,43,TWrex-cause,813359,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis,seizure,syndrome
725480693,5/25/2015 12:44:15,1642998084,5/25/2015 12:43:58,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,102,35,,,110,43,SEIZURE,SYNDROME,contralateral SEIZURES,88-102,22-29-35,Sturge Weber SYNDROME,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis.,102,35,102,35,1,110,43,TWrex-cause,813359,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis,seizure,syndrome
725480693,5/25/2015 12:44:51,1642998140,5/25/2015 12:44:24,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,102,35,,,110,43,SEIZURE,SYNDROME,glaucoma and contralateral SEIZURES,75-84-88-102,18-22-29-35-44-52-64,the Sturge Weber SYNDROME include ipsilateral congenital,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis.,102,35,102,35,1,110,43,TWrex-cause,813359,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis,seizure,syndrome
725480693,5/25/2015 12:51:31,1642999467,5/25/2015 12:51:18,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,102,35,,,110,43,SEIZURE,SYNDROME,contralateral SEIZURES,88-102,22-29-35,Sturge Weber SYNDROME,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis.,102,35,102,35,1,110,43,TWrex-cause,813359,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis,seizure,syndrome
725480693,5/25/2015 12:57:49,1643000612,5/25/2015 12:57:34,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,102,35,,,110,43,SEIZURE,SYNDROME,glaucoma and contralateral SEIZURES caused by leptomeningeal,75-84-88-102-111-118-121,18-22-29-35-44-52-64-75-84-88-102,the Sturge Weber SYNDROME include ipsilateral congenital glaucoma and contralateral seizures,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis.,102,35,102,35,1,110,43,TWrex-cause,813359,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis,seizure,syndrome
725480693,5/25/2015 12:59:16,1643000842,5/25/2015 12:58:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,102,35,,,110,43,SEIZURE,SYNDROME,contralateral SEIZURES,88-102,22-29-35,Sturge Weber SYNDROME,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis.,102,35,102,35,1,110,43,TWrex-cause,813359,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis,seizure,syndrome
725480693,5/25/2015 13:10:55,1643002894,5/25/2015 13:10:28,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,102,35,,,110,43,SEIZURE,SYNDROME,SEIZURES leptomeningeal,102-121,22-35-29,Sturge Weber SYNDROME,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis.,102,35,102,35,1,110,43,TWrex-cause,813359,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis,seizure,syndrome
725480693,5/25/2015 13:16:39,1643003911,5/25/2015 13:16:03,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,102,35,,,110,43,SEIZURE,SYNDROME,contralateral SEIZURES,88-102,22-29-35,Sturge Weber SYNDROME,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis.,102,35,102,35,1,110,43,TWrex-cause,813359,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis,seizure,syndrome
725480693,5/25/2015 13:19:16,1643004439,5/25/2015 13:18:51,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,102,35,,,110,43,SEIZURE,SYNDROME,Sturge Weber syndrome ipsilateral congenital glaucoma contralateral SEIZURES leptomeningeal angiomatosis.,22-29-35-52-64-75-88-102-121-136,22-29-35-44-52-64-75-88-102-121-136,Sturge Weber SYNDROME include ipsilateral congenital glaucoma contralateral seizures leptomeningeal angiomatosis.,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis.,102,35,102,35,1,110,43,TWrex-cause,813359,Other features of the Sturge-Weber syndrome include ipsilateral congenital glaucoma and contralateral seizures caused by leptomeningeal angiomatosis,seizure,syndrome
725480694,5/25/2015 08:18:22,1642939212,5/25/2015 08:17:54,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,0,27,,,6,42,ZOSTER,VARICELLA VIRUS,ZOSTER,0,27-37,VARICELLA VIRUS,zoster     Reactivation of varicella virus years after the initial infection with chickenpox.,0,27 37,0,27,1,6,42,TWrex-cause,814960,zoster     Reactivation of varicella virus years after the initial infection with chickenpox,zoster,varicella virus
725480694,5/25/2015 08:47:51,1642944335,5/25/2015 08:47:36,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,0,27,,,6,42,ZOSTER,VARICELLA VIRUS,ZOSTER Reactivation of varicella virus,0-11-24-27-37,0-11-24-27-37,zoster Reactivation of VARICELLA VIRUS,zoster     Reactivation of varicella virus years after the initial infection with chickenpox.,0,27 37,0,27,1,6,42,TWrex-cause,814960,zoster     Reactivation of varicella virus years after the initial infection with chickenpox,zoster,varicella virus
725480694,5/25/2015 08:48:03,1642944373,5/25/2015 08:47:49,false,elite,1.0,26544151,GBR,"","",213.205.252.245,0,27,,,6,42,ZOSTER,VARICELLA VIRUS,ZOSTER,0,27-37,VARICELLA VIRUS,zoster     Reactivation of varicella virus years after the initial infection with chickenpox.,0,27 37,0,27,1,6,42,TWrex-cause,814960,zoster     Reactivation of varicella virus years after the initial infection with chickenpox,zoster,varicella virus
725480694,5/25/2015 08:55:20,1642945721,5/25/2015 08:54:59,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,0,27,,,6,42,ZOSTER,VARICELLA VIRUS,ZOSTER,0,27-37,VARICELLA VIRUS,zoster     Reactivation of varicella virus years after the initial infection with chickenpox.,0,27 37,0,27,1,6,42,TWrex-cause,814960,zoster     Reactivation of varicella virus years after the initial infection with chickenpox,zoster,varicella virus
725480694,5/25/2015 09:00:35,1642946423,5/25/2015 09:00:18,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,0,27,,,6,42,ZOSTER,VARICELLA VIRUS,ZOSTER,0,27-37,VARICELLA VIRUS,zoster     Reactivation of varicella virus years after the initial infection with chickenpox.,0,27 37,0,27,1,6,42,TWrex-cause,814960,zoster     Reactivation of varicella virus years after the initial infection with chickenpox,zoster,varicella virus
725480694,5/25/2015 09:08:02,1642947629,5/25/2015 09:07:45,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,0,27,,,6,42,ZOSTER,VARICELLA VIRUS,ZOSTER Reactivation of varicella virus years after the initial infection with chickenpox.,0-11-24-27-37-43-49-55-59-67-77-82,0-11-24-27-37-43-49-55-59-67-77-82,zoster Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,zoster     Reactivation of varicella virus years after the initial infection with chickenpox.,0,27 37,0,27,1,6,42,TWrex-cause,814960,zoster     Reactivation of varicella virus years after the initial infection with chickenpox,zoster,varicella virus
725480694,5/25/2015 09:13:47,1642948371,5/25/2015 09:12:48,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,0,27,,,6,42,ZOSTER,VARICELLA VIRUS,ZOSTER,0,27-37,VARICELLA VIRUS,zoster     Reactivation of varicella virus years after the initial infection with chickenpox.,0,27 37,0,27,1,6,42,TWrex-cause,814960,zoster     Reactivation of varicella virus years after the initial infection with chickenpox,zoster,varicella virus
725480694,5/25/2015 09:30:15,1642950931,5/25/2015 09:29:58,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,0,27,,,6,42,ZOSTER,VARICELLA VIRUS,ZOSTER,0,27-37,VARICELLA VIRUS,zoster     Reactivation of varicella virus years after the initial infection with chickenpox.,0,27 37,0,27,1,6,42,TWrex-cause,814960,zoster     Reactivation of varicella virus years after the initial infection with chickenpox,zoster,varicella virus
725480694,5/25/2015 09:34:37,1642951759,5/25/2015 09:34:28,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,0,27,,,6,42,ZOSTER,VARICELLA VIRUS,ZOSTER,0,27-37,VARICELLA VIRUS,zoster     Reactivation of varicella virus years after the initial infection with chickenpox.,0,27 37,0,27,1,6,42,TWrex-cause,814960,zoster     Reactivation of varicella virus years after the initial infection with chickenpox,zoster,varicella virus
725480694,5/25/2015 09:44:15,1642953277,5/25/2015 09:44:05,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,0,27,,,6,42,ZOSTER,VARICELLA VIRUS,ZOSTER,0,27-37,VARICELLA VIRUS,zoster     Reactivation of varicella virus years after the initial infection with chickenpox.,0,27 37,0,27,1,6,42,TWrex-cause,814960,zoster     Reactivation of varicella virus years after the initial infection with chickenpox,zoster,varicella virus
725480695,5/25/2015 08:14:28,1642938503,5/25/2015 08:14:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,333,202,,,344,209,DEHYDRATION,GLUCOSE,"DEHYDRATION,",333,202,"GLUCOSE,","Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.",333,202,333,202,1,344,209,TWrex-cause,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy",dehydration,glucose
725480695,5/25/2015 08:19:33,1642939472,5/25/2015 08:19:15,false,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,333,202,,,344,209,DEHYDRATION,GLUCOSE,"conditions such as renal failure, DEHYDRATION, diabetes, and pregnancy.",299-315-318-324-333-346-356-360-310,133-143-171-185-190-202-211-221-227-149,"improving Blood tests electrolytes, BUN, creatinine, GLUCOSE, pregnancy test, cultures)","Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.",333,202,333,202,1,344,209,TWrex-cause,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy",dehydration,glucose
725480695,5/25/2015 08:37:35,1642942744,5/25/2015 08:37:17,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,333,202,,,344,209,DEHYDRATION,GLUCOSE,"DEHYDRATION,",333,202,"GLUCOSE,","Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.",333,202,333,202,1,344,209,TWrex-cause,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy",dehydration,glucose
725480695,5/25/2015 08:43:44,1642943766,5/25/2015 08:43:23,false,elite,1.0,26544151,GBR,"","",213.205.252.245,333,202,,,344,209,DEHYDRATION,GLUCOSE,"DEHYDRATION,",333,202,"GLUCOSE,","Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.",333,202,333,202,1,344,209,TWrex-cause,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy",dehydration,glucose
725480695,5/25/2015 08:51:29,1642945080,5/25/2015 08:51:05,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,333,202,,,344,209,DEHYDRATION,GLUCOSE,"DEHYDRATION,",333,202,"GLUCOSE,","Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.",333,202,333,202,1,344,209,TWrex-cause,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy",dehydration,glucose
725480695,5/25/2015 08:55:35,1642945730,5/25/2015 08:55:14,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,333,202,,,344,209,DEHYDRATION,GLUCOSE,"DEHYDRATION,",333,202,"GLUCOSE,","Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.",333,202,333,202,1,344,209,TWrex-cause,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy",dehydration,glucose
725480695,5/25/2015 08:59:36,1642946269,5/25/2015 08:58:17,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,333,202,,,344,209,DEHYDRATION,GLUCOSE,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures) To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION, diabetes, and pregnancy.",0-14-22-29-32-40-43-46-53-58-63-66-72-83-86-92-97-104-108-116-120-127-130-133-143-149-155-161-166-171-185-190-202-211-221-227-245-248-258-262-271-274-284-288-299-315-318-324-333-346-356-360-310,0-14-22-29-32-40-43-46-53-58-63-66-72-83-86-92-97-104-108-116-120-127-130-133-143-149-155-161-166-171-185-190-202-211-221-227-245-248-258-262-271-274-284-288-299-310-315-318-324-333-346-356-360,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE, pregnancy test, cultures) To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.","Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.",333,202,333,202,1,344,209,TWrex-cause,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy",dehydration,glucose
725480695,5/25/2015 09:02:32,1642946729,5/25/2015 09:01:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,333,202,,,344,209,DEHYDRATION,GLUCOSE,"DEHYDRATION,",333,202,"GLUCOSE,","Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.",333,202,333,202,1,344,209,TWrex-cause,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy",dehydration,glucose
725480695,5/25/2015 09:23:35,1642949809,5/25/2015 09:23:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,333,202,,,344,209,DEHYDRATION,GLUCOSE,"DEHYDRATION,",333,202,"GLUCOSE,","Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.",333,202,333,202,1,344,209,TWrex-cause,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy",dehydration,glucose
725480695,5/25/2015 09:27:01,1642950410,5/25/2015 09:26:43,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,333,202,,,344,209,DEHYDRATION,GLUCOSE,"DEHYDRATION,",333,202,"GLUCOSE,","Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy.",333,202,333,202,1,344,209,TWrex-cause,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, glucose, pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, dehydration, diabetes, and pregnancy",dehydration,glucose
725480696,5/25/2015 08:20:28,1642939679,5/25/2015 08:20:11,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,164,0,,,168,9,LOUSE,MALATHION,Live LICE,159-164,0-10,MALATHION lotion,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",164,0,164,0,-1,168,9,TWrex-cause,803323,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article",louse,malathion
725480696,5/25/2015 08:50:10,1642944849,5/25/2015 08:49:46,false,elite,1.0,26544151,GBR,"","",213.205.252.245,164,0,,,168,9,LOUSE,MALATHION,LICE,164,0,MALATHION,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",164,0,164,0,-1,168,9,TWrex-cause,803323,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article",louse,malathion
725480696,5/25/2015 08:50:30,1642944953,5/25/2015 08:50:04,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,164,0,,,168,9,LOUSE,MALATHION,Live LICE,159-164,0-10,MALATHION lotion,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",164,0,164,0,-1,168,9,TWrex-cause,803323,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article",louse,malathion
725480696,5/25/2015 08:57:39,1642946070,5/25/2015 08:57:18,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,164,0,,,168,9,LOUSE,MALATHION,LICE,164,0,MALATHION,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",164,0,164,0,-1,168,9,TWrex-cause,803323,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article",louse,malathion
725480696,5/25/2015 09:03:36,1642946835,5/25/2015 09:03:07,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,164,0,,,168,9,LOUSE,MALATHION,LICE,164,0,MALATHION,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",164,0,164,0,-1,168,9,TWrex-cause,803323,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article",louse,malathion
725480696,5/25/2015 09:15:10,1642948517,5/25/2015 09:13:48,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,164,0,,,168,9,LOUSE,MALATHION,"Malathion lotion vs bug busting for treatment of head lice in children + Outcome Malathion Bug busting RRR (95% CI) NNT (CI) Live LICE at 7 d after 23% 63% 64% (34 to 81) 2 (2 to 6) treatment + Abbreviations defined in Glossary ; RRR, NNT, and CI calculated from data in article.",0-10-17-20-24-32-36-46-49-54-59-62-71-74-101-115-119-131-135-140-150-154-159-164-169-172-174-176-184-196-210-214-218-221-227-229-232-235-238-249-251-265-273-277-286-288-293-298-302-305-316-321-326-329,0-10-17-20-24-32-36-46-49-54-59-62-71-74-101-115-119-131-135-140-150-154-159-164-169-172-174-176-184-196-210-214-218-221-227-229-232-235-238-249-251-265-273-277-286-288-293-298-302-305-316-321-326-329,"MALATHION lotion vs bug busting for treatment of head lice in children + Outcome Malathion Bug busting RRR (95% CI) NNT (CI) Live lice at 7 d after 23% 63% 64% (34 to 81) 2 (2 to 6) treatment + Abbreviations defined in Glossary ; RRR, NNT, and CI calculated from data in article.","Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",164,0,164,0,-1,168,9,TWrex-cause,803323,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article",louse,malathion
725480696,5/25/2015 09:21:57,1642949635,5/25/2015 09:20:21,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,164,0,,,168,9,LOUSE,MALATHION,Live LICE,159-164,0-10,MALATHION lotion,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",164,0,164,0,-1,168,9,TWrex-cause,803323,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article",louse,malathion
725480696,5/25/2015 09:32:23,1642951306,5/25/2015 09:32:10,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,164,0,,,168,9,LOUSE,MALATHION,LICE,164,0,MALATHION,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",164,0,164,0,-1,168,9,TWrex-cause,803323,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article",louse,malathion
725480696,5/25/2015 09:48:26,1642953894,5/25/2015 09:48:07,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,164,0,,,168,9,LOUSE,MALATHION,Live LICE,159-164,0,MALATHION,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",164,0,164,0,-1,168,9,TWrex-cause,803323,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article",louse,malathion
725480696,5/25/2015 09:54:53,1642954808,5/25/2015 09:54:43,false,clixsense,1.0,24763049,GBR,Y8,Welshpool,81.135.56.139,164,0,,,168,9,LOUSE,MALATHION,LICE,164,0,MALATHION,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",164,0,164,0,-1,168,9,TWrex-cause,803323,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    Malathion     Bug busting     RRR (95% CI)       NNT (CI) Live lice at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article",louse,malathion
725480697,5/25/2015 10:54:35,1642976066,5/25/2015 10:54:18,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,79,42,,,82,54,PDA,INDOMETHACIN,PDA.,79,42,INDOMETHACIN,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA.",79,42,79,42,-1,82,54,TWrex-cause,800189,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA",pda,indomethacin
725480697,5/25/2015 11:00:23,1642977117,5/25/2015 10:59:59,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,79,42,,,82,54,PDA,INDOMETHACIN,M. Digoxin indomethacin preterm infants with PDA.,27-30-58-66-74-79-42,27-30-38-42-55-58-66-79-74,M. Digoxin and INDOMETHACIN in preterm infants with PDA.,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA.",79,42,79,42,-1,82,54,TWrex-cause,800189,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA",pda,indomethacin
725480697,5/25/2015 11:36:21,1642984071,5/25/2015 11:36:10,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,79,42,,,82,54,PDA,INDOMETHACIN,PDA.,79,42,INDOMETHACIN,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA.",79,42,79,42,-1,82,54,TWrex-cause,800189,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA",pda,indomethacin
725480697,5/25/2015 11:45:21,1642985760,5/25/2015 11:45:11,false,dailyrewardsca,1.0,32438879,CAN,NB,Fredericton,156.57.46.234,79,42,,,82,54,PDA,INDOMETHACIN,PDA.,79,42,INDOMETHACIN,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA.",79,42,79,42,-1,82,54,TWrex-cause,800189,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA",pda,indomethacin
725480697,5/25/2015 11:53:19,1642987428,5/25/2015 11:53:09,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,79,42,,,82,54,PDA,INDOMETHACIN,PDA.,79,42,INDOMETHACIN,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA.",79,42,79,42,-1,82,54,TWrex-cause,800189,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA",pda,indomethacin
725480697,5/25/2015 11:54:06,1642987536,5/25/2015 11:53:39,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,79,42,,,82,54,PDA,INDOMETHACIN,PDA.,79,42-55-58-66,INDOMETHACIN in preterm infants,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA.",79,42,79,42,-1,82,54,TWrex-cause,800189,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA",pda,indomethacin
725480697,5/25/2015 11:57:11,1642987983,5/25/2015 11:57:00,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,79,42,,,82,54,PDA,INDOMETHACIN,PDA.,79,42,INDOMETHACIN,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA.",79,42,79,42,-1,82,54,TWrex-cause,800189,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA",pda,indomethacin
725480697,5/25/2015 12:13:32,1642991566,5/25/2015 12:13:16,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,79,42,,,82,54,PDA,INDOMETHACIN,PDA.,79,42,INDOMETHACIN,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA.",79,42,79,42,-1,82,54,TWrex-cause,800189,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA",pda,indomethacin
725480697,5/25/2015 12:32:11,1642995624,5/25/2015 12:31:49,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,79,42,,,82,54,PDA,INDOMETHACIN,preterm infants with PDA.,58-66-74-79,27-30-38-42,M. Digoxin and INDOMETHACIN,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA.",79,42,79,42,-1,82,54,TWrex-cause,800189,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA",pda,indomethacin
725480697,5/25/2015 12:34:22,1642996233,5/25/2015 12:34:10,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,79,42,,,82,54,PDA,INDOMETHACIN,preterm infants with PDA.,58-66-74-79,27-30-38-42-55-58-66,M. Digoxin and INDOMETHACIN in preterm infants,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA.",79,42,79,42,-1,82,54,TWrex-cause,800189,"Zarfin Y, Koren G, Perlman M. Digoxin and indomethacin in preterm infants with PDA",pda,indomethacin
725480698,5/25/2015 11:39:07,1642984456,5/25/2015 11:38:52,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,103,37,,,111,48,SYNDROME,ZIPRASIDONE,Tourette's SYNDROME:,92-103,37,ZIPRASIDONE,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.",103,37,103,37,-1,111,48,TWrex-cause,800745,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study",syndrome,ziprasidone
725480698,5/25/2015 11:55:54,1642987784,5/25/2015 11:55:41,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,103,37,,,111,48,SYNDROME,ZIPRASIDONE,SYNDROME:,103,37,ZIPRASIDONE,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.",103,37,103,37,-1,111,48,TWrex-cause,800745,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study",syndrome,ziprasidone
725480698,5/25/2015 12:00:08,1642988468,5/25/2015 11:59:33,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,103,37,,,111,48,SYNDROME,ZIPRASIDONE,Tourette's SYNDROME:,92-103,37,ZIPRASIDONE,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.",103,37,103,37,-1,111,48,TWrex-cause,800745,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study",syndrome,ziprasidone
725480698,5/25/2015 12:23:02,1642993662,5/25/2015 12:21:44,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,103,37,,,111,48,SYNDROME,ZIPRASIDONE,SYNDROME:,103,37,ZIPRASIDONE,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.",103,37,103,37,-1,111,48,TWrex-cause,800745,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study",syndrome,ziprasidone
725480698,5/25/2015 12:37:25,1642996904,5/25/2015 12:37:16,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,103,37,,,111,48,SYNDROME,ZIPRASIDONE,adolescents with Tourette's SYNDROME: a pilot study.,75-87-92-103-113-115-121,27-30-33-37-49-59-62,CG et al. ZIPRASIDONE treatment of children,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.",103,37,103,37,-1,111,48,TWrex-cause,800745,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study",syndrome,ziprasidone
725480698,5/25/2015 12:40:33,1642997425,5/25/2015 12:39:47,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,103,37,,,111,48,SYNDROME,ZIPRASIDONE,adolescents with Tourette's SYNDROME:,75-87-92-103,37-49-59-62,ZIPRASIDONE treatment of children,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.",103,37,103,37,-1,111,48,TWrex-cause,800745,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study",syndrome,ziprasidone
725480698,5/25/2015 12:40:53,1642997463,5/25/2015 12:40:26,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,103,37,,,111,48,SYNDROME,ZIPRASIDONE,Tourette's SYNDROME:,92-103,37,ZIPRASIDONE,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.",103,37,103,37,-1,111,48,TWrex-cause,800745,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study",syndrome,ziprasidone
725480698,5/25/2015 12:46:02,1642998317,5/25/2015 12:45:41,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,103,37,,,111,48,SYNDROME,ZIPRASIDONE,Tourette's SYNDROME:,92-103,37-49,ZIPRASIDONE treatment,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.",103,37,103,37,-1,111,48,TWrex-cause,800745,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study",syndrome,ziprasidone
725480698,5/25/2015 12:47:23,1642998633,5/25/2015 12:46:57,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,103,37,,,111,48,SYNDROME,ZIPRASIDONE,Tourette's SYNDROME:,103-92,37,ZIPRASIDONE,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.",103,37,103,37,-1,111,48,TWrex-cause,800745,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study",syndrome,ziprasidone
725480698,5/25/2015 12:49:19,1642999046,5/25/2015 12:48:52,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,103,37,,,111,48,SYNDROME,ZIPRASIDONE,Tourette's SYNDROME:,92-103,37-49,ZIPRASIDONE treatment,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.",103,37,103,37,-1,111,48,TWrex-cause,800745,"Sallee FR, Kurlan R, Goetz CG et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study",syndrome,ziprasidone
725480699,5/25/2015 08:16:04,1642938772,5/25/2015 08:15:45,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,36,83,,,39,89,NM,AGENT,increased risk of NMS,18-28-36-33,69-83,antipsychotic AGENTS,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",36,83,36,83,1,39,89,TWrex-cause,812299,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies",nm,agent
725480699,5/25/2015 08:20:40,1642939747,5/25/2015 08:20:27,false,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,36,83,,,39,89,NM,AGENT,increased risk of NMS and increased sensitivity antipsychotic agents,18-28-33-36-40-44-54-69-83,36-44-54-66-69-83-90-93-102-33,of NMS increased sensitivity to antipsychotic AGENTS in patients with,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",36,83,36,83,1,39,89,TWrex-cause,812299,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies",nm,agent
725480699,5/25/2015 08:40:03,1642943198,5/25/2015 08:39:47,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,36,83,,,39,89,NM,AGENT,NMS,36,69-83,antipsychotic AGENTS,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",36,83,36,83,1,39,89,TWrex-cause,812299,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies",nm,agent
725480699,5/25/2015 08:45:30,1642944049,5/25/2015 08:45:14,false,elite,1.0,26544151,GBR,"","",213.205.252.245,36,83,,,39,89,NM,AGENT,NMS,36,83,AGENTS,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",36,83,36,83,1,39,89,TWrex-cause,812299,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies",nm,agent
725480699,5/25/2015 08:53:27,1642945462,5/25/2015 08:53:08,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,36,83,,,39,89,NM,AGENT,NMS,36,69-83,antipsychotic AGENTS,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",36,83,36,83,1,39,89,TWrex-cause,812299,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies",nm,agent
725480699,5/25/2015 08:58:21,1642946178,5/25/2015 08:58:07,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,36,83,,,39,89,NM,AGENT,NMS,36,69-83,antipsychotic AGENTS,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",36,83,36,83,1,39,89,TWrex-cause,812299,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies",nm,agent
725480699,5/25/2015 09:04:42,1642947009,5/25/2015 09:03:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,36,83,,,39,89,NM,AGENT,"Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",9-18-28-33-36-40-44-54-66-69-83-90-93-102-107-120-129-132-141-146-151-159-174-177-189-193-201-212-225-234-246-251-256-265-274-277-292-300-326-335-340-347-355-358-361-364-373-379-387-397-402-411-416-429-438,9-18-28-33-36-40-44-54-66-69-83-90-93-102-107-120-129-132-141-146-151-159-174-177-189-193-201-212-225-234-246-251-256-265-274-277-292-300-326-335-340-347-355-358-361-364-373-379-387-397-402-411-416-429-438,"Possible increased risk of NMS and increased sensitivity to antipsychotic AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.","a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",36,83,36,83,1,39,89,TWrex-cause,812299,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies",nm,agent
725480699,5/25/2015 09:07:15,1642947496,5/25/2015 09:06:40,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,36,83,,,39,89,NM,AGENT,NMS,36,69-83,antipsychotic AGENTS,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",36,83,36,83,1,39,89,TWrex-cause,812299,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies",nm,agent
725480699,5/25/2015 09:24:57,1642949961,5/25/2015 09:24:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,36,83,,,39,89,NM,AGENT,NMS,36,69-83,antipsychotic AGENTS,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",36,83,36,83,1,39,89,TWrex-cause,812299,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies",nm,agent
725480699,5/25/2015 09:28:25,1642950694,5/25/2015 09:28:09,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,36,83,,,39,89,NM,AGENT,NMS,36,83,AGENTS,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",36,83,36,83,1,39,89,TWrex-cause,812299,"a ,   b  Possible increased risk of NMS and increased sensitivity to antipsychotic agents in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies",nm,agent
725480700,5/25/2015 10:54:16,1642976051,5/25/2015 10:54:00,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,73,17,,,77,29,PAIN,ENDOMETRIOMA,acute abdominal PAIN,57-63-73,17,ENDOMETRIOMA,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms.",73,17,73,17,1,77,29,TWrex-cause,813574,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms",pain,endometrioma
725480700,5/25/2015 10:59:58,1642977057,5/25/2015 10:59:39,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,73,17,,,77,29,PAIN,ENDOMETRIOMA,"endometrioma ruptures or leaks, causing acute abdominal PAIN and peritoneal symptoms.",17-30-39-49-57-63-73-78-82-93-42,0-14-17-30-39-42-49-73-82-93,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing pain peritoneal symptoms.","Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms.",73,17,73,17,1,77,29,TWrex-cause,813574,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms",pain,endometrioma
725480700,5/25/2015 11:36:09,1642984010,5/25/2015 11:35:52,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,73,17,,,77,29,PAIN,ENDOMETRIOMA,acute abdominal PAIN,57-63-73,17,ENDOMETRIOMA,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms.",73,17,73,17,1,77,29,TWrex-cause,813574,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms",pain,endometrioma
725480700,5/25/2015 11:45:10,1642985717,5/25/2015 11:44:57,false,dailyrewardsca,1.0,32438879,CAN,NB,Fredericton,156.57.46.234,73,17,,,77,29,PAIN,ENDOMETRIOMA,PAIN,73,17,ENDOMETRIOMA,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms.",73,17,73,17,1,77,29,TWrex-cause,813574,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms",pain,endometrioma
725480700,5/25/2015 11:53:08,1642987403,5/25/2015 11:52:56,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,73,17,,,77,29,PAIN,ENDOMETRIOMA,PAIN,73,17,ENDOMETRIOMA,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms.",73,17,73,17,1,77,29,TWrex-cause,813574,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms",pain,endometrioma
725480700,5/25/2015 11:53:38,1642987449,5/25/2015 11:53:10,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,73,17,,,77,29,PAIN,ENDOMETRIOMA,acute abdominal PAIN,57-63-73,17,ENDOMETRIOMA,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms.",73,17,73,17,1,77,29,TWrex-cause,813574,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms",pain,endometrioma
725480700,5/25/2015 11:56:59,1642987968,5/25/2015 11:56:44,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,73,17,,,77,29,PAIN,ENDOMETRIOMA,acute abdominal PAIN,57-63-73,17,ENDOMETRIOMA,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms.",73,17,73,17,1,77,29,TWrex-cause,813574,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms",pain,endometrioma
725480700,5/25/2015 12:13:14,1642991457,5/25/2015 12:13:01,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,73,17,,,77,29,PAIN,ENDOMETRIOMA,PAIN,73,17,ENDOMETRIOMA,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms.",73,17,73,17,1,77,29,TWrex-cause,813574,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms",pain,endometrioma
725480700,5/25/2015 12:31:48,1642995531,5/25/2015 12:30:43,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,73,17,,,77,29,PAIN,ENDOMETRIOMA,causing acute abdominal PAIN and peritoneal symptoms.,49-57-63-73-78-82-93,14-17-30-39-42,"an ENDOMETRIOMA ruptures or leaks,","Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms.",73,17,73,17,1,77,29,TWrex-cause,813574,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms",pain,endometrioma
725480700,5/25/2015 12:34:08,1642996166,5/25/2015 12:33:58,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,73,17,,,77,29,PAIN,ENDOMETRIOMA,causing acute abdominal PAIN and peritoneal symptoms.,49-57-63-73-78-82-93,14-17-30-39-42,"an ENDOMETRIOMA ruptures or leaks,","Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms.",73,17,73,17,1,77,29,TWrex-cause,813574,"Occasionally, an endometrioma ruptures or leaks, causing acute abdominal pain and peritoneal symptoms",pain,endometrioma
725480701,5/25/2015 08:20:48,1642939765,5/25/2015 08:20:29,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,167,107,,,176,120,PREGNANCY,METRONIDAZOLE,1st trimester of PREGNANCY,150-154-164-167,107,METRONIDAZOLE,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.",167,107,167,107,-1,176,120,TWrex-cause,803307,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity",pregnancy,metronidazole
725480701,5/25/2015 08:50:29,1642944905,5/25/2015 08:50:12,false,elite,1.0,26544151,GBR,"","",213.205.252.245,167,107,,,176,120,PREGNANCY,METRONIDAZOLE,PREGNANCY,167,107,METRONIDAZOLE,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.",167,107,167,107,-1,176,120,TWrex-cause,803307,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity",pregnancy,metronidazole
725480701,5/25/2015 08:50:46,1642944997,5/25/2015 08:50:31,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,167,107,,,176,120,PREGNANCY,METRONIDAZOLE,PREGNANCY,167,107,METRONIDAZOLE,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.",167,107,167,107,-1,176,120,TWrex-cause,803307,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity",pregnancy,metronidazole
725480701,5/25/2015 08:58:04,1642946146,5/25/2015 08:57:43,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,167,107,,,176,120,PREGNANCY,METRONIDAZOLE,1st trimester of PREGNANCY,150-154-164-167,107,METRONIDAZOLE,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.",167,107,167,107,-1,176,120,TWrex-cause,803307,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity",pregnancy,metronidazole
725480701,5/25/2015 09:04:05,1642946878,5/25/2015 09:03:43,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,167,107,,,176,120,PREGNANCY,METRONIDAZOLE,PREGNANCY,167,107,METRONIDAZOLE,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.",167,107,167,107,-1,176,120,TWrex-cause,803307,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity",pregnancy,metronidazole
725480701,5/25/2015 09:16:05,1642948720,5/25/2015 09:15:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,167,107,,,176,120,PREGNANCY,METRONIDAZOLE,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",0-9-23-26-29-33-37-46-48-57-61-66-69-78-81-84-92-95-99-107-121-128-131-139-146-150-154-164-167-177-185-188-197-203-207,0-9-23-26-29-33-37-46-48-57-61-66-69-78-81-84-92-95-99-107-121-128-131-139-146-150-154-164-167-177-185-188-197-203-207,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.","Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.",167,107,167,107,-1,176,120,TWrex-cause,803307,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity",pregnancy,metronidazole
725480701,5/25/2015 09:22:49,1642949735,5/25/2015 09:21:59,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,167,107,,,176,120,PREGNANCY,METRONIDAZOLE,PREGNANCY,167,107-121-128-131,METRONIDAZOLE should be avoided,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.",167,107,167,107,-1,176,120,TWrex-cause,803307,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity",pregnancy,metronidazole
725480701,5/25/2015 09:32:42,1642951399,5/25/2015 09:32:24,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,167,107,,,176,120,PREGNANCY,METRONIDAZOLE,PREGNANCY,167,107,METRONIDAZOLE,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.",167,107,167,107,-1,176,120,TWrex-cause,803307,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity",pregnancy,metronidazole
725480701,5/25/2015 09:48:45,1642953943,5/25/2015 09:48:27,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,167,107,,,176,120,PREGNANCY,METRONIDAZOLE,PREGNANCY,167,107,METRONIDAZOLE,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.",167,107,167,107,-1,176,120,TWrex-cause,803307,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity",pregnancy,metronidazole
725480701,5/25/2015 09:55:12,1642954898,5/25/2015 09:54:56,false,clixsense,1.0,24763049,GBR,Y8,Welshpool,81.135.56.139,167,107,,,176,120,PREGNANCY,METRONIDAZOLE,PREGNANCY,167,107,METRONIDAZOLE,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity.",167,107,167,107,-1,176,120,TWrex-cause,803307,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), metronidazole should be avoided during the 1st trimester of pregnancy because of concerns about its mutagenicity",pregnancy,metronidazole
725480702,5/25/2015 10:55:40,1642976337,5/25/2015 10:55:25,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,97,141,,,112,150,TYPE 2 DIABETES,METFORMIN,"TYPE 2 DIABETES,",97-102-104,141,METFORMIN,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",97 102 104,141,97,141,-1,112,150,TWrex-cause,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment",type 2 diabetes,metformin
725480702,5/25/2015 11:03:02,1642977646,5/25/2015 11:01:43,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,97,141,,,112,150,TYPE 2 DIABETES,METFORMIN,"Clinical trials patients with TYPE 2 DIABETES,",17-26-83-97-102-104-92,17-26-37-44-83-92-97-102-104-132-141-151-157-160-169-174-180,"Clinical trials cohort studies patients with type 2 diabetes, compared METFORMIN alone or combined with other treatments","STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",97 102 104,141,97,141,-1,112,150,TWrex-cause,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment",type 2 diabetes,metformin
725480702,5/25/2015 11:37:16,1642984245,5/25/2015 11:37:02,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,97,141,,,112,150,TYPE 2 DIABETES,METFORMIN,"TYPE 2 DIABETES,",97-102-104,123-141,1 METFORMIN,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",97 102 104,141,97,141,-1,112,150,TWrex-cause,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment",type 2 diabetes,metformin
725480702,5/25/2015 11:54:15,1642987547,5/25/2015 11:54:00,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,97,141,,,112,150,TYPE 2 DIABETES,METFORMIN,"TYPE 2 DIABETES,",97-102-104,141,METFORMIN,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",97 102 104,141,97,141,-1,112,150,TWrex-cause,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment",type 2 diabetes,metformin
725480702,5/25/2015 11:56:13,1642987853,5/25/2015 11:55:46,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,97,141,,,112,150,TYPE 2 DIABETES,METFORMIN,"TYPE 2 DIABETES,",97-102-104,141,METFORMIN,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",97 102 104,141,97,141,-1,112,150,TWrex-cause,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment",type 2 diabetes,metformin
725480702,5/25/2015 11:58:33,1642988210,5/25/2015 11:58:02,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,97,141,,,112,150,TYPE 2 DIABETES,METFORMIN,"TYPE 2 DIABETES,",97-102-104,141,METFORMIN,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",97 102 104,141,97,141,-1,112,150,TWrex-cause,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment",type 2 diabetes,metformin
725480702,5/25/2015 12:18:36,1642992827,5/25/2015 12:16:37,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,97,141,,,112,150,TYPE 2 DIABETES,METFORMIN,"TYPE 2 DIABETES,",97-102-104,141,METFORMIN,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",97 102 104,141,97,141,-1,112,150,TWrex-cause,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment",type 2 diabetes,metformin
725480702,5/25/2015 12:34:30,1642996269,5/25/2015 12:33:54,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,97,141,,,112,150,TYPE 2 DIABETES,METFORMIN,"included patients with TYPE 2 DIABETES,",74-83-92-97-102-104,123-125-132-141-151-157-160,"1 month, compared METFORMIN alone or combined","STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",97 102 104,141,97,141,-1,112,150,TWrex-cause,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment",type 2 diabetes,metformin
725480702,5/25/2015 12:35:29,1642996478,5/25/2015 12:35:16,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,97,141,,,112,150,TYPE 2 DIABETES,METFORMIN,"included patients with TYPE 2 DIABETES, lasted 1 month,",74-83-92-97-102-104-114-123-125,123-125-132-141-151-157-160,"1 month, compared METFORMIN alone or combined","STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",97 102 104,141,97,141,-1,112,150,TWrex-cause,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment",type 2 diabetes,metformin
725480702,5/25/2015 12:37:45,1642996953,5/25/2015 12:37:20,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,97,141,,,112,150,TYPE 2 DIABETES,METFORMIN,"TYPE 2 DIABETES,",97-102-104,141,METFORMIN,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",97 102 104,141,97,141,-1,112,150,TWrex-cause,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with type 2 diabetes, lasted ≥ 1 month, compared metformin alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment",type 2 diabetes,metformin
725480703,5/25/2015 12:48:44,1642998917,5/25/2015 12:48:11,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,33,82,,,52,100,CHRONIC HEPATITIS B,INTERFERON ALFA 2B,CHRONIC HEPATITIS B Virus (HBV),33-41-51-53-59,82-93-98,INTERFERON ALFA 2B,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",33 41 51,82 93 98,33,82,-1,52,100,TWrex-cause,800860,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly",chronic hepatitis b,interferon alfa 2b
725480703,5/25/2015 13:01:22,1643001166,5/25/2015 13:01:07,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,33,82,,,52,100,CHRONIC HEPATITIS B,INTERFERON ALFA 2B,CHRONIC HEPATITIS B,33-41-51,82-93-98,INTERFERON ALFA 2B,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",33 41 51,82 93 98,33,82,-1,52,100,TWrex-cause,800860,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly",chronic hepatitis b,interferon alfa 2b
725480703,5/25/2015 13:04:35,1643001719,5/25/2015 13:04:12,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,33,82,,,52,100,CHRONIC HEPATITIS B,INTERFERON ALFA 2B,CHRONIC HEPATITIS B Virus (HBV),33-41-51-53-59,82-93-98,INTERFERON ALFA 2B,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",33 41 51,82 93 98,33,82,-1,52,100,TWrex-cause,800860,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly",chronic hepatitis b,interferon alfa 2b
725480703,5/25/2015 13:17:29,1643004145,5/25/2015 13:16:55,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,33,82,,,52,100,CHRONIC HEPATITIS B,INTERFERON ALFA 2B,CHRONIC HEPATITIS B Virus Infection,33-41-51-53-65,82-93-98-109-112-116-101,INTERFERON ALFA 2B (Intron ® A) Sub,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",33 41 51,82 93 98,33,82,-1,52,100,TWrex-cause,800860,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly",chronic hepatitis b,interferon alfa 2b
725480703,5/25/2015 13:24:16,1643005471,5/25/2015 13:23:51,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,33,82,,,52,100,CHRONIC HEPATITIS B,INTERFERON ALFA 2B,CHRONIC HEPATITIS B Virus (HBV) Infection,33-41-51-53-65-59,33-41-51-53-59-65-76-82-93-98-112,Chronic Hepatitis B Virus (HBV) Infection &gt; INTERFERON ALFA 2B A),"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",33 41 51,82 93 98,33,82,-1,52,100,TWrex-cause,800860,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly",chronic hepatitis b,interferon alfa 2b
725480703,5/25/2015 13:24:15,1643005473,5/25/2015 13:24:03,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,33,82,,,52,100,CHRONIC HEPATITIS B,INTERFERON ALFA 2B,Patients Treatment of CHRONIC HEPATITIS B Virus (HBV) Infection,10-20-30-33-41-51-53-65-59,59-65-76-82-93-98,(HBV) Infection &gt; INTERFERON ALFA 2B,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",33 41 51,82 93 98,33,82,-1,52,100,TWrex-cause,800860,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly",chronic hepatitis b,interferon alfa 2b
725480703,5/25/2015 13:24:40,1643005617,5/25/2015 13:23:53,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,33,82,,,52,100,CHRONIC HEPATITIS B,INTERFERON ALFA 2B,CHRONIC HEPATITIS B Virus,33-41-51-53,82-93-98,INTERFERON ALFA 2B,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",33 41 51,82 93 98,33,82,-1,52,100,TWrex-cause,800860,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly",chronic hepatitis b,interferon alfa 2b
725480703,5/25/2015 13:25:02,1643005753,5/25/2015 13:24:40,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,33,82,,,52,100,CHRONIC HEPATITIS B,INTERFERON ALFA 2B,CHRONIC HEPATITIS B Virus (HBV) Infection,33-41-51-53-65-59,82-93-98-109-112-101,INTERFERON ALFA 2B (Intron ® A),"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",33 41 51,82 93 98,33,82,-1,52,100,TWrex-cause,800860,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly",chronic hepatitis b,interferon alfa 2b
725480703,5/25/2015 13:26:23,1643006043,5/25/2015 13:25:22,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,33,82,,,52,100,CHRONIC HEPATITIS B,INTERFERON ALFA 2B,"CHRONIC HEPATITIS B Virus (HB<span id=""transmark""></span>V) Infection",33-41-51-53-65-59,82-93-98-101-109-112,INTERFERON ALFA 2B (Intron ® A),"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",33 41 51,82 93 98,33,82,-1,52,100,TWrex-cause,800860,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly",chronic hepatitis b,interferon alfa 2b
725480703,5/25/2015 13:26:35,1643006083,5/25/2015 13:25:17,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,33,82,,,52,100,CHRONIC HEPATITIS B,INTERFERON ALFA 2B,CHRONIC HEPATITIS B Virus,33-41-51-53,82-93-98,INTERFERON ALFA 2B,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",33 41 51,82 93 98,33,82,-1,52,100,TWrex-cause,800860,"Pediatric Patients  Treatment of Chronic Hepatitis B Virus (HBV) Infection  >     Interferon Alfa-2b (Intron ®  A)  Sub-Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly",chronic hepatitis b,interferon alfa 2b
725480704,5/25/2015 09:52:03,1642954465,5/25/2015 09:51:49,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,32,96,,,36,116,PAIN,TRIGEMINAL NEURALGIA,PAIN,32,96-107,TRIGEMINAL NEURALGIA,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87.,32,96 107,32,96,1,36,116,TWrex-cause,814889,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87,pain,trigeminal neuralgia
725480704,5/25/2015 10:01:02,1642955981,5/25/2015 10:00:48,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,32,96,,,36,116,PAIN,TRIGEMINAL NEURALGIA,PAIN,32,85-96-107,refractory TRIGEMINAL NEURALGIA,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87.,32,96 107,32,96,1,36,116,TWrex-cause,814889,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87,pain,trigeminal neuralgia
725480704,5/25/2015 10:02:34,1642956251,5/25/2015 10:01:46,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,32,96,,,36,116,PAIN,TRIGEMINAL NEURALGIA,PAIN,32,85-96-107,refractory TRIGEMINAL NEURALGIA,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87.,32,96 107,32,96,1,36,116,TWrex-cause,814889,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87,pain,trigeminal neuralgia
725480704,5/25/2015 10:08:01,1642957085,5/25/2015 10:07:42,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,32,96,,,36,116,PAIN,TRIGEMINAL NEURALGIA,PAIN,32,85-96-107,refractory TRIGEMINAL NEURALGIA,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87.,32,96 107,32,96,1,36,116,TWrex-cause,814889,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87,pain,trigeminal neuralgia
725480704,5/25/2015 10:08:41,1642957173,5/25/2015 10:08:06,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,32,96,,,36,116,PAIN,TRIGEMINAL NEURALGIA,PAIN,32,85-96-107,refractory TRIGEMINAL NEURALGIA,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87.,32,96 107,32,96,1,36,116,TWrex-cause,814889,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87,pain,trigeminal neuralgia
725480704,5/25/2015 10:21:26,1642959674,5/25/2015 10:21:04,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,32,96,,,36,116,PAIN,TRIGEMINAL NEURALGIA,PAIN,32,85-96-107,refractory TRIGEMINAL NEURALGIA,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87.,32,96 107,32,96,1,36,116,TWrex-cause,814889,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87,pain,trigeminal neuralgia
725480704,5/25/2015 10:25:14,1642960977,5/25/2015 10:24:57,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,32,96,,,36,116,PAIN,TRIGEMINAL NEURALGIA,PAIN,32,85-96-107,refractory TRIGEMINAL NEURALGIA,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87.,32,96 107,32,96,1,36,116,TWrex-cause,814889,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87,pain,trigeminal neuralgia
725480704,5/25/2015 10:31:28,1642963831,5/25/2015 10:30:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,32,96,,,36,116,PAIN,TRIGEMINAL NEURALGIA,PAIN,32,85-96-107,refractory TRIGEMINAL NEURALGIA,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87.,32,96 107,32,96,1,36,116,TWrex-cause,814889,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87,pain,trigeminal neuralgia
725480704,5/25/2015 10:36:59,1642968160,5/25/2015 10:36:24,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,32,96,,,36,116,PAIN,TRIGEMINAL NEURALGIA,PAIN,32,85-96-107,refractory TRIGEMINAL NEURALGIA,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87.,32,96 107,32,96,1,36,116,TWrex-cause,814889,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87,pain,trigeminal neuralgia
725480704,5/25/2015 10:42:10,1642972766,5/25/2015 10:41:53,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,32,96,,,36,116,PAIN,TRIGEMINAL NEURALGIA,• PAIN,10-32,85-96-107,refractory TRIGEMINAL NEURALGIA,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87.,32,96 107,32,96,1,36,116,TWrex-cause,814889,Evidence: • Gabapentin relieved pain completely in six of seven patients with MS and refractory trigeminal neuralgia and significantly in the seventh patient ( 87,pain,trigeminal neuralgia
725480705,5/25/2015 11:58:54,1642988257,5/25/2015 11:58:38,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,103,44,,,109,48,PAPULE,WART,PAPULE,103,44,WART),"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",103,44,103,44,1,109,48,TWrex-cause,813738,"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color",papule,wart
725480705,5/25/2015 12:45:44,1642998241,5/25/2015 12:45:14,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,103,44,,,109,48,PAPULE,WART,PAPULE or plaque,103-110-113,32-44,(seborrheic WART),"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",103,44,103,44,1,109,48,TWrex-cause,813738,"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color",papule,wart
725480705,5/25/2015 12:54:52,1643000055,5/25/2015 12:54:34,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,103,44,,,109,48,PAPULE,WART,PAPULE,103,32-44,(seborrheic WART),"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",103,44,103,44,1,109,48,TWrex-cause,813738,"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color",papule,wart
725480705,5/25/2015 13:01:31,1643001212,5/25/2015 13:01:00,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,103,44,,,109,48,PAPULE,WART,PAPULE,103,11-22-32-44,Seborrheic keratosis (seborrheic WART),"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",103,44,103,44,1,109,48,TWrex-cause,813738,"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color",papule,wart
725480705,5/25/2015 13:13:20,1643003222,5/25/2015 13:12:55,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,103,44,,,109,48,PAPULE,WART,PAPULE,103,32-44,(seborrheic WART),"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",103,44,103,44,1,109,48,TWrex-cause,813738,"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color",papule,wart
725480705,5/25/2015 13:16:28,1643003901,5/25/2015 13:16:14,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,103,44,,,109,48,PAPULE,WART,rough or smooth PAPULE or plaque,87-93-96-103-110-113,11-22-32-44,Seborrheic keratosis (seborrheic WART),"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",103,44,103,44,1,109,48,TWrex-cause,813738,"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color",papule,wart
725480705,5/25/2015 13:17:41,1643004183,5/25/2015 13:17:26,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,103,44,,,109,48,PAPULE,WART,PAPULE,103,32-44,(seborrheic WART),"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",103,44,103,44,1,109,48,TWrex-cause,813738,"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color",papule,wart
725480705,5/25/2015 13:21:22,1643004894,5/25/2015 13:20:51,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,103,44,,,109,48,PAPULE,WART,"Seborrheic keratosis (seborrheic wart) circumscribed, PAPULE plaque",11-22-32-44-72-103-113,11-22-32-44-72-103-113,"Seborrheic keratosis (seborrheic WART) circumscribed, papule plaque","Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",103,44,103,44,1,109,48,TWrex-cause,813738,"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color",papule,wart
725480705,5/25/2015 13:21:26,1643004907,5/25/2015 13:21:08,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,103,44,,,109,48,PAPULE,WART,PAPULE,103,32-44,(seborrheic WART),"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",103,44,103,44,1,109,48,TWrex-cause,813738,"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color",papule,wart
725480705,5/25/2015 13:21:36,1643004941,5/25/2015 13:21:15,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,103,44,,,109,48,PAPULE,WART,smooth PAPULE,96-103,11-22-32-44,Seborrheic keratosis (seborrheic WART),"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",103,44,103,44,1,109,48,TWrex-cause,813738,"Diagnosis  Seborrheic keratosis (seborrheic wart) consists of a sharply circumscribed, rough or smooth papule or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color",papule,wart
725480706,5/25/2015 09:33:26,1642951569,5/25/2015 09:32:32,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,12,70,,,21,91,HEMATURIA,MICROSCOPIC HEMATURIA,Macroscopic HEMATURIA,0-12,70-82,MICROSCOPIC HEMATURIA,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections.",12,70 82,12,70,1,21,91,TWrex-cause,814758,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections",hematuria,microscopic hematuria
725480706,5/25/2015 09:36:44,1642952199,5/25/2015 09:36:32,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,12,70,,,21,91,HEMATURIA,MICROSCOPIC HEMATURIA,HEMATURIA,12,70-82,MICROSCOPIC HEMATURIA,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections.",12,70 82,12,70,1,21,91,TWrex-cause,814758,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections",hematuria,microscopic hematuria
725480706,5/25/2015 09:51:15,1642954308,5/25/2015 09:51:00,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,12,70,,,21,91,HEMATURIA,MICROSCOPIC HEMATURIA,Macroscopic HEMATURIA,0-12,70-82,MICROSCOPIC HEMATURIA,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections.",12,70 82,12,70,1,21,91,TWrex-cause,814758,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections",hematuria,microscopic hematuria
725480706,5/25/2015 10:00:06,1642955870,5/25/2015 09:59:55,false,prodege,1.0,31508822,CAN,AB,Calgary,206.75.77.133,12,70,,,21,91,HEMATURIA,MICROSCOPIC HEMATURIA,Macroscopic HEMATURIA,0-12,70-82,MICROSCOPIC HEMATURIA,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections.",12,70 82,12,70,1,21,91,TWrex-cause,814758,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections",hematuria,microscopic hematuria
725480706,5/25/2015 10:00:25,1642955887,5/25/2015 09:59:50,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,12,70,,,21,91,HEMATURIA,MICROSCOPIC HEMATURIA,Macroscopic HEMATURIA,0-12,70-82,MICROSCOPIC HEMATURIA,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections.",12,70 82,12,70,1,21,91,TWrex-cause,814758,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections",hematuria,microscopic hematuria
725480706,5/25/2015 10:06:56,1642956917,5/25/2015 10:06:43,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,12,70,,,21,91,HEMATURIA,MICROSCOPIC HEMATURIA,Macroscopic HEMATURIA,0-12,70-82,MICROSCOPIC HEMATURIA,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections.",12,70 82,12,70,1,21,91,TWrex-cause,814758,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections",hematuria,microscopic hematuria
725480706,5/25/2015 10:07:05,1642956926,5/25/2015 10:06:41,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,12,70,,,21,91,HEMATURIA,MICROSCOPIC HEMATURIA,Macroscopic HEMATURIA,0-12,70-82,MICROSCOPIC HEMATURIA,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections.",12,70 82,12,70,1,21,91,TWrex-cause,814758,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections",hematuria,microscopic hematuria
725480706,5/25/2015 10:20:24,1642959367,5/25/2015 10:20:09,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,12,70,,,21,91,HEMATURIA,MICROSCOPIC HEMATURIA,Macroscopic HEMATURIA,0-12,70-82,MICROSCOPIC HEMATURIA,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections.",12,70 82,12,70,1,21,91,TWrex-cause,814758,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections",hematuria,microscopic hematuria
725480706,5/25/2015 10:24:16,1642960583,5/25/2015 10:24:02,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,12,70,,,21,91,HEMATURIA,MICROSCOPIC HEMATURIA,Macroscopic HEMATURIA,0-12,70-82,MICROSCOPIC HEMATURIA,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections.",12,70 82,12,70,1,21,91,TWrex-cause,814758,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections",hematuria,microscopic hematuria
725480706,5/25/2015 10:25:17,1642960997,5/25/2015 10:24:07,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,12,70,,,21,91,HEMATURIA,MICROSCOPIC HEMATURIA,Macroscopic HEMATURIA,0-12,70-82,MICROSCOPIC HEMATURIA,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections.",12,70 82,12,70,1,21,91,TWrex-cause,814758,"Macroscopic hematuria usually resolves spontaneously within days, and microscopic hematuria often occurs between mucosal infections",hematuria,microscopic hematuria
725480707,5/25/2015 10:10:29,1642957393,5/25/2015 10:10:16,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,79,55,,,92,58,GENITAL WART,HPV,"external GENITAL WARTS,",70-79-87,47-55-59,"genital HPV infection,","1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.",79 87,55,79,55,1,92,58,TWrex-cause,811269,"1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia",genital wart,HPV
725480707,5/25/2015 10:10:51,1642957485,5/25/2015 10:10:24,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,79,55,,,92,58,GENITAL WART,HPV,"external GENITAL WARTS,",70-79-87,47-55-59,"genital HPV infection,","1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.",79 87,55,79,55,1,92,58,TWrex-cause,811269,"1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia",genital wart,HPV
725480707,5/25/2015 10:13:22,1642957942,5/25/2015 10:13:01,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,79,55,,,92,58,GENITAL WART,HPV,"external GENITAL WARTS,",70-79-87,47-55-59,"genital HPV infection,","1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.",79 87,55,79,55,1,92,58,TWrex-cause,811269,"1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia",genital wart,HPV
725480707,5/25/2015 10:24:24,1642960673,5/25/2015 10:24:07,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,79,55,,,92,58,GENITAL WART,HPV,"GENITAL WARTS,",79-87,55-59,"HPV infection,","1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.",79 87,55,79,55,1,92,58,TWrex-cause,811269,"1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia",genital wart,HPV
725480707,5/25/2015 10:38:27,1642969610,5/25/2015 10:38:13,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,79,55,,,92,58,GENITAL WART,HPV,"external GENITAL WARTS,",70-79-87,47-55-59,"genital HPV infection,","1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.",79 87,55,79,55,1,92,58,TWrex-cause,811269,"1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia",genital wart,HPV
725480707,5/25/2015 10:40:09,1642971138,5/25/2015 10:39:54,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,79,55,,,92,58,GENITAL WART,HPV,"external GENITAL WARTS,",70-79-87,47-55-59,"genital HPV infection,","1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.",79 87,55,79,55,1,92,58,TWrex-cause,811269,"1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia",genital wart,HPV
725480707,5/25/2015 10:44:21,1642974161,5/25/2015 10:44:07,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,79,55,,,92,58,GENITAL WART,HPV,"external GENITAL WARTS,",70-79-87,47-55-59,"genital HPV infection,","1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.",79 87,55,79,55,1,92,58,TWrex-cause,811269,"1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia",genital wart,HPV
725480707,5/25/2015 10:44:53,1642974458,5/25/2015 10:44:34,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,79,55,,,92,58,GENITAL WART,HPV,"HPV infection, external GENITAL WARTS, or cervical neoplasia.",55-59-70-79-87-94-97-106,31-39-47-55-59-70-79-97-106,"condoms prevent genital HPV infection, external genital cervical neoplasia.","1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.",79 87,55,79,55,1,92,58,TWrex-cause,811269,"1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia",genital wart,HPV
725480707,5/25/2015 10:46:44,1642974871,5/25/2015 10:46:22,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,79,55,,,92,58,GENITAL WART,HPV,"external GENITAL WARTS,",70-79-87,47-55-59,"genital HPV infection,","1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.",79 87,55,79,55,1,92,58,TWrex-cause,811269,"1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia",genital wart,HPV
725480707,5/25/2015 10:48:42,1642975231,5/25/2015 10:48:13,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,79,55,,,92,58,GENITAL WART,HPV,"condoms prevent HPV infection, external GENITAL WARTS,",31-55-59-70-79-87-39,31-39-47-55-59-70-79-87-94-97-106,"condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.","1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia.",79 87,55,79,55,1,92,58,TWrex-cause,811269,"1]  Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia",genital wart,HPV
725480708,5/25/2015 10:54:52,1642976115,5/25/2015 10:54:36,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,0,43,,,11,52,SPARGANOSIS,TAPEWORM,SPARGANOSIS,0,36-43,larval TAPEWORMS,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",0,43,0,43,1,11,52,TWrex-cause,812045,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium",sparganosis,tapeworm
725480708,5/25/2015 11:00:43,1642977178,5/25/2015 11:00:24,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,0,43,,,11,52,SPARGANOSIS,TAPEWORM,SPARGANOSIS represents infection by larval tapeworms,0-12-23-33-36-43,0-23-33-36-43-53-56-60-67,Sparganosis infection by larval TAPEWORMS of the genus Spirometra,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",0,43,0,43,1,11,52,TWrex-cause,812045,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium",sparganosis,tapeworm
725480708,5/25/2015 11:36:34,1642984121,5/25/2015 11:36:23,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,0,43,,,11,52,SPARGANOSIS,TAPEWORM,SPARGANOSIS,0,36-43,larval TAPEWORMS,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",0,43,0,43,1,11,52,TWrex-cause,812045,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium",sparganosis,tapeworm
725480708,5/25/2015 11:53:32,1642987432,5/25/2015 11:53:21,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,0,43,,,11,52,SPARGANOSIS,TAPEWORM,SPARGANOSIS,0,43,TAPEWORMS,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",0,43,0,43,1,11,52,TWrex-cause,812045,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium",sparganosis,tapeworm
725480708,5/25/2015 11:54:42,1642987589,5/25/2015 11:54:07,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,0,43,,,11,52,SPARGANOSIS,TAPEWORM,SPARGANOSIS represents infection by larval tapeworms of the genus Spirometra,0-12-23-33-36-43-53-56-60-67,36-43-53-56-60-67,larval TAPEWORMS of the genus Spirometra,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",0,43,0,43,1,11,52,TWrex-cause,812045,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium",sparganosis,tapeworm
725480708,5/25/2015 11:57:25,1642988018,5/25/2015 11:57:13,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,0,43,,,11,52,SPARGANOSIS,TAPEWORM,SPARGANOSIS,0,36-43,larval TAPEWORMS,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",0,43,0,43,1,11,52,TWrex-cause,812045,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium",sparganosis,tapeworm
725480708,5/25/2015 12:08:37,1642990242,5/25/2015 12:08:27,false,dailyrewardsca,1.0,32438879,CAN,NB,Fredericton,156.57.46.234,0,43,,,11,52,SPARGANOSIS,TAPEWORM,SPARGANOSIS,0,43,TAPEWORMS,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",0,43,0,43,1,11,52,TWrex-cause,812045,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium",sparganosis,tapeworm
725480708,5/25/2015 12:14:44,1642991914,5/25/2015 12:13:33,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,0,43,,,11,52,SPARGANOSIS,TAPEWORM,SPARGANOSIS,0,43,TAPEWORMS,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",0,43,0,43,1,11,52,TWrex-cause,812045,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium",sparganosis,tapeworm
725480708,5/25/2015 12:32:33,1642995707,5/25/2015 12:32:13,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,0,43,,,11,52,SPARGANOSIS,TAPEWORM,SPARGANOSIS represents infection,0-12-23,23-33-36-43-53-56-60,infection by larval TAPEWORMS of the genus,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",0,43,0,43,1,11,52,TWrex-cause,812045,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium",sparganosis,tapeworm
725480708,5/25/2015 12:34:40,1642996300,5/25/2015 12:34:25,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,0,43,,,11,52,SPARGANOSIS,TAPEWORM,SPARGANOSIS represents infection by,0-12-23-33,36-43-53-56-60,larval TAPEWORMS of the genus,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",0,43,0,43,1,11,52,TWrex-cause,812045,"Sparganosis represents infection by larval tapeworms of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium",sparganosis,tapeworm
725480709,5/25/2015 11:38:35,1642984394,5/25/2015 11:38:14,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,123,145,,,127,157,PONS,MYELINOLYSIS,"basal PONS (central pontine myelinolysis),",117-123-137-145-128,123-128-137-145,"pons (central pontine MYELINOLYSIS),","56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter.",123,145,123,145,-1,127,157,TWrex-cause,802621,"56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter",pons,myelinolysis
725480709,5/25/2015 11:55:19,1642987687,5/25/2015 11:55:05,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,123,145,,,127,157,PONS,MYELINOLYSIS,PONS,123,145,"MYELINOLYSIS),","56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter.",123,145,123,145,-1,127,157,TWrex-cause,802621,"56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter",pons,myelinolysis
725480709,5/25/2015 11:58:48,1642988248,5/25/2015 11:58:18,false,prodege,1.0,22429517,USA,VA,Charlottesville,76.5.71.105,123,145,,,127,157,PONS,MYELINOLYSIS,"basal PONS (central pontine myelinolysis),",117-123-137-145-128,117-123-128-137-145,"basal pons (central pontine MYELINOLYSIS),","56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter.",123,145,123,145,-1,127,157,TWrex-cause,802621,"56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter",pons,myelinolysis
725480709,5/25/2015 12:21:15,1642993339,5/25/2015 12:20:26,false,instagc,1.0,26024737,GBR,A9,Blackpool,2.97.97.40,123,145,,,127,157,PONS,MYELINOLYSIS,PONS,123,145,"MYELINOLYSIS),","56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter.",123,145,123,145,-1,127,157,TWrex-cause,802621,"56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter",pons,myelinolysis
725480709,5/25/2015 12:36:51,1642996753,5/25/2015 12:36:37,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,123,145,,,127,157,PONS,MYELINOLYSIS,"of the basal PONS pontine myelinolysis),",110-113-117-123-137-145,123-128-137-145-160-164,"pons (central pontine MYELINOLYSIS), but histologically","56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter.",123,145,123,145,-1,127,157,TWrex-cause,802621,"56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter",pons,myelinolysis
725480709,5/25/2015 12:39:25,1642997188,5/25/2015 12:38:07,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,123,145,,,127,157,PONS,MYELINOLYSIS,of the basal PONS,110-113-117-123,123-128-137-145-160-164-179,"pons (central pontine MYELINOLYSIS), but histologically similar","56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter.",123,145,123,145,-1,127,157,TWrex-cause,802621,"56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter",pons,myelinolysis
725480709,5/25/2015 12:39:41,1642997261,5/25/2015 12:39:15,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,123,145,,,127,157,PONS,MYELINOLYSIS,basal PONS,117-123,128-137-145,"(central pontine MYELINOLYSIS),","56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter.",123,145,123,145,-1,127,157,TWrex-cause,802621,"56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter",pons,myelinolysis
725480709,5/25/2015 12:44:49,1642998135,5/25/2015 12:44:24,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,123,145,,,127,157,PONS,MYELINOLYSIS,basal PONS,117-123,128-137-145,"(central pontine MYELINOLYSIS),","56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter.",123,145,123,145,-1,127,157,TWrex-cause,802621,"56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter",pons,myelinolysis
725480709,5/25/2015 12:46:43,1642998511,5/25/2015 12:46:14,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,123,145,,,127,157,PONS,MYELINOLYSIS,PONS,123,128-137-145,"(central pontine MYELINOLYSIS),","56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter.",123,145,123,145,-1,127,157,TWrex-cause,802621,"56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter",pons,myelinolysis
725480709,5/25/2015 12:48:50,1642998933,5/25/2015 12:47:52,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,123,145,,,127,157,PONS,MYELINOLYSIS,"basal PONS (central pontine myelinolysis),",117-123-137-145-128,117-123-128-137-145,"basal pons (central pontine MYELINOLYSIS),","56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter.",123,145,123,145,-1,127,157,TWrex-cause,802621,"56 - 58   Lesions, which are best identified by magnetic resonance imaging, are typically found in the center of the basal pons (central pontine myelinolysis), but histologically similar lesions may also occur in a symmetrical distribution in extrapontine areas of the brain where there is a close admixture of gray and white matter",pons,myelinolysis
725480710,5/25/2015 10:09:38,1642957240,5/25/2015 10:07:23,false,clixsense,1.0,6330007,AUS,02,Sydney,49.195.38.217,9,114,,,20,127,PLEURODYNIA,ENTEROVIRUS,"PLEURODYNIA,",9,114,ENTEROVIRUSES.,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses.",9,114,9,114,1,20,127,TWrex-cause,810784,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses",pleurodynia,enterovirus
725480710,5/25/2015 10:09:49,1642957332,5/25/2015 10:09:39,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,9,114,,,20,127,PLEURODYNIA,ENTEROVIRUS,"Epidemic PLEURODYNIA,",0-9,114,ENTEROVIRUSES.,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses.",9,114,9,114,1,20,127,TWrex-cause,810784,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses",pleurodynia,enterovirus
725480710,5/25/2015 10:12:41,1642957853,5/25/2015 10:12:23,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,9,114,,,20,127,PLEURODYNIA,ENTEROVIRUS,"Epidemic PLEURODYNIA,",0-9,114,ENTEROVIRUSES.,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses.",9,114,9,114,1,20,127,TWrex-cause,810784,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses",pleurodynia,enterovirus
725480710,5/25/2015 10:23:47,1642960381,5/25/2015 10:23:31,false,clixsense,1.0,6338946,CAN,ON,Brampton,216.58.108.145,9,114,,,20,127,PLEURODYNIA,ENTEROVIRUS,"Epidemic PLEURODYNIA,",0-9,114,ENTEROVIRUSES.,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses.",9,114,9,114,1,20,127,TWrex-cause,810784,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses",pleurodynia,enterovirus
725480710,5/25/2015 10:28:19,1642962130,5/25/2015 10:28:10,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,9,114,,,20,127,PLEURODYNIA,ENTEROVIRUS,"Epidemic PLEURODYNIA,",0-9,114,ENTEROVIRUSES.,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses.",9,114,9,114,1,20,127,TWrex-cause,810784,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses",pleurodynia,enterovirus
725480710,5/25/2015 10:37:41,1642968827,5/25/2015 10:36:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,9,114,,,20,127,PLEURODYNIA,ENTEROVIRUS,"Epidemic PLEURODYNIA,",0-9,114,ENTEROVIRUSES.,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses.",9,114,9,114,1,20,127,TWrex-cause,810784,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses",pleurodynia,enterovirus
725480710,5/25/2015 10:39:39,1642970749,5/25/2015 10:39:21,false,neodev,1.0,11659309,USA,KS,Derby,68.102.136.12,9,114,,,20,127,PLEURODYNIA,ENTEROVIRUS,"Epidemic PLEURODYNIA,",0-9,114,ENTEROVIRUSES.,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses.",9,114,9,114,1,20,127,TWrex-cause,810784,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses",pleurodynia,enterovirus
725480710,5/25/2015 10:43:50,1642973897,5/25/2015 10:43:34,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,9,114,,,20,127,PLEURODYNIA,ENTEROVIRUS,"Epidemic PLEURODYNIA,",9-0,114,ENTEROVIRUSES.,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses.",9,114,9,114,1,20,127,TWrex-cause,810784,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses",pleurodynia,enterovirus
725480710,5/25/2015 10:44:18,1642974156,5/25/2015 10:43:53,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,9,114,,,20,127,PLEURODYNIA,ENTEROVIRUS,"Epidemic PLEURODYNIA, hand foot and herpangina, poliomyelitis enteroviruses.",0-9-22-27-32-51-67-114,0-9-51-92-99-111-114-67,"Epidemic pleurodynia, herpangina, poliomyelitis almost exclusively by ENTEROVIRUSES.","Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses.",9,114,9,114,1,20,127,TWrex-cause,810784,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses",pleurodynia,enterovirus
725480710,5/25/2015 10:45:57,1642974750,5/25/2015 10:45:23,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,9,114,,,20,127,PLEURODYNIA,ENTEROVIRUS,"Epidemic PLEURODYNIA,",0-9,114,ENTEROVIRUSES.,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses.",9,114,9,114,1,20,127,TWrex-cause,810784,"Epidemic pleurodynia, hand-foot-and-mouth disease, herpangina, and poliomyelitis are caused almost exclusively by enteroviruses",pleurodynia,enterovirus
725480711,5/25/2015 08:14:10,1642938452,5/25/2015 08:13:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,0,62,,,4,75,PAIN,ACETAMINOPHEN,PAIN without inflammation,0-5-13,62,ACETAMINOPHEN.,Pain without inflammation is usually more safely treated with acetaminophen.,0,62,0,62,-1,4,75,TWrex-cause,804167,Pain without inflammation is usually more safely treated with acetaminophen,pain,acetaminophen
725480711,5/25/2015 08:18:00,1642939126,5/25/2015 08:17:52,false,instagc,1.0,31130954,USA,IL,Glen Ellyn,99.135.172.175,0,62,,,4,75,PAIN,ACETAMINOPHEN,PAIN,0,62,ACETAMINOPHEN.,Pain without inflammation is usually more safely treated with acetaminophen.,0,62,0,62,-1,4,75,TWrex-cause,804167,Pain without inflammation is usually more safely treated with acetaminophen,pain,acetaminophen
725480711,5/25/2015 08:19:14,1642939386,5/25/2015 08:19:04,false,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,0,62,,,4,75,PAIN,ACETAMINOPHEN,PAIN without inflammation is treated with acetaminophen.,0-5-13-26-49-57-62,0-5-42-49-57-62-13,Pain without inflammation safely treated with ACETAMINOPHEN.,Pain without inflammation is usually more safely treated with acetaminophen.,0,62,0,62,-1,4,75,TWrex-cause,804167,Pain without inflammation is usually more safely treated with acetaminophen,pain,acetaminophen
725480711,5/25/2015 08:37:11,1642942715,5/25/2015 08:36:54,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,0,62,,,4,75,PAIN,ACETAMINOPHEN,PAIN,0,62,ACETAMINOPHEN.,Pain without inflammation is usually more safely treated with acetaminophen.,0,62,0,62,-1,4,75,TWrex-cause,804167,Pain without inflammation is usually more safely treated with acetaminophen,pain,acetaminophen
725480711,5/25/2015 08:43:21,1642943708,5/25/2015 08:43:11,false,elite,1.0,26544151,GBR,"","",213.205.252.245,0,62,,,4,75,PAIN,ACETAMINOPHEN,PAIN,0,62,ACETAMINOPHEN.,Pain without inflammation is usually more safely treated with acetaminophen.,0,62,0,62,-1,4,75,TWrex-cause,804167,Pain without inflammation is usually more safely treated with acetaminophen,pain,acetaminophen
725480711,5/25/2015 08:43:28,1642943736,5/25/2015 08:43:21,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,0,62,,,4,75,PAIN,ACETAMINOPHEN,PAIN,0,62,ACETAMINOPHEN.,Pain without inflammation is usually more safely treated with acetaminophen.,0,62,0,62,-1,4,75,TWrex-cause,804167,Pain without inflammation is usually more safely treated with acetaminophen,pain,acetaminophen
725480711,5/25/2015 08:51:04,1642945018,5/25/2015 08:50:48,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,0,62,,,4,75,PAIN,ACETAMINOPHEN,PAIN,0,62,ACETAMINOPHEN.,Pain without inflammation is usually more safely treated with acetaminophen.,0,62,0,62,-1,4,75,TWrex-cause,804167,Pain without inflammation is usually more safely treated with acetaminophen,pain,acetaminophen
725480711,5/25/2015 08:55:13,1642945701,5/25/2015 08:54:56,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,0,62,,,4,75,PAIN,ACETAMINOPHEN,PAIN,0,62,ACETAMINOPHEN.,Pain without inflammation is usually more safely treated with acetaminophen.,0,62,0,62,-1,4,75,TWrex-cause,804167,Pain without inflammation is usually more safely treated with acetaminophen,pain,acetaminophen
725480711,5/25/2015 08:58:16,1642946171,5/25/2015 08:58:01,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,0,62,,,4,75,PAIN,ACETAMINOPHEN,PAIN without inflammation is usually more safely treated with acetaminophen.,0-5-13-26-29-37-42-49-57-62,0-5-13-26-29-42-49-57-62-37,Pain without inflammation is usually more safely treated with ACETAMINOPHEN.,Pain without inflammation is usually more safely treated with acetaminophen.,0,62,0,62,-1,4,75,TWrex-cause,804167,Pain without inflammation is usually more safely treated with acetaminophen,pain,acetaminophen
725480711,5/25/2015 09:01:13,1642946586,5/25/2015 09:00:51,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,0,62,,,4,75,PAIN,ACETAMINOPHEN,PAIN,0,62,ACETAMINOPHEN.,Pain without inflammation is usually more safely treated with acetaminophen.,0,62,0,62,-1,4,75,TWrex-cause,804167,Pain without inflammation is usually more safely treated with acetaminophen,pain,acetaminophen
725480712,5/25/2015 11:58:38,1642988211,5/25/2015 11:58:24,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,35,11,,,44,24,INFECTION,MYCOBACTERIUM,INFECTION,35,11,MYCOBACTERIUM,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.",35,11,35,11,1,44,24,TWrex-cause,811820,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome",infection,mycobacterium
725480712,5/25/2015 12:45:12,1642998202,5/25/2015 12:44:55,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,35,11,,,44,24,INFECTION,MYCOBACTERIUM,Pulmonary Mycobacterium kansasii INFECTION,0-11-25-35,0-11,Pulmonary MYCOBACTERIUM,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.",35,11,35,11,1,44,24,TWrex-cause,811820,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome",infection,mycobacterium
725480712,5/25/2015 12:54:33,1642999976,5/25/2015 12:52:37,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,35,11,,,44,24,INFECTION,MYCOBACTERIUM,Mycobacterium kansasii INFECTION,11-25-35,11,MYCOBACTERIUM,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.",35,11,35,11,1,44,24,TWrex-cause,811820,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome",infection,mycobacterium
725480712,5/25/2015 13:00:58,1643001147,5/25/2015 13:00:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,35,11,,,44,24,INFECTION,MYCOBACTERIUM,Pulmonary Mycobacterium kansasii INFECTION,0-11-25-35,0-11-25-35,Pulmonary MYCOBACTERIUM kansasii infection,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.",35,11,35,11,1,44,24,TWrex-cause,811820,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome",infection,mycobacterium
725480712,5/25/2015 13:12:55,1643003158,5/25/2015 13:12:02,false,prodege,1.0,6309240,USA,CA,San Diego,50.113.93.215,35,11,,,44,24,INFECTION,MYCOBACTERIUM,Pulmonary Mycobacterium kansasii INFECTION,0-11-25-35,0-11,Pulmonary MYCOBACTERIUM,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.",35,11,35,11,1,44,24,TWrex-cause,811820,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome",infection,mycobacterium
725480712,5/25/2015 13:16:13,1643003844,5/25/2015 13:16:04,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,35,11,,,44,24,INFECTION,MYCOBACTERIUM,Pulmonary Mycobacterium kansasii INFECTION,0-11-25-35,0-11-25-35,Pulmonary MYCOBACTERIUM kansasii infection,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.",35,11,35,11,1,44,24,TWrex-cause,811820,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome",infection,mycobacterium
725480712,5/25/2015 13:17:26,1643004124,5/25/2015 13:17:11,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,35,11,,,44,24,INFECTION,MYCOBACTERIUM,Pulmonary Mycobacterium kansasii INFECTION,11-25-35-0,0-11-25-35,Pulmonary MYCOBACTERIUM kansasii infection,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.",35,11,35,11,1,44,24,TWrex-cause,811820,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome",infection,mycobacterium
725480712,5/25/2015 13:20:49,1643004766,5/25/2015 13:20:18,false,neodev,1.0,31326282,NLD,"","",82.169.243.65,35,11,,,44,24,INFECTION,MYCOBACTERIUM,Pulmonary Mycobacterium kansasii INFECTION,0-11-25-35,0-11-25-35,Pulmonary MYCOBACTERIUM kansasii infection,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.",35,11,35,11,1,44,24,TWrex-cause,811820,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome",infection,mycobacterium
725480712,5/25/2015 13:21:03,1643004821,5/25/2015 13:20:39,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,35,11,,,44,24,INFECTION,MYCOBACTERIUM,kansasii INFECTION,25-35,0-11,Pulmonary MYCOBACTERIUM,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.",35,11,35,11,1,44,24,TWrex-cause,811820,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome",infection,mycobacterium
725480712,5/25/2015 13:21:09,1643004851,5/25/2015 13:20:54,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,35,11,,,44,24,INFECTION,MYCOBACTERIUM,Pulmonary Mycobacterium kansasii INFECTION,0-11-25-35,0-11-25-35,Pulmonary MYCOBACTERIUM kansasii infection,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.",35,11,35,11,1,44,24,TWrex-cause,811820,"Pulmonary  Mycobacterium kansasii  infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome",infection,mycobacterium
725480713,5/25/2015 08:19:53,1642939537,5/25/2015 08:19:39,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,13,44,,,25,54,HYPERTENSION,METHYLDOPA,HYPERTENSION,13,44,METHYLDOPA:,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.,13,44,13,44,-1,25,54,TWrex-cause,800850,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study,hypertension,methyldopa
725480713,5/25/2015 08:49:05,1642944665,5/25/2015 08:48:51,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,13,44,,,25,54,HYPERTENSION,METHYLDOPA,HYPERTENSION,13,44,METHYLDOPA:,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.,13,44,13,44,-1,25,54,TWrex-cause,800850,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study,hypertension,methyldopa
725480713,5/25/2015 08:49:24,1642944741,5/25/2015 08:49:06,false,elite,1.0,26544151,GBR,"","",213.205.252.245,13,44,,,25,54,HYPERTENSION,METHYLDOPA,HYPERTENSION,13,44,METHYLDOPA:,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.,13,44,13,44,-1,25,54,TWrex-cause,800850,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study,hypertension,methyldopa
725480713,5/25/2015 08:56:44,1642945929,5/25/2015 08:56:27,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,13,44,,,25,54,HYPERTENSION,METHYLDOPA,HYPERTENSION,13,44,METHYLDOPA:,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.,13,44,13,44,-1,25,54,TWrex-cause,800850,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study,hypertension,methyldopa
725480713,5/25/2015 09:02:19,1642946714,5/25/2015 09:01:54,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,13,44,,,25,54,HYPERTENSION,METHYLDOPA,HYPERTENSION,13,44,METHYLDOPA:,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.,13,44,13,44,-1,25,54,TWrex-cause,800850,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study,hypertension,methyldopa
725480713,5/25/2015 09:11:29,1642948025,5/25/2015 09:11:15,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,13,44,,,25,54,HYPERTENSION,METHYLDOPA,Treatment of HYPERTENSION in pregnancy with methyldopa:,0-10-13-26-29-39-44,0-10-26-29-39-44-13,Treatment of hypertension in pregnancy with METHYLDOPA:,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.,13,44,13,44,-1,25,54,TWrex-cause,800850,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study,hypertension,methyldopa
725480713,5/25/2015 09:18:58,1642949142,5/25/2015 09:17:50,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,13,44,,,25,54,HYPERTENSION,METHYLDOPA,HYPERTENSION,13,44,METHYLDOPA:,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.,13,44,13,44,-1,25,54,TWrex-cause,800850,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study,hypertension,methyldopa
725480713,5/25/2015 09:31:23,1642951135,5/25/2015 09:31:08,false,clixsense,1.0,6340330,USA,NY,Canajoharie,67.248.115.74,13,44,,,25,54,HYPERTENSION,METHYLDOPA,HYPERTENSION,13,44,METHYLDOPA:,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.,13,44,13,44,-1,25,54,TWrex-cause,800850,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study,hypertension,methyldopa
725480713,5/25/2015 09:47:52,1642953822,5/25/2015 09:46:04,false,clixsense,1.0,26492726,GBR,C2,Halifax,2.103.117.226,13,44,,,25,54,HYPERTENSION,METHYLDOPA,HYPERTENSION,13,44,METHYLDOPA:,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.,13,44,13,44,-1,25,54,TWrex-cause,800850,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study,hypertension,methyldopa
725480713,5/25/2015 09:54:25,1642954714,5/25/2015 09:54:11,false,clixsense,1.0,24763049,GBR,Y8,Welshpool,81.135.56.139,13,44,,,25,54,HYPERTENSION,METHYLDOPA,HYPERTENSION,13,44,METHYLDOPA:,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.,13,44,13,44,-1,25,54,TWrex-cause,800850,Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study,hypertension,methyldopa
